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Abstract 
Global methylation of the human genome has led to the depletion of CpG dinucleotides. 
CpG islands (CGIs) represent a conspicuous exception to this rule as they generally lack 
cytosine methylation and are characterised by clustered CpG dinucleotides. These sequences 
are non-randomly distributed throughout the genome, colocalising with approximately 60% 
of gene promoters. CGIs generally associate with transcription start sites (TSSs), a small 
proportion of which are normally methylated and correlate with gene inactivity. This 
phenomenon is best characterised in the context of X-inactivation, where the majority of 
CGIs are specifically methylated on one of the two X chromosomes. Aberrant CGI 
methylation is also a common feature of neoplastic cells and has been suggested to play a 
role in tumour development and propagation. 
We devised a preparative chromatographic tool for the enrichment of CGI sequences based 
on the empirical criterion of clustered nonmethylated CpGs. Characterisation of a novel 
somatic CGI set derived from human blood DNA identified a population of islands which 
were missed by commonly applied bioinformatic criterion. The identified CGIs were 
enriched in gene rich portions of the genome, and preferentially associated with chromosome 
ends proximal to the telomeres. Despite association with gene promoters, approximately fifty 
percent of CGIs were found to be either intra- or intergenic. An arrayed set, comprising 
-.17,000 unique sequences, allowed the investigation of the methylated CGI component of 
human blood, brain, muscle and spleen. This identified 6-8% of normally methylated CGIs 
across the 22 human autosomes. These hypermethylated islands were enriched in regions 
distal to annotated promoters and preferentially associated with developmental gene loci. 
The reagents and observations discussed in this thesis allow detailed analysis of the 
abundance and distribution of methylated CGIs in 'normal' human somatic cells. 
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Chapter 1: 	Introduction 
Approximately 40 rounds of cell division are required to generate the 10x1013 cells 
comprising the human body. These can be subdivided into more than 700 phenotypically 
distinct cell types, the function and identity of which are dictated by the specific expression 
pattern of approximately 22,000 protein coding genes. These patterns are maintained via a 
highly orchestrated transcriptional regulatory system following cell type specification. The 
mechanisms governing the identity of these cells are highly complex, requiring cell specific 
signals to translate the same genetic material into the protein composition required for 
specific cellular functions. Despite the fact that this system is regulated by sequence specific 
transcription factors, these alone cannot account for the functional diversity of these 
genetically identical human cells. Accordingly, non-genetic information, in the form of 
epigenetic modifications, is also required for correct gene regulation. 
1.1 Epigenetics 
The prefix Epi- describes an event which occurs 'upon' and therefore Epigenetic literally 
translates into 'upon the gene'. Epigenetics, in its simplest form, refers to any modulation of 
cellular phenotype which is not directly encoded in the DNA sequence. A recent definition 
states: "the structural adaptation of chromosomal regions so as to register, signal or 
perpetuate altered activity states" (Bird, 2007). This includes various contemporary features 
of cell biology such as the Polycomb and Trithorax system, histone modifications and DNA 
methylation. 
The initial sequencing of the human genome seven years ago, heralded a new era for global 
sequence based analysis (Lander et al., 2001). In particular, this has allowed the generation 
of DNA microarrays which have been applied to the dissection of epigenetic features on a 
genome wide scale. Moreover, programmes such as the HEP (Human Epigenome Project), 
HEROIC (High-throughput Epigenetic Regulatory Organisation In Chromatin) and 
ENCODE (ENCyclopedia Of DNA Elements) have provided extensive information 
regarding the global distribution of human epigenetic components (Birney et al., 2007; 
Eckhardt et al., 2004; Eckhardt et al., 2006; ENCODE Project Consortium, 2004). 
Epigenetic mechanisms serve to increase the coding potential of the DNA sequence by 
providing information regarding an activity state, either past or present. Transcription in 
small bacterial genomes is regulated principally by sequence specific transcription factors, 
which bind their cognate sites and elicit an effect. Eukaryotic genomes are many orders of 
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magnitudes bigger than their bacterial counterparts and may have evolved epigenetic 
mechanisms to reduce the effective complexity of the genome. Condensed chromatin, as 
dictated by epigenetic factors, restricts access to the majority of the non coding portion of the 
genome, and consequently facilitates association of transcriptional machinery to their 
cognate sites. This concept has led to the idea that chromatin serves as a modulator of 
transcriptional permissivity. However, genetic studies have determines that various core 
components of epigenetic mechanisms are essential in mammals (Li et al., 1992; Okano et 
al., 1999). This suggests that epigenetic systems may not merely 'fine tune' the genome but 
rather play a fundamental role in its architecture and gene regulation. Consequently, 
chromatin modifications, polycomb/Trithorax proteins and DNA methylation have all been 
investigated in a bid to elucidate their function in genomic regulation. The following section 
provides a brief overview of chromatin structure to provide a context for the discussion of 
epigenetic systems discussed in this thesis. 
1.1.1 Chromatin Modulation 
Eukaryotes package their genetic material into a nucleoprotein structure referred to as 
chromatin. Chromatin provides a structure which can be modulated to elicit compaction (up 
to 10,000 fold) or accessibility of the DNA as is required for specific biological processes 
(Fig. 1.1-1). The nucleosome represents the core component of this structure which is 
composed of approximately 150bp of DNA wrapped around an octamer of four conserved 
histone proteins (H3, H4, H2A and H2B; (Luger et al., 1997)). The fundamental role for this 
structure is to spatially and temporally modulate DNA accessibility to facilitate cellular 
processes (Kouzarides, 2007; Li et al., 2007a). What mechanisms mediate the physical 
properties of chromatin to afford such dynamic functionality? 
Covalent Chromatin Modifications 
Histones are largely globular proteins with the exception of their highly unstructured amino 
terminal tails which protrude past the DNA (Luger et al., 1997). These tails serve as a 
scaffold on which numerous posttranslational modifications can be bestowed. These 
modifications include; Methylation (me), Phosphorylation (ph), Acetylation (ac); ADP 
ribosylation (ar), IJbiquitination (ub) and Sumoylation (su). In excess of 100 modifications 
have been identified, owing to their ability to occur on multiple amino acids and, in the case 























Figure 1.1-1. Compaction of nuclear DNA 
Eukaryotic DNA is assembled into chromatin, by superhelical wrapping around histone octamers to 
comprise nucleosomes. The lOnm fiber is further compacted into higher order structures which 
comprise s chromosomal heterochromatin (Figure adapted from http://employees.csbsju 
.edu/hjakubowski/classes/ch331/dna/chromosome .gif) 
These modifications can largely be partitioned into two distinct categories representing open 
transcriptionally permissive and restrictive transcriptionally inert chromatin conformations. 
With respect to transcription, H3K4me2, H3K4me3, H3K36me3, H3K27mel, H3K9mel, 
H3/1-14ac, H4K20mel, H2BK5meI and H213ubl have all been associated with 
transcriptional activity in mammalian cells (Barski et al., 2007; Bernstein et al., 2005; 
Kouzarides, 2007; Li et al., 2007a; Rob et al., 2005). Alternatively, H3K9me2, H3K9me3, 
H3K27me3 and hypoacetylation of H3/H4 have been associated with transcriptional 
silencing (Barski et al., 2007; Kouzarides, 2007). This is not an exhaustive list and additional 
modifications appear to be involved in both activation and repression in a context specific 
manner (Barski et al., 2007; Bernstein et al., 2005; Kouzarides, 2007; Li et al., 2007a; Roh et 
al., 2005). Acetylation effects transcription by directly altering the physical characteristics of 
chromatin. The acetyl groups neutralise the positive charge of the histone tails, destabilizing 
inter-nucleosome interactions and facilitating chromatin decondensation (Luger et al., 1997). 
Alternatively, histone modifications can provide binding sites which recruit protein factors 
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and facilitate or antagonize transcription. Methylation of H3K9 and H3K27 recruits 
heterochromatin proteini (HP1) and Polycomb (Pc) respectively which maintain 
transcriptional silencing through formation of a repressive chromatin environment (Bannister 
et al., 2001; Cao and Zhang, 2004; Lachner et al., 2001). Alternatively, H3K4 methylation 
directly associates with the basal transcriptional machinery in mammals whilst abrogating 
DNMT (DNA Methyltransferase) binding to facilitate transcriptional activity (Ooi et al., 
2007; Vermeulen et al., 2007). These modifications can mediate cross-talk between different 
epigenetic systems. This is highlighted by the requirement for H3K9me3 in N. crassa which 
is essential for establishing DNA methylation patterns (Tamaru et al., 2003). 
The existence of a histone code has been proposed, which implies that a combination of 
posttranslational modifications will dictate and therefore predict a transcriptional state 
(Margueron et al., 2005; Nightingale et al., 2006). In light of these observations this 
proposition is logical; however it provides a somewhat 'black and white' view of chromatin 
regulation. Modifications which are often associated with transcriptional activity or inertia 
do not always concord with the observed transcriptional state (Bernstein et al., 2006). 
Moreover, this notion does not directly account for transcriptional factors which 
fundamentally govern gene expression levels. This is not to say that epigenetic modifications 
do not underpin transcriptional regulation. Indeed if this was not the case, treatments with 
pharmacological agents such as 5-Azacytidine (5AzaC) and TSA (Trichostatin A) would 
have little effect on global expression patterns, which is not consistent with experimental 
observations (Hansen and Gartler, 1990; Mohandas et al., 1981; Yoshida et al., 1995). The 
evidence suggests that histone modifications facilitate or abrogate access to functionally 
important DNA sequences. These would serve to reduce the complexity of large genomes, 
and mediate the correct localisation of transcription factors to their cognate sites (Bird, 
2002). 
Chromatin remodeling and Histone Replacement 
Interaction between sequence specific protein factors and DNA can be precluded by 
nucleosomes (Saha et al., 2006; Varga-Weisz, 2001). In the 'ground state', nucleosome 
positioning is largely dictated by DNA sequence composition, which provides 
thermodynamically favorable localisation sites (Ioshikhes et al., 2006; Satchwell et al., 
1986). However, nucleosome translocation along DNA can allow specific DNA sequence to 
become accessible or occluded for protein factor interactions which can effect gene 
expression (Muchardt and Yaniv, 1999; Saha et al., 2006; Sudarsanam et al., 2000). This 
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dynamic mechanism is provided by ATP-dependent nucleosomal remodeling, intrinsic to 
several families of multisubunit protein complexes. Mammalian co-repressor complexes 
such as NuRD, contain chromatin remodeling components required for transcriptional 
repression (Le Guezennec et al., 2006; Zhang et al., 1999). 
Chromatin remodeling has also been implicated in replication independent histone 
replacement, whereby canonical histones are substituted for variants in response to cellular 
triggers including transcription and DNA damage (Mizuguchi et al., 2004). H3.3 is a variant 
H3 isoform which differs from H3.1 (the major form) by 4 amino acids. Unlike H3.1, this 
variant can be deposited onto active chromatin independently of DNA replication (Ahmad 
and Henikoff, 2002). This has been suggested to facilitate transcription via the erasure of 
inactivating chromatin modifications such H3K9 methylation (Ahmad and Henikoff, 2002; 
Janicki et al., 2004). A second H3 isoform, CENPA, is a component of centromere specific 
nucleosomes. CENPA is required for the establishment of centromeric heterochromatin, and 
provides a scaffold for the recruitment of kinetochore proteins involved in spindle formation 
and chromosome segregation during mitosis (Smith, 2002). The 112A variants H2AZ and 
H2AX facilitate nucleosome expulsion and DNA repair respectively. H2AZ, is localised to 
the promoter proximal regions of active genes, and has been proposed to have a role in 
destabilizing chromatin to facilitate transcription ((Schones et al., 2008) and references 
therein). H2AX localizes throughout the genome and becomes rapidly phosphorylated in 
response to double strand breaks (Redon et al., 2002). Possibly, one of the most striking 
examples of histone replacement occurs during the formation of the male germ line. 
Spermatocyte heterochromatin is restructured by replacing histones with protamines. 
Protamines are unrelated to histones and result in the formation of a distinct, highly 
compacted nucleoprotein structure which is highly condensed with respect to somatic 
chromatin (Wouters-Tyrou et al., 1998). Both chromatin remodeling and nucleosome 
replacement provide mechanisms by which chromatin structure can be modulated in 
response to cellular signals. 
1.1.2 Polycomb and Trithorax proteins 
Polycomb (PcG) and Trithorax (TrxG) proteins represent two classes of antagonistic factors 
which are highly conserved in metazoans. They were first characterised based on mutational 
phenotypes which resembled those of homeotic genes in Drosophila (Kennison, 1995). They 
function to regulate and memorise transcriptional activity of developmental genes, and 
maintain the expression state even when the initial cues are diminished. They exert their 
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influence on transcription by modulating the activity of specific chromatin loci through 
histone modification and nucleosome remodeling. Such mechanisms are required to maintain 
cellular identity through maintenance of appropriate gene activity in differentiated cells (Cao 
and Zhang, 2004; Schuettengruber et al., 2007). 
PcG proteins are negative regulators of developmental gene expression, and are broadly 
categorised into two repressive multisubunit complexes. The PRC1 (Polycomb repressive 
complex 1) contains the archetypal Polycomb protein (HPC1-3)', HPHI-3 (Polyhomeoitic), 
BMI1 (BMI1 polycomb ring finger oncogene) and R1NGIA/B. The RING proteins can 
modify histone H2A by the addition of ubiquitin on Kl 19 (de Napoles et al., 2004). The 
second complex is PRC2 (Polycomb repressive complex 2) which catalyses the formation of 
H3K27me2 and me3 (Cao and Zhang, 2004). This activity is provided by EZH2 (Enhancer 
of Zeste homologue 2) which in combination with EED (Embryo Ectoderm Development), 
SUZ12 (Suppressor of Zeste 12) and RbAp48 comprise the core of the PRC2 complex (Cao 
and Zhang, 2004; Schuettengruber et al., 2007). 
PcG proteins are required to mediate the correct expression of lineage specific genes during 
cellular differentiation (Cao and Zhang, 2004; Chamberlain et al., 2008). Consistent with 
this, genes which associate with SUZ12 in human Embryonic Stem (ES) cells were 
preferentially activated during artificial differentiation (Lee et al., 2006). Tissue specific 
genes not required in a particular cell lineage maintained SUZ12 association at the promoter 
consistent with transcriptional inactivity (Lee et al., 2006). PRC1 can be recruited to 
chromatin bearing H3K27 methylation via interaction with the chromodomain of the 
polycomb protein. This interaction provides a mechanism whereby the activity of PRC2 can 
facilitate PRC1 association with chromatin (Cao and Zhang, 2004; Schuettengruber et al., 
2007). 
The ncRNA (non-coding RNA) HOTAIR, was recently shown to recruit PRC2 to the HOXD 
locus and was required for H3K27 methylation (Rinn et al., 2007). During mammalian X 
inactivation, both PRC1 and PRC2 are recruited to the inactive X chromosome (de Napoles 
et al., 2004; Plath et al., 2003). However PRC1 can associate independently of PRC2 via an 
interaction with the ncRNA; Xist (The role of PcG in X inactivation will be discussed later; 
(Schoeftner et al., 2006). These data suggest that PRC1 and PRC2 recruitment can be 
facilitated by interaction with RNA molecules. 
All PcG and TrxG subunits are named as per the human nomenclature. 
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TrxG proteins are involved in memorising and propagating transcriptional activity. In 
humans, the SWIISNF and NURF TrxG complexes provide remodeling activities whereas 
the MLL1-3 complex contains a histone methyl transferase (HMTase) (Schuettengruber et 
al., 2007). The in vitro chromatin remodeling activity of the SWIJSNF complex was shown 
to be abolished by purified PRC1 from Drosophila extracts (Shao et al., 1999). MLL 
contains a SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain which specifically 
methylates H3K4 (Dou et al., 2005; Nakamura et al., 2002). Interestingly, both the MLL and 
CFP1 (CGBP) components of the MLLI-3 complex possess CXXC motifs which have been 
shown to bind DNA containing non-methylated CpG sites (Birke et al., 2002; Voo et al., 
2000). A recent study, investigating histone methylation in murine ES cells, indicated that 
the vast majority of CpG Island (CGI) promoters were trimethylated at H3K4 sites 
(Mikkelsen et al., 2007). Moreover TFIID, a multisubunit component of the mammalian 
basal transcription machinery, has been shown to interact with trimethylated H3K4 
(Vermeulen et al., 2007). This suggests a possible link between the underlying DNA 
methylation status and activation of developmental genes. 
Recent, analysis of conserved regions of the mouse genome led to the identification of 
'bivalent chromatin domains', comprising large domains of H3K27me3, over-laid with more 
discrete regions of H3K4me3 (Bernstein et al., 2006; Mikkelsen et al., 2007). Consistent 
with the functional role of the PcG and TrxG complexes which distribute the modifications; 
these regions were found to associate with cell type specific genes. It has been proposed that 
the combination of these opposing marks, maintains these genes in a poised state to be 
activated or repressed during linage specification. These domains generally resolve into 
either the K4 or K27 methylated states which correspond with gene activity and repression 
respectively (Fig. 1.1-I; (Bernstein et al., 2006; Mikkelsen et al., 2007)). 
Recently, there has been extensive characterisation of chromatin modifying enzymes which 
can specifically demethylate lysine residues on histone tails (reviewed in (Klose and Zhang, 
2007)). Such activities could conceivably facilitate the resolution of these domains during 
cellular differentiation. The TrxG protein UTX (Ultratrithorax) was characterised as an 
H3K27 di- and trimethyl specific demethylase (Agger et al., 2007). Moreover, proteomic 
analysis determined that UTX could physically associate with the MLL histone 
methyltransferase complex in HEK293 nuclear extracts (Lee et al., 2007a). This interaction 
suggests a link between H3K4 methylation and H3K27 demethylation during development 
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(Agger et al., 2007; Lee et al., 2007a). Conversely, the Drosophila Lid (Little Imaginal Disc) 
protein can catalyse the removal of H3K4 di- and tn-methyl marks. Lid is related to the 
mammalian JARID family members, and although no equivalent protein has been described 
in mammals, LSDI, an unrelated protein can demethylate H3K4me2 (Lee et al., 2007b; Shi 
et al., 2004). The identification of PcG and TrxG proteins which can dynamically methylate 
and demethylate these opposing marks provides a possible mechanism for the resolution of 
bivalent domains upon lineage commitment (Fig. 1.1-2). 
Bivalent Domain - Pluripotent Cells 
Tissue A TF 
SWIISNF 
K4Me3 Domain - Tissue A 	 K27Me3 Domain - Tissue B 
Active Tissue - gene A 	 Repressed Tissue - gene A 
MLLl - 	 LSDI 
UTX 	TFIID 
r 
SWI/SNF 	 SWI/SNF 
Figure 1.1-2. PcG, TrxG and Bivalent Chromatin Domains 
Hypothetical schematic representing the mechanism whereby bivalent chromatin domains may be 
resolved by the PcG and TrxG proteins upon tissue differentiation. In ES cells the bivalent domains are 
maintained by the H3K27 HMTase activity of the PRC2 complex (filled blue circles) which then recruits 
the PRC1 complex (filled green circles) via interaction with the methyl moiety. PRC1 then ubiquitinates 
H2A tails at lysine 119 (data based on evidence from X inactivation; (de Napoles et al., 2004)). 
Chromatin remodeling by the SWI/SNF complex (filled orange ovals) is antagonized by the presence of 
PRC1. MLL1 -3 (filled red ovals) trimethylates H3K4, but is insufficient to induce promoter activity due to 
the presence of the inactive marks, and lack of chromatin remodeling. Upon differentiation, the 
domains may then be resolved by either the demethylase activities of UTX (filled green circle) or a Lid 
like JARID protein (filled green ovals). In the active state SWI/SNF may afford promoter access by 
nucleosome remodeling and in conjunction with TFIID facilitate transcription. H3K4me3 (small red 
circles) and H3K27me3 (small blue circles) are indicated. 
Drosophila PcG and TrxG have the ability to stably transmit memory of transcriptional 
activity through mitosis and meiosis (Cavalli and Paro, 1998). How do these proteins and 
their modifications memorise the transcriptional state following cellular division? It is 
22 
possible that semi-conservative nucleosomal replacement provides a template to perpetuate 
these modifications following S-phase (Martin and Zhang, 2007). Alternatively, large 
kilobase tracts of H3K27 methylation may facilitate the modification of newly assembled 
chromatin through association with PRC2 present downstream of the replication forks 
(Bernstein et al., 2006; Cao and Zhang, 2004; Mikkelsen et al., 2007). Another possibility is 
that DNA methylation status or other external factors could recruit PcG and TrxG proteins 
following replication. Accordingly, depletion of DNMT1 in the human U205 cells was 
shown to disrupt the localisation of PRC1 subunits (Hernandez-Munoz et al., 2005). The 
rapid accumulation of knowledge pertaining to this field will hopefully provide mechanistic 
insight into the heritable nature of the PcG and TrxG systems. 
1.2 DNA Methylation 
The epigenetic mechanisms so far discussed involve alteration of chromatin structure via 
modulation of its protein components. However, DNA bases can be chemically modified 
directly through the addition of methyl-groups to the carbon-5 (C5) and carbon-6 (C6) 
positions of cytosine and adenine bases respectively. DNA methylation exists in all 
kingdoms of life, although the distribution of the methyl mark varies widely between 
species. Functionally it has been implicated in transcriptional repression, mammalian 
imprinting, suppression of transposition and recombination and chromatin organisation. 
1.2.1 Distributive Diversity of DNA methylation 
DNA Methylation in Fungi 
5-Methylcytosine (5MeC) is the most prevalent modified base in eukaryotes, although not all 
species possess the modification. In fungi, neither of the ascomycetes S. cen'isiae and S. 
pombe possesses DNA methylation (Proffitt et al., 1984). In contrast, the filamentous fungi 
Neurospora crassa has methyl-cytosine levels comparable to that observed in mammals 
(Selker et al., 2003). In Neurospora, DNA methylation is almost exclusively localised to 
relics of repetitive elements, disrupted by RIP (Repeat induced Point mutation; (Selker, 
2002; Selker et al., 2003)). Consistent with this idea, ablation of DNA methylation via 
5AzaC treatment has been shown to reactivate transposition (Zhou et al., 2001). The related 
species Ascobolus shows a similar methylation distribution which has been implicated in the 
repression of deleterious recombination events (Maloisel and Rossignol, 1998). This data is 
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consistent with DNA methylation providing a genome defense mechanism against parasitic 
DNA elements. 
DNA Methylation in Plants 
A broad spectrum of DNA methylation composition is observed in plant species. The 
Arabidopsis genome (120Mb) contains 6% 5MeC which is approximately quarter of the 
level found in the maize genome (2500Mb; (Bender, 2004)). In contrast to most eukaryotes, 
Arabidopsis contains methylation in the context of both CpG, and non CpG sequences. The 
methylation is distributed across repetitive sequences including telomeric, centromeric and 
pericentromeric chromatin as well as transposable elements (Cokus et al., 2008; Zhang et al., 
2006; Zilberman et al., 2007). The majority of genes are completely unmethylated, however 
approximately 20-30% are heavily methylated at CpG" dinucleotides which correlate with 
transcriptional activity (Cokus et al., 2008; Zhang et al., 2006; Zilberman et al., 2007). In 
contrast, the small proportion of genes which possess promoter methylation show a more 
tissue restricted expression profile (Zhang et al., 2006). Met] mutation results in the 
expression of pseudogenes and transposons suggesting that CpG methylation is required for 
transcriptional repression (Zhang et al., 2006). Similar to various fungi, this data is indicative 
of a central genome defense function for DNA methylation in plants. 
DNA Methylation in Invertebrates 
DNA methylation has been most extensively investigated in animals, which has provided a 
detailed picture of its genomic distribution (Tweedie et al., 1997). Invertebrates invariably 
contain low level methylation relative to their vertebrate counterparts (Tweedie et al., 1997). 
Indeed nematodes such as Caenorhabditis elegans lack DNA methylation and only 0.4% of 
rneCpG (Methyl-CpG) is detected during early Drosophila embryogenesis (Gutierrez and 
Sommer, 2004; Lyko et al., 2000). The sea squirt (Ciona intestinalls) is a urochordate and 
therefore represents one of the most 'vertebrate-like' invertebrate species. It contains a 
mosaic pattern of DNA methylation which is reminiscent of more primitive invertebrates 
such as the sea urchin (Echinoderm) (Simmen et al., 1999; Suzuki et al., 2007). Methylation 
is present in distinct compartments and preferentially localizes to more than half of sea squirt 
genes, whilst showing no preference for repetitive elements (Simmen et al., 1999; Suzuki et 
al., 2007). Moreover, the methylated genes were found to be moderately expressed 
CpG methylation is catalysed by the Metl methyltransferase in Arabidopsis which is 
homologous to mammalian DNMT1 (Chan, S.W., Henderson, l.R., and Jacobsen, S.E. 
(2005). Gardening the genome: DNA methylation in Arabidopsis thaliana. Nature reviews 6, 
351-360.). 
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housekeeping genes, equivalent to a similar distribution in Arabidopsis (Suzuki et al., 2007; 
Zilberman et al., 2007). These findings illustrate that invertebrate genomes are divided up 
into compartments with respect to DNA methylation, and that transition boundaries between 
these domains can occur very sharply as illustrated in Ciona (Suzuki et al., 2007). 
DNA Methylation in Vertebrates 
Interestingly the development of a backbone coincides with a gross transition from fractional 
to global CpG methylation at the vertebrate invertebrate boundary (Tweedie et al., 1997). 
Analysis of vertebrate methylation indicated that even the genomes of jawless fish 
(Agnathans), the most primitive vertebrates, are heavily methylated (Tweedie et al., 1997). 
Whilst invertebrate gene methylation is largely restricted to those with housekeeping 
function", all vertebrate genes are methylated throughout the majority of their length (Suzuki 
et al., 2007; Tweedie et al., 1997). Moreover, ribosomal DNA (rDNA) sequences have 
acquired mosaic methylation in vertebrates consistent with intragenic methylation (Bird, 
1980; Tweedie et al., 1997). It is unclear whether genome defense is a major function of 
vertebrate DNA methylation as 5MeC is distributed globally and largely independent of 
specific sequence. However, global hypomethylation associated with human neoplasia has 
been shown to reactivate certain transposable elements suggesting that this function is 
important, but may be partially redundant with additional repressive mechanisms (Fukasawa, 
2005; Rodriguez et al., 2006). It has been posited that global methylation arose due to the 
increased gene content and genomic complexity of the vertebrate lineage (Bird, 1995). 
Therefore gross alteration of DNA methylation may have resulted in the acquisition of 
specialized functions to combat the increased transcriptional burden associated with 
expanded genome size (Colot and Rossignol, 1999). 
1.2.2 DNA Methylation in Mammals 
Genetic analysis has shown that DNA methylation is essential for mammalian development 
(Li et al., 1992; Okano et al., 1999). Somatic methylation is restricted to cytosines in the 
context of the palindromic dinucleotide CpG and, as for all vertebrates, is heavily methylated 
at the majority of these sites (approximately 70% of CpGs; (Ehrlich et al., 1982)). The 
genome can be categorised into two distinct fractions with respect to DNA methylation and 
sequence composition. The major fraction (-98%) is methylated at almost all CpGs sites 
and, due to the process of spontaneous deamination, is CpG deficient (-0.21 
Housekeeping genes, are characterised by ubiquitous expression in all or most cell types, 
indicative of a primary role in cellular regulation. 
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observed/expected CpG frequency; (Bird, 1980)). This fraction includes both intragenic 
regions, transposable elements and endogenous repeat sequences, although it is somewhat 
depleted for regulatory sequence elements (Eckhardt et al., 2006; Rollins et al., 2006; Weber 
et al., 2005). The minor fraction (<2%), is generally devoid of methylation and therefore 
shows little CpG suppression (Bird, 2002; Bird et al., 1995). This fraction represents short 
stretches of DNA sequence which are termed CpG Islands (see section 1.3; (Bird et al., 
1985)). 
Methylation patterns are established de novo, during gametogeneisis, embryogenesis and 
cellular differentiation (Reik, 2007; Reik et al., 2001; Weber and Schubeler, 2007). 
Consequently, there is a requirement for global demethylation to remove somatic 
methylation, and subsequent re-methylation to establish the appropriate genomic distribution 
during development. Reprogramming is required to erase epigenetic abnormalities which 
would otherwise be perpetuated across subsequent generations. Once established, 5MeC 
patterns are maintained through a postsynthetic semi-conservative copying mechanism (see 
section 1.2.4). 
Demethylation: Setting and Resetting the Methylation Stage 
In mammalian development there are two distinct phases in which DNA methylation is 
stripped from the genome. During gametogenesis, the primordial germ cells transit to the 
genital ridge prior to the formation of the gonads. During embryonic days 8-12.5 (E8-12.5), 
postmigratory germ cells undergo global demethylation including single copy genes, 
repetitive elements and parentally imprinted sequences (Hajkova et al., 2002; Kafri et al., 
1992; Lee et al., 2002; Maatouk et al., 2006). This temporal demethylation process is 
equivalent in both male and female embryos and is required to reprogram methylation 
patterns established in the preimplantation embryo. It is unclear whether demethylation at 
this stage is an active or passive process". A recent study identified extensive alterations in 
chromatin composition and modification both prior to and during the phase of demethylation 
(Hajkova et al., 2008). Global reduction of histone modifications during this period suggests 
that an active demethylation may proceed through a repair mechanism equivalent to that 
observed in plants (Hajkova et al., 2008). Prospermatogonia initiate de novo methylation at 
IV  There are two potential mechanisms whereby DNA methylation can be removed from DNA. 
Transient demethylation implies that cell division procedes in the absence of maintenance 
methylation at the replication forks which results in a 50% decrease in methylation level per 
cell division. Alternatively, active demethylation requires an enzymatic activity to catalyse the 
removal of the methyl moiety from the cytosine base. Active demethylation is independent of 
cell division and can result in extensive DNA hypomethylation very rapidly. 
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approximately E15-16 (Davis et al., 1999; Davis et al., 2000; Kafri et al., 1992; Lees-
Murdock et al., 2003; Ueda et al., 2000). Developing oocytes re-acquire DNA methylation at 
a later stage, with complete re-methylation being achieved post partum (Chaillet et al., 
1991). Temporal differences in de novo methylation during gamete maturation may reflect 
the substantial mechanistic differences between spermatogenesis and oogenesis. 
Reprogramming is required to activate pluripotency factors and to reinstate parent specific 
imprints which are essential for development (Maatouk et al., 2006). The global dynamics of 
DNA methylation during germ cell development are summarised in Fig. 1.2-1a. 
A second wave of DNA demethylation occurs during the first 7-cell divisions of 
embryogenesis prior to the formation of the blastocyst. In contrast to gametic demethylation, 
the temporal and mechanistic events are distinct for the maternal and paternal genomes. 
Upon fertilization, DNA derived from sperm is relatively methylated in comparison to that 
of the oocyte (Kafri et al., 1992; Mayer et al., 2000; Monk et al., 1987). The paternal 
pronucleus is then rapidly demethylated following zygote formation. This was elegantly 
illustrated in two studies through immunostaining with an antibody specific for 5MeC 
(Mayer et al., 2000; Santos et al., 2002). Demethylation was shown to occur rapidly, with 
extensive depletion of 5MeC by 4-6 hours post fertilization (Mayer et al., 2000; Oswald et 
al., 2000; Santos et al., 2002). This suggests demethylation proceeds via an active process as 
it occurs in the absence of cell division, although no enzymatic activity has thus far been 
identified (Santos et al., 2002). In contrast to this active process, the female pronucleus 
undergoes transient demethylation during the 4-6 cell division stage (Mayer et al., 2000; 
Santos et al., 2002). This passive demethylation is concomitant with a reduction in methyl-
transferase activity at this stage suggesting that it occurs due to lack of maintenance 
methylation following DNA synthesis (Monk et al., 1991). Global de novo methylation of 
both parental genomes is observed by the blastocyst stage of embryogenesis (Kafri et al., 
1992; Santos et al., 2002). This methylation is established by the de novo methyltransferases 
which are highly expressed during this phase of embryogenesis (see section 1.2.4). 
There are sequences which avoid demethylation, including lAP elements and parentally 
imprinted sequences (Howlett and Reik, 1991; Huntriss et al., 1998; Tremblay et al., 1997). 
A recent study identified Stella, a maternal specific protein factor which localizes to DNA. 
Genetic ablation of this protein is embryonically lethal and leads to hypomethylation at 
various imprinted regions and lAP elements, consistent with a role in maintenance of site 
specific methylation (Nakamura et al., 2007). Mechanistically, protection could be afforded 
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by steric hindrance of the demethylation machinery. Alternatively, maintenance of 
methylation at specific sites in the maternal genome may be facilitated by recruitment of 
Dnmt3L and associated de novo methyltransferases. This mechanism is supported by the 
observation that Dnmt3L deficiency results in the loss of parental specific methylation 
imprints in murine cells (Bourchis et al., 2001; Hata et al., 2006; Hata et al., 2002; Webster 
et al., 2005). Reprogramming of methylation during early embryonic development is 
summarised in Fig. 1.2-1b. 
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Figure 1.2-1. Global DNA Methylation Dynamics During Mammalian Development 
a) Schematic representation of methylation levels during gametogeneisis. Both paternal and maternal 
primordial germ cells (PGCs) are heavily methylated following de novo methylation in the 
preimplantation embryo. subsequently, global DNA demethylation occurs at approximately El 1 .5 
which is then followed by de novo methylation of the paternal PGCs at approximately E13.5. De novo 
methylation occurs later in the female germ line such that it is not complete until after birth. b) 
Schematic representation of methylation levels during embryogenesis. Upon fertilization, the paternal 
pronucleus is actively demethylated within 4-6 hours. Subsequently, the maternal genome is passively 
demethylated during cleavage stage cell divisions 4-6. Nuclear DNA from cells of the extraembryonic 
(EX) and embryonic (EM) lineages are then de novo methylated by the formation of the blastocyst, 




The mechanism of active DNA demethylation in mammalian cells remains elusive. 
Biochemical analysis has thus far been precluded by the limited quantities of protein 
available at these early developmental stages. However, in Arabidopsis site specific 
demethylation is achieved by the DNA glycosylase DEMETER, ROS1 and DML (Morales-
Ruiz et al., 2006; Penterman et al., 2007). Moreover, there have been studies which claim to 
have identified equivalent activities in mammalian systems, although confirmatory evidence 
has not been forthcoming (Bhattacharya et al., 1999; Ng et al., 1999). In murine cells 
demethylation of a regulatory site in the interleukin-2 (IL-2) promoter region, is required for 
activation of transcription during T-cell differentiation (Bruniquel and Schwartz, 2003). 
Furthermore, two recent studies indicate that methylation levels vary periodically at the 
pS2/17'F] promoter upon oestrogen activation. Intriguingly, it has been proposed that methyl 
groups are removed by deamination facilitated by the DNMTs themselves (Kangaspeska et 
al., 2008; Metivier et al., 2008). The role of DNA demethylation during embryogenesis and 
the potential for more specific functions in terminally differentiated cells, will likely fuel 
future investigation into this enigmatic process. 
1.2.3 Function of Mammalian DNA Methylation 
Mice deficient for the major DNMTs have reduced DNA methylation levels and die during 
embryogenesis (Li et al., 1992; Okano et al., 1999). Also global hypomethylation and 
concomitant gross chromosomal rearrangements are common features of neoplasia (Jones, 
2002). The severe consequence caused by perturbations in correct genome-wide methylation 
levels illustrates the functional importance of DNA methylation in mammalian cells. 
Transcriptional Repression 
One of the best characterised functions of DNA methylation is transcriptional repression. 
Initial evidence supporting this mechanism came from reporter assays carried out in the 
oocytes of the amphibian Xenopus laevis. Expression of Ade2 driven from the E2a promoter 
region of adenovirus was extinguished upon artificial introduction of methyl-groups within 
this sequence (Vardimon et al., 1982). An equivalent result was observed when the coding 
sequence of APRT was transfected into mouse L-cells (Stein et al., 1982). More recently, 
global methylation analysis using DNA microarrays identified a panel of gene promoters 
which associate with methylated CGIs. These methylated islands were found to be devoid of 
RNA polymerase II, and therefore transcriptionally silent (Weber et al., 2007). However 
these observations do not preclude the possibility that DNA methylation is a secondary event 
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during transcriptional silencing. Several independent studies have described the initiation of 
transcriptional repression prior to the accumulation of DNA methylation (Gautsch and 
Wilson, 1983; Lock et al., 1987). A striking example of this occurs during X-inactivation. A 
coordinated process leads to transcriptional repression of the majority of genes on one of the 
two X chromosomes. Despite the requirement for DNA methylation in this process, de novo 
methylation does not accumulate at gene promoters until after transcriptional repression is 
completed (Csankovszki et al., 2001; Gilbert and Sharp, 1999; Lock et al., 1987; Norris et 
al., 1991; Tribioli et al., 1992; Wutz and Jaenisch, 2000; Yen et al., 1984). These findings 
indicate that DNA methylation may facilitate stable transcriptional silencing, rather than 
being directly involved in its establishment. However, the application of the DNA 
methyltransferase inhibitor 5AzaC was shown to reactivate certain genes that were 
previously methylated on the inactive X chromosome (Xi; (Mohandas et al., 1981)). The role 
in transcriptional repression is further complicated by the observation that tissue-specific 
gene promoters containing low density CpG methylation can initiate transcription efficiently 
(Weber et al., 2007). 
TFs bind to regulatory elements and recruit RNA polymerase II (RNA poll) to initiate 
transcription (Fig. 1.2-2a; (Ptashne, 2005)). In light of this fact, there are two tenable 
mechanisms whereby methylation-dependent transcriptional repression could be achieved. 
The first is via direct steric hindrance of TF binding where methyl-groups located in the 
major groove antagonize association with consensus sites (Fig. 1.2-2b). Consistently, 
methylation of the recognition sites of the transcription factors E2F1, MLTF and ETS have 
been shown to inhibit DNA binding concomitant with transcriptional repression (Campanero 
et al., 2000; Gaston and Fried, 1995; Watt and Molloy, 1988). Further support was provided 
by investigation of the chromatin boundary element CTCF, which functions as an insulator, 
separating promoters from distal enhancer elements (Filippova, 2008). CTCF binding is 
inhibited by DNA methylation which is known to function in imprinted transcriptional 
regulation of the IgJ2r locus (Bell and Felsenfeld, 2000; Szabo et al., 2000). However, 
binding of various ubiquitous transcription factors including Spi are unaffected by DNA 
methylation (Harrington et al., 1988). Accordingly, certain mammalian genes can be 
repressed by DNA methylation, even when transcription factor occupancy is unaffected 
(Becker et al., 1987). Therefore, the steric hindrance model alone is insufficient to account 
for methylation-dependent transcriptional repression. Consistently, recruitment of 
transcriptional co-repressors has been shown to indirectly mediate gene silencing. Initial 
support for this model was provided by the purification a repressor protein from mammalian 
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nuclear extracts which had specific affinity for clusters of n,CpG sites (Boyes and Bird, 
1991; Meehan et al., 1989). Indirect gene silencing was suggested by the ability to titrate out 
this repressive activity using non-specific methylated competitor DNA in HeLa nuclear 
extracts (Boyes and Bird, 1991). Subsequently, a family of related MeCPG  Binding Domain 
(MBDs) co-repressors were identified, several of which could invoke transcriptional 
repression by facilitating the formation of a repressive heterochromatin environment (Fig. 
1.2-2c; (Cross et al., 1997b; Hendrich and Bird, 1998; Lewis et al., 1992)). MBD proteins 






Figure 1.2-2. DNA methylation mediated transcriptional repression 
a) Transcription initiation from a protein coding gene promoter with RNA polymerase II (RNA polll; filled 
blue circle) and sequence specific transcription factor (TF; filled red circle) bound proximal to the 
transcription start site (arrowed). b) Transcriptional repression resulting from steric hindrance of 
transcription factor binding by CpG methylation in proximity to the promoter. C) Transcriptional 
repression by methyl-binding protein (MBP; filed grey circle) recruitment and the association of histone 
deacetylase (HDAC; filled green circle) and chromatin remodellers (CR; filled yellow circles). Chromatin 
remodeling is indicated by the reduced separation between nucleosomes (filled light blue circle). 
Transcriptional repression (dashed red cross) and methylated CpGs (CH3) are indicated. 
Silencing Cryptic Promoter Elements 
In other species there is evidence to suggest that gene body methylation results in the 
inhibition of transcriptional elongation, leading to aborted transcripts (Barry et al., 1993). 
However, mammalian genes are heavily methylated throughout their coding sequence whilst 
being transcriptionally permissive suggesting that intragenic methylation does not inhibit 
transcriptional elongation in mammalian cells (although there is evidence to suggest that 
high density methylation can reduce its efficiency; (Hellman and Chess, 2007; Jones, 1999; 
Lorincz et al., 2004)). Interestingly, low density methylation was shown to be sufficient to 
repress transcription from a weak promoter, but not from a more potent one containing an 
enhancer element (Boyes and Bird, 1992). Taken together this data suggests that DNA 
methylation suppresses transcription initiation in a rneCpG  density dependent fashion. This 
suggests that gene body methylation provides a mechanism to 'dampen' spurious 
transcription by silencing cryptic promoter elements within intragenic regions (Bird, 1995; 
Suzuki and Bird, 2008). Accordingly, DNA methylation in plants and invertebrates 
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frequently associates with the bodies of moderately transcribed genes which may be more 
susceptible to spurious internal transcription (Suzuki et al., 2007; Zilberman et al., 2007). 
This proposed mechanism is analogous to H3K36 methylation of intragenic transcribed 
regions in yeast, which is deposited following the passage of RNA polymerase to prevent 
internal transcription initiation events (Carrozza et al., 2005). 
Antisense Transcriptional Repression 
An alternative function of intragenic methylation is to silence antisense transcripts which can 
negatively regulate the sense transcript. Indeed such ncRNAs have been reported to repress 
transcription of homologous sequences, some of which are transcribed in a methylation 
sensitive fashion (Panning and Jaenisch, 1996; Rinn et al., 2007; Sleutels et al., 2002; Wutz 
et al., 1997). Whether this represents a general silencing mechanism is unclear, but two lines 
of evidence support this possibility. 1) Global transcription studies have detected a large 
number of functionally unknown ncRNAs which may play a role in such a mechanism 
(Bertone et al., 2004; Birney et al., 2007). 2) Double stranded RNA arising from 
transcription of both DNA strands can invoke RNA mediated transcriptional silencing 
(discussed in section 1.2.5; reviewed in (Yang and Kuroda, 2007)). 
Genome Defense 
Despite a major function in transcriptional repression, the majority of genomic meCpG  is 
localised outwith regulatory elements (Rollins et al., 2006). Furthermore, the global 
distribution of DNA methylation across the genome suggests that it may provide additional 
functions. DNA methylation has been shown to maintain genome integrity in various non-
mammalian species through the suppression of homologous recombination and transposition 
of parasitic sequences (Barry et al., 1993; Maloisel and Rossignol, 1998; Selker, 2002; 
Selker et al., 2003). There is evidence which suggests that DNA methylation may provide an 
equivalent stabilizing function in mammalian cells. 
CpG deficiency results from the fixation of C to T transition mutations arising due to germ 
line methylation at these sites (Bird, 1980). An analysis of DNA sequence composition 
determined that various transposable elements were extensively CpG-depleted indicating that 
these sequences are hypermethylated in the germline (Rollins et al., 2006). Association of 
methylation with these potentially deleterious sequences suggests a possible role in genome 
defense. Deficiency of Dnmt3L, a factor known to facilitate de novo DNA methylation, 
results in extensive hypomethylation and concomitant expression of dispersed repeat 
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sequences during spermatogenesis (Bourchis and Bestor, 2004; Gowher et al., 2005; Hata et 
al., 2002)1. Deficient spermatocytes showed extensive meiotic chromosomal abnormalities 
which precluded the formation of mature sperm cells (Bourc'his and Bestor, 2004; Webster 
et al., 2005). Similarly, Dnmtl deficient mouse embryos display a significant reduction in 
methylation levels and elevated expression of various classes of ZAP proviral sequences 
(Walsh et al., 1998). Targeted mutation of the active site of Dnmt3b in MEFs resulted in 
global hypomethylation, chromosomal instability and aneuploidy, the latter of which is 
indicative of defects in mitotic segregation and chromosomal rearrangements (Dodge et al., 
2005). 
Maintenance of Genomic Integrity 
Global hypomethylation and chromosomal abnormalities are hallmarks of neoplastic cells 
(Fukasawa, 2005; Rodriguez et al., 2006; Weber et al., 2005). Chromosomal segments with 
an elevated incidence of rearrangements were generally found to be more hypomethylated 
relative to adjacent parenchyma from matched colorectal biopsy samples (Rodriguez et al., 
2006). In the human cancer cell line HCTI 16, disruption of the catalytic domain of human 
DNMTI resulted in cell cycle arrest. It was proposed that this was due to activation of the 
damage-induced G2IM checkpoint in response to double stand breaks in the DNA. Gross 
abnormalities occurred despite a modest depletion of methylation, suggesting that subtle 
disruption is sufficient to cause the observed chromosomal lesions (Chen et al., 2007). 
Moreover, an independent study identified extensive chromosomal rearrangements in 
HCT1 16 cells deficient for both DNMT1 and DNMT3b (Karpf and Matsui, 2005). Dnmtl 
hypomorphic mice crossed onto a tumour prone background showed elevated loss of 
heterozygosity, which is indicative of increased homologous recombination or the 
production of unresolved double strand breaks (Eden et al., 2003). These findings suggest 
that global hypomethylation may promote tumorigenesis by facilitating chromosomal 
disruption. Further evidence for a genome integrity function comes from patients afflicted 
with the genetic disorder ICF (immunodeficiency, centromeric heterochromatin and facial 
anomalies). ICF is characterised by chromosomal segregation defects which are associated 
with hypomethylated pericentric satellite repeat sequences (Ehrlich, 2003). Consistent with 
the hypomethylated phenotype, analysis of five ICF patients identified mutations in the 
coding sequence of the de novo methyl transferase DNMT3B (Xu et al., 1999). These data 
suggests that global DNA methylation in vertebrates and more specifically mammalian 
species may have a function in maintaining the structural integrity of the genome. 
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1.2.4 DNMTs: Methylafing the genome 
A family of enzymes collectively referred to as the DNMTs is responsible for establishing 
and propagating genomic methylation patterns. DNMTs are divided into two classes with 
respect to template specificity. The de novo DNMTs bestow methylation upon unmodified 
DNA, whilst a second class propagates methylation by copying the pattern postreplicatively. 
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Figure 1.2-3. Structure and Catalytic mechanism of the DNMTs 
a) Schematic representation of the domain structure of the five main mammalian DNMTs. The carboxy 
terminal domain contains the conserved catalytic motifs (roman numerals; red bars) whilst the variable 
amino terminal region contains (grey bars) domains required for intracellular delivery and allosteric 
regulation of the catalytic C terminus (adapted from (Hermann et al., 2004)). b) Transfer of a methyl 
group from the donor molecule SAM (red shading) to the 05 position of a cytosine residue. The 
catalytic mechanism is mediated by the DNMT C terminal domain as determined for bacterial 
methyltransf erase enzyme M.HhaI. Major enzyme sequence motifs mediating the reaction are 
indicated (light blue shading; adapted from (Jeltsch, 2002). 
All 5MeC DNMTs thus far characterised share a highly conserved catalytic domain which 
was identified by investigating bacterial methyltransferases (Klimasauskas et al., 1994; 
Reinisch et al., 1995). This domain comprises 10 highly conserved peptide motifs located in 
the carboxy terminal domain (Fig. 1.2-3a; (Hermann et al., 2004; Jeltsch, 2002)). These 
motifs fold into a characteristic f3-sheet flanked by one or more ci-helices to create both the 
active site and binding interface for SAM (S-adenosyl-L-Methionine) the methyl donor 
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molecule. Functional differences between the DNMTs occur due to specific motifs encoded 
in the variable amino-terminal domain (Klimasauskas et al., 1994; Reinisch et al., 1995). 
The methyl group is enzymatically transferred from the SAM to the C5 position of the 
cytosine pyrimidine ring. Initially, the DNMT disrupts C/G base pairing and flips the 
cytosine base out of the DNA helix to facilitate catalysis. SAM is bound to motifs I, III and 
X of the catalytic domain and is destabilized by interaction with a conserved cysteine residue 
which makes it receptive to nucleophilic attack. Nucleophilic attack at the C6 position by a 
thiol group in motif IV is stabilised by protonation of the pyrimidine ring by motifs VI and 
VIII. Electrophilic attack by the activated Carbon 5 position followed by deprotonation 
resolves the reaction intermediates with the release of S-adenosyl-L-homocysteine (Fig. 1.2-
3b; (Hermann et al., 2004; Jeltsch, 2002)). 
DNMT] 
DNMTI is the maintenance methyltransferase required to faithfully propagate patterns of 
DNA methylation following DNA replication. DNMTI processively copies the methylation 
pattern onto the newly synthesized DNA strands, by preferentially methylating 
hemimethylated DNA (Bestor, 1992; Yoder et al., 1997). Coordinated replication and DNA 
methylation is achieved by association of DNMTI with PCNA (proliferating cell nuclear 
antigen) and the replication forks during S-phase. Interaction studies determined that 
localisation was facilitated by a charged region and a PCNA interaction motif (Fig 1.2-4; 
(Chuang et al., 1997; Leonhardt et al., 1992)). The preference for hemimethylated DNA is 
due to the amino terminal domain as deletion of this region abolishes this specificity and 
increases DNMTI's intrinsic de novo activity (Fig. 1.2-4; (Bestor, 1992; Chuang et al., 1997; 
Yoder et al., 1997). It has been suggested that this binding specificity is encoded by the 
CXXC domain within the N terminal domain, which has been shown to bind DNA in a 
methylation dependent manner in other proteins (Bestor, 1992; Jorgensen et al., 2004; Lee et 
al., 2001). The amino terminal domain also contains a polybromo domain which consists of 
two BAH motifs, and is implicated in chromatin association (Fig. 1.2-4; (Hermann et al., 
2004)). Targeting to the nucleus is achieved through an NLS (Nuclear localisation signal; 
Fig. 1.2-4), however, during early embryonic development, Dnmtl is excluded from the 
nucleus. This is thought to facilitate the passive demethylation of the female pronucleus in 
the preimplantation embryo. During the wave of global demethylation in gametogenesis, 
certain imprinted DNA loci maintain DNA methylation. Dnmtlo is a DNMT1 isoform 
specific to preimplantation embryos and developing oocytes and is believed to maintain 
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methylation at these target sequences (Ratnam et al., 2002). Consistent with its function, 
Dnmtl is ubiquitously expressed in all replicating somatic cells. 
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Figure 1.2-4. Dnmtl domain structures 
Schematic representation of the domain structure of DNMT1. The C terminal domain contains the 
conserved catalytic motifs (red bars). All charcaterised amino terminal domains are indicated (grey 
bars). The charged region (CG), PCNA binding site (PCNA), Nuclear localisation signal (NLS), 
replication foci targeting region (Rep' Target), CXXC domain and the polybromo domain consisting of 2 
BAH motifs (adapted from (Hermann et al., 2004)). 
DNMT1 deficiency in mouse is embryonic lethal, terminating shortly after gastrulation and 
is coincident with a 70% reduction in DNA methylation levels (Li et al., 1992). The viability 
of cultured ES cells despite a comparable loss of methylation suggests that the mouse 
phenotype is caused by an inability to complete the developmental programme (Li et al., 
1992). Despite the global loss of DNA methylation, the ability to de nova methylate an 
integrated proviral sequence was unaffected in I)NMTI deficient ES cells (Lei et al., 1996). 
DNMT2 
Mammalian DNMT2 was identified as a homolog of yeast prniI by homology to the carboxy 
terminal domain (Okano et al., 1998b; Yoder and Bestor, 1998). DNMT2 possesses an intact 
catalytic domain; however preliminary analysis indicated that it was unable to methylate 
DNA in vitro (Okano et al., 1998b). DNMT2 deficiency, both in ES cells and transgenic 
mice, resulted in normal physiology and did not disrupt the ability to methylate a newly 
integrated retroviral sequence (Lei et al., 1996; Okano et al., 1998b). Taken together, these 
results suggested that DNMT2 provides neither de nova nor maintenance methylase 
activities in viva. In Drosophila, discovery of low level DNA methylation during early 
embryogenesis led to the identification of a single I)NMT coding sequence homologous to 
mammalian DNMT2 (Kunert et al., 2003; Lyko et al., 2000). Depletion of the endogenous 
transcript by RNAi resulted in complete loss of all DNA methylation, indicating that it 
provides the sole methyltransferase activity in Drosophila (Kunert et al., 2003). 
Subsequently, a refined HPLCITLC technique determined that human DNMT2 could 
provide residual methylase activity, but with more restricted sequence specificity than that 
identified for related DNMTs (Hermann et al., 2003). Recent investigation has suggested that 
DNMT2 might target methylation to specific tRNAs (Goll et al., 2006). Therefore, it is 
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unclear whether DNMT2 represents a functionless evolutionary relic or plays a more discrete 
role in selective methylation in mammalian cells. 
DNMT3a and b 
DNMT3a and b were identified as the de nova methyltransferases required to establish the 
initial methylation patterns during garnetogenesis and embryogenesis. Neither protein has a 
significant preference for hernirnethylated DNA templates implying that DNMT3s do not 
function as maintenance methyltransferases (Gowher and Jeltsch, 2001; Okano et al., 1999). 
Furthermore the expression of both enzymes is largely restricted to embryonic tissues 
(Okano et al., 1998a). Depletion of the Dnmt3s reduces DNA methylation levels despite the 
fact that Dnmtl has been shown to possess de nova methyltransferase activity (Bestor, 1992; 
Okano et al., 1999; Yoder et al., 1997). Both de nova DNMTs have a PWWP domain and 
PHD finger domains which are involved in transcriptional regulation and chromatin 
association (Fig. 1.2-5; see section 1.2.5). Interestingly, both Dnmts were found to methylate 
cytosines in contexts outwith CpG dinucleotides (Gowher and Jeltsch. 2001; Ramsahoye et 
al., 2000; Suetake et al., 2003). This is consistent with elevated non-CpG cytosine 
methylation levels in ES cells where the de nova Dnmts are highly expressed (Gowher and 
Jeltsch, 2001; Ramsahoye et al., 2000; Suetake et al., 2003). However it is unclear if these 
modifications have any biological relevance as they are absent in somatic cells due to lack of 
maintenance by Dnmtl (Ramsahoye et al., 2000). 
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Figure 1.2-5. Dnmt3a and b domain structures 
Schematic representation of the domain structure of the de novo DNA methyltransferases. The carboxy 
terminal domain contains the conserved catalytic motifs (red bars). The N terminal domain of both 
proteins encodes both PWWP and PHD domains (adapted from (Hermann et al., 2004)). 
Sequence similarity and domain structure conservation between the two enzymes, suggests 
overlapping functionality in viva (Okano et at., 1998a). Consistent with this idea, both 
enzymes were shown to redundantly methylate an inserted retroviral sequence and A/uI 
elements in viva (Lei et al., 1996; Okano et al., 1999). The increased phenotypic severity of 
mice deficient for both de nova DNMTs suggests a synergistic effect (Okano et al., 1999). 
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However, disparate phenotypes of the individual knock-out mice indicate that the two 
proteins are not entirely functionally equivalent (Okano et al., 1999). Mice deficient for 
Dnmt3a are phenotypically normal at birth but become runted and die at approximately 4 
weeks post-partum (Okano et al., 1999). Molecular analysis indicated that Dnmt3a is 
required for methylation of the major satellite repeats and for establishing maternal imprints 
through interaction with Dnmt3L (Chen et al., 2003b; Hata et al., 2002). Alternatively 
ablation of Dnmt3b activity, results in embryonic lethality at approximately 15.5dpc (days 
post coitum), and shows hypomethylation of specific minor satellite repeats (Chen et al., 
2003b; Okano et al., 1999). The human genetic disorder ICF is associated with perturbations 
in the DNMT3b coding sequence, resulting in hypomethylation of specific endogenous 
repeats and promoter CGIs on the female Xi chromosome (Hansen et al., 2000; Okano et al., 
1999; Wijmenga et al., 1998). The etiology of this disorder, in conjunction with the Dnmt3b 
deficient phenotype in mouse, suggests an essential role in the methylation of certain 
endogenous repeat sequences including the minor satellite repeat (Miniou et al., 1997; 
Okano et al., 1999). Another fundamental difference between the de novo Dnmts is the 
nature of their enzymatic function. Dnmt3b is processive and can track along DNA to 
methylate multiple CpG sites. In contrast, Dnmt3a acts distributively and appears to be 
targeted to discrete genomic loci (Gowher and Jeltsch, 2001; Kim et al., 2002). 
DNMT3L 
DNMT3L resembles the carboxy terminus of the de novo methyltransferases, but lacks 
essential sequence motifs rendering it catalytically inactive (Bourc'his et al., 2001; Hata et 
al., 2002). Despite this, genetic analysis has shown it to be essential for spermatogenesis and 
the methylation of maternally imprinted DMRs (Differentially methylated regions). 
Deficient male mice are infertile which is likely due to defects in sperm maturation 
(Bourchis et al., 2001; Hata et al., 2006; Hata et al., 2002). Dnmt3L is temporally and 
spatially expressed during gametogenesis suggesting that it may be involved in the 
establishment of methylation patterns. Indeed the timing coincides with global methylation 
of PGCs and the generation of imprinted signals (Sakai et al., 2004). Furthermore, Dnmt3a 
and b physically interact with a carboxy terminal region of Dnmt3L in vivo and this can 
enhance their respective activities (Gowher et al., 2005; Hata et al., 2002; Suetake et al., 
2004). Interestingly, Dnmt3L was also found to bind directly to DNA in vitro and associate 
with the core histones in vivo (Gowher et al., 2005; Ooi et al., 2007). This suggests that it 
may function as a modulator of activity and provide spatial targeting of de novo methylation 
in vivo. Preliminary investigation indicated that Dnmt3L deficiency did not affect global 
methylation levels which may indicate that it functions at discrete genomic loci (Bourchis et 
al., 2001). Consistently, Dnmt3L deficiency was shown to cause hypomethylation of specific 
endogenous repetitive sequence elements (Hata et al., 2006; Webster et al., 2005). 
It is interesting to note that whilst the categorisation of Dnmts into de novo and maintenance 
functions is grossly accurate, there is a level of cooperativity between the two systems (Kim 
et al., 2002; Liang et al., 2002). Dnmtl and the de novo methyltransferases can physically 
interact in vivo via their amino terminal domains. This interaction results in a synergistic 
increase in methylation activity (Kim et al., 2002). An early study indicated that the process 
of methylating an exogenous sequence was intrinsically low fidelity resulting in 5% 
methylation errors per cell division (Pollack et al., 1980; Wigler et al., 1981). Maintenance 
methylation of repetitive elements is highly inefficient in the absence of the de novo Dnmts 
in mice (Liang et al., 2002). Many cancers have aberrant DNA methylation, and this is often 
concordant with increased de novo DNMT activity (Roll et al., 2008; Ting et al., 2006). 
Moreover, cancer cells with elevated DNMT3b levels were found to generate increased 
numbers of methylation errors (Linhart et al., 2007; Ushijima et al., 2005). Taken together, 
this suggests that the de novo methyltransferases cooperate with Dnmtl to accurately 
maintain DNA methylation patterns postreplicatively. 
1.2.5 Targeting de novo Methylation 
The mammalian genome is heavily methylated along the majority of its length; however, 
there are certain sequences which are more prone to the acquisition of DNA methylation. 
Imprinted genes, transposable elements and certain CGI sequences have all been reported to 
be more frequently targeted by the methylation machinery (Bock et al., 2006; Meunier et al., 
2005; Reik, 2007; Weber et al., 2007). However, the mechanism by which these sequences 
are preferentially targeted for de novo methylation is still poorly understood. Conceptually, 
targeting could be achieved via four distinct mechanisms. 1) Dnmts may have an intrinsic 
preference for specific DNA sequences or chromatin structures specified by interaction 
motifs (Fig. 1.2-6a). 2) Interaction with protein cofactors could direct methylation to specific 
genomic loci (Fig. 1.2-6b). 3) Methylation may be targeted via an RNAi mediated 
transcriptional repression pathway (Fig. 1.2-6c). 4) DNMTs may be occluded from certain 
DNA sites by steric hindrance from bound factors. These mechanisms need not be mutually 
exclusive and could provide a failsafe mechanism for distributing the methyl-mark in vivo. 
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Sequence Specific Targeting 
There is little evidence for sequence specificity for any of the main Dnmts outwith the 
central CpG site. However, Dnmt3a has been reported to have slight preferential activity at 
CpG sites flanked by pyrimidines (Lin et al., 2002). The PWWP domain (pfam: PF00855), 
present in the amino terminus of both de novo methyl-transferases is essential for targeting to 
chromatin (Ge et al., 2004; Qiu et al., 2002). In plants and fungi, DNA methylation is 
targeted to DNA sequences which are present in multiple copies (Selker et al., 2003; Zhang 
et al., 2006). There is less direct evidence for such an instructive mechanism in mammalian 
systems. Meunier and coworkers utilised CpG transition mutations as indicators of genomic 
methylation levels in the germline of primates. This analysis identified transposable elements 
as being the most heavily methylated component of the genome (Meunier et al., 2005). It has 
been proposed that hemimethylated sequences produced by recombination between such 
endogenous repeats and newly integrated homologous sequences may provide preferential 
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Figure 1.2-6. Mechanisms for DNA targeting. 
Three possible mechanisms for DNMT targeting include; direct association (a), binding by sequence 
specific protein cofactors (b) and recruitment facilitated by an RNA dependent DNA Methylation 
(AdAM) nucleoprotein complex (c). a) de novo methyltransfe rase (filled green circle) can directly bind 
chromatin (string of blue circles) through interaction with their amino terminal PWWP domains. b). 
Sequence specific transcription factors (red circle) can direct Dnmts to gene promoters (arrowed). C) 
RNA interference pathway targets DNA in a site specific manner, through sequence recognition by a 
nucleoprotein complex (RdDM; light blue circle). This could recruit DNMTs to specific gene loci as has 
been described in plants. Figure adapted from (Klose and Bird, 2006). 
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Targeting by Protein Interactions 
An alternative mechanism by which methylation may be targeted to specific sequences is via 
protein interacting partners. Dnmt3L can directly bind DNA and can associate with the four 
core histories in vivo (Gowher et al., 2005; Ooi et al., 2007). Furthermore Dnmt3L can 
physically associate with both de novo methyltransferase suggesting that it may act as a 
chromatin association factor (Suetake et al., 2004). Interestingly, chromatin association was 
found to be sensitive to H3K4 methylation, a modification associated with transcriptional 
activity (Ooi et al., 2007). This may indicate a mechanism whereby de novo DNA 
methylation is specifically excluded from sites of active transcription, as has been proposed 
for the existence of CpG Islands (see section 3.1.1). Dnmt3L may also have a role in 
targeting DNA methylation to imprinted gene loci. Structural determination and 
chromatographic purification of Dnmt3a complexed with Dnmt3L indicated the formation of 
a heterodimer which could then oligomerise on DNA (Jia et al., 2007). The authors proposed 
that this structure imposes a periodicity of active site/DNA contacts consistent with m CpG 
spacing observed in several imprinted genes. Dnmt3a and Dnmt3L are essential for the 
maintenance of methylation at imprinted DMRs and this structure may confer a preference 
towards these sequences (Bourc'his et al., 2001; Hata et al., 2002). 
The oncogenic TF PML-RAR is found in Acute Promyelocytic Leukemia (APLs). It binds to 
the promoter region of R4R/32, a frequent target of aberrant methylation in cancer cells. 
Transfected PML-RAR was shown to recruit Dnmtl and Dnmt3a to a RAR/32 reporter and 
elicit transcriptional repression in a DNA methylation dependent manner (Di Croce et al., 
2002). Dnmt3a was found to be targeted to the promoter of p2]Cip] through it's interaction 
with Myc and the sequence specific targeting factor; Miz- 1. Targeted silencing was shown to 
be dependent on DNA methylation (Brenner et al., 2005). NoRC (nucleolar remodeling 
complex) is required to silence specific rDNA genes and facilitates repression via chromatin 
modulation, nucleosome remodeling and DNMT activity, all of which are functionally 
indispensable (Santoro and Grummt, 2005; Santoro et al., 2002). Targeting of this complex 
was shown to be dependent on association with ']ITFl which facilitated recruitment of both 
Dnmtl and Dnmt3b to the promoter (Santoro and Grummt, 2005). These data suggest that, 
sequence specific targeting by accessory factors may be a general molecular mechanism by 
which Dnmts can elicit transcriptional repression (Fig. 1.2-6b). 
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RNA directed Targeting 
It is hard to imagine a better system for sequence recognition than that facilitated by 
nucleotide base-pairing. RNA interference (RNAi) involves the targeting of short RNA 
molecules to complementary nucleotide sequences which invokes transcriptional gene 
silencing (TGS). This process has been extensively studied in plants, yeast and insects 
(Grewal and Elgin, 2007; Lippman and Martienssen, 2004; Matzke and Birchler, 2005). 
Short double stranded RNA molecules are generated by the activity of DICER', which 
preferentially cleaves double stranded RNA into 21-26nt oligonucleotides. The antisense 
strand provides sequence specificity to target a nucleoprotein complex to a complementary 
nucleotide sequences. This can mediate transcriptional repression, by targeted degradation of 
the complementary RNA transcript, or by recruiting chromatin modifying activities to the 
complementary DNA sequence. In plants, one consequence of the later mechanism is RNA 
directed DNA methylation (RdDM), which results in highly localised DNA methylation at 
complementary sequences (Lippman and Martienssen, 2004; Matzke and Birchler, 2005), 
However, the existence of an equivalent system in mammals is a contentious issue. 
Mammals possess much of the enzymatic machinery required for RNAi and can silence 
transcription by targeting synthetic short interfering RNAs (siRNAs) to endogenous gene 
loci (Kanellopoulou et al., 2005; Morris et al., 2004). Murine cells, deficient for Dicer have 
disrupted heterochromatin and are hypornethylated at certain sequences throughout the 
genome (Benetti et al., 2008; Kanellopoulou et al., 2005; Sinkkonen et al., 2008). 
Introduction of RNA molecules complementary to endogenous EFIA (Elongation Factor 
1A), resulted in transcriptional repression and increased methylation at the locus (Morris et 
al., 2004). However, similar RNA targeting to the CDHI promoter in the human carcinoma 
cell line HCTI 16, showed reduced RNA and protein levels without a concomitant increase 
in DNA methylation (Ting et al., 2005). More recently, analysis of Dicer hypomorphs 
displayed up-regulation of a panel of genes consistent with the depletion of promoter DNA 
methylation (Ting et al., 2008). Two studies have indicated that an RNA mediated pathway 
may indirectly effect DNA methylation (Benetti et al., 2008; Sinkkonen et al., 2008). Dicer, 
deficiency in both mice and murine ES cells was found to result in derepression of Oct4 and 
stimulate telomeric recombination and elongation. These regions were also found to be 
aberrantly hypomethylated. Molecular analysis indicated that this was not due to DNA 
methylation targeting but instead the misregulation of the micro RNA cluster, miR-290. This 
'Dicer or equivalent ribonuclease, as processing has also been described for Piwi proteins, 
which function in p1RNA mediated transcriptional repression (Aravin, A.A., and Bourchis, D. 
(2008). Small RNA guides for de novo DNA methylation in mammalian germ cells. Genes 
Dev 22, 970-975.. 
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was subsequently found, to directly repress RbL-1, a transcriptional repressor of the Dnmts. 
Therefore, Dicer deficiency was reported to result in DNA hypomethylation as a 
consequence of reduced methyltransferase activity, rather than targeted DNA methylation 
(Benetti et al., 2008; Sinkkonen et al., 2008). A recently discovered class of small RNAs 
(piRNAs; piwi interacting RNAs) have been implicated in DNA methylation targeting 
during mammalian spermatogenesis (Aravin and Bourchis, 2008). At this stage it remains 
unclear as to whether DNA methylation targeting via an RNA mediated pathway is a 
primary silencing mechanism in mammalian cells. However, it is also probable that 
methylation can be recruited by other chromatin modifications, as an indirect response to this 
pathway (Fig. 1.2-6c). 
1.2.6 DNMT Interactions: Routes to Repression 
There is evidence to suggest that Dnmts can repress transcription directly, in a methylation 
independent manner (Myant and Stancheva, 2008; Rountree et al., 2000). In order to fully 
appreciate the role of the Dnmt proteins in transcriptional regulation, it is necessary to 
review some of the interactions with other nuclear components. 
Several studies have identified HDACs (Histone Deacetylases) as Dnmt binding partners 
(Fuks et al., 2000; Myant and Stancheva, 2008; Robertson et al., 2000; Rountree et al., 
2000). Transfection studies have indicated that Dnmtl can inhibit transcription in an HDAC 
dependent manner (Fuks et al., 2003b; Rountree et al., 2000). Chromatographic purification 
of Dnmtl confirmed these interactions and identified additional interaction partners 
including Rb and E2171 (Robertson et al., 2000). Co-transfection of Dnmtl and Rb, indicated 
cooperative transcriptional repression of an E2F1 target gene. This sequence specific 
repression was found to be independent of methyltransferase activity or de novo methylation 
(Robertson et al., 2000). The same group purified Dnmtl complexed with the SNF2 ATP 
dependent chromatin remodeller (Robertson et al., 2004). SNF2 remodeling activity was 
shown to be essential for site specific DNA methylation and transcriptional repression, of 
specific rRNA genes (Santoro and Grummt, 2005). Deficiency of the putative chromatin 
remodeller Lsh (Lymphoid Specific helicase), results in genomic DNA hypomethylation in 
mice (Sun et al., 2004). A recent study has determined that Lsh can associate with Dnmtl 
and Dnmt3b in vitro and in vivo. This interaction facilitates the association of HDACs I and 
2, and can repress transcription when targeted to a gene promoter (Myant and Stancheva, 
2008). Interestingly, DNMTI catalytic activity is not required for this process, and targeting 
of this activity was not found to result in de novo methylation. This data suggests that 
- 	 43 
interactions with Dnmtl and Dnmt3a may be sufficient to repress transcription, in the 
absence of methylation (Myant and Stancheva, 2008). Further work will be required to 
elucidate the role of this interaction in the hypomethylation phenotype observed in the 
deficient mouse model. It is interesting to postulate, that chromatin remodeling facilitates 
DNA methylation by exposing CpG sites which would otherwise be inaccessible due to 
nucleosome positioning. 
Immunoprecipitation of EZH2 (see section 1.1.2: Polycomb and Trithorax proteins) from 
HeLa cells copurified DNMT activity from endogenous cell extracts. The interaction was 
mapped to the PHD domain of both de novo methyltransferases and to the amino terminus of 
DNMTI. Other components of the Prc2 complex were also found to associate with Dnmts. 
CUP analysis indicated that EZH2 was required for Dnmtl recruitment and that its depletion 
led to reactivation of a panel of Prc2 target genes. EZH2 depletion corresponded with a loss 
of Dnmtl binding and reduced DNA methylation levels at associated gene promoters (Vire 
et al., 2006). 
Dnmt3L has been shown to directly interact with chromatin and depletion led to a reduction 
in H3K9 methylation levels (Webster et al., 2005). It has previously been shown that histone 
methylation at this position is a prerequisite for effective DNA methylation in other model 
systems (Tamaru et al., 2003). Therefore this may provide a mechanism by which the de 
novo methyltransferases cooperate with other repressive histone marks to reinforce a 
repressed chromatin state. This may explain the inability of Dnmt3L deficient cells to 
complete spermatogenesis, as abnormal chromatin conformation could disrupt the 
synaptonemal complex and prevent the completion of meiosis (Ooi et al., 2007; Webster et 
al., 2005) Consistent with this scheme, there is evidence to suggest that both HP1 and 
SUV39hI interact with Dnmtl (Fuks et al., 2003a; Lehnertz et al., 2003). 
DMAP1 is a transcriptional repressor which can associate with the extreme amino terminus 
of Dnmtl to repress transcription, independent of catalytic activity (Rountree et al,, 2000). 
HDAC2 is recruited to this complex late in S-phase, suggesting that this interaction may 
serve to remove acetyl-groups from the newly deposited histones, in a methylation 
dependent manner (Rountree et al., 2000). This would be in accordance with the observation 
that transcriptionally inert chromatin replicates late in S-phase. 
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These regulatory networks suggest mechanistic links between DNA methylation and other 
epigenetic components, including histone modifications and chromatin remodeling. 
However, Dnmts may play a role in DNA methylation independent transcriptional 
repression, by interaction with sequence specific cofactors and chromatin modulating 
activities. Indeed, there is data in Xenopus to suggest that xDNMT1 has an essential role in 
development, which is fully intact even in the absence of methyltransferase activity (Dunican 
et al., 2008). These data suggest that DNMTs have two overlapping, but distinct regulatory 
functions. 
1.2.7 Mediators of the methyl mark 
CpG methylation results in long term transcriptional repression of specific gene targets. One 
mechanism by which DNA methylation can be translated into transcriptional repression 
involves the recruitment of repressive complexes by Methyl-Binding Proteins (MBP5). Such 
interactions could conceptually prevent transcription, via occlusion of cognate transcription 
factor binding sites or direct steric hindrance of the basal transcriptional machinery. 
Alternatively, recruitment of nucleosome modifying activities could sequester DNA 
sequences into transcriptionally inert chromatin (Bird and Wolffe, 1999). This notion was 
supported by the observation that repression of exogenous DNA templates was delayed prior 
to assembly of chromatin (Kass et al., 1997). Further support for this idea came from the 
observation that, treatment with TSA' resulted in extensive gene derepression (Yoshida et 
al., 1995). 
MBPs were initially identified by the biochemical purification of a nuclear activity which 
specifically recognized methylated CpG sites, and could repress transcription in vitro (Lewis 
et al., 1992; Meehan et al., 1989). Mutational analysis of a related protein MeCP2, identified 
the minimal sequence motif required for DNA binding affinity and was termed the "CpG -
binding domain (MBD; (Nan et al., 1993)). Databases searching led to the identification of a 
further 4 polypeptides bearing the conserved motif (Fig. 1.2-7; (Cross et al., 1997b; Hendrich 
and Bird, 1998)). 
MeCP2 
Methyl-CpG-binding protein 2 (MeCP2), possesses both the characteristic MBD consensus 
sequence and a carboxy-terminal transcriptional repressor domain (TRD; (Nan et al., 1997; 
VI  ISA is a HDAC inhibitor. 
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Nan et al., 1993)). The MBD domain can bind methylated CpG sites both in vitro and in vivo 
(Nan et al., 1993). Interestingly, preferential binding was observed for a portion of MeCP2 
containing the MBD (amino acids 77-161) for a central methylated CpG site flanked by a run 
of [A/T] >4 residues (Klose et al., 2005). This selectivity seems to prevent MeCP2 from 
occupying methyl CpG sites usually bound by other members of the MBD family (Klose et 
al., 2005). Methyl-specific transcriptional repression was identified and linked to an 
association with a Sin3a HDAC corepressor complex (Nan et al., 1998). Furthermore, 
MeCP2 has been shown to associate with the histone H3K9 methyltransferase, Suvar 3-9 in 
vivo (Fuks et al., 2003b). Such interactions are likely to be temporally regulated or transient 
as the majority of cellular MeCP2 is monomeric (Klose and Bird, 2004). 
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Figure 1.2-7. Mammalian Methyl Binding Proteins 
MeCP2 binds to methylated DNA via its MBD which is characteristic of the MBD family proteins 
(bracketed). This mediates transcriptional repression through a C terminal TRD. MBD1 is similar but 
can target unmethylated DNA sequences through interaction with one of the CXXC motifs (CXXC). 
MBD2 also binds DNA via its MBD and mediates repression via interactions with a TRD. MBD2 
contains unstructured Glycine I Arginine repeats (RG). MBD3 has an N terminal MBD domain although 
a Tyrosine to Phenylalanine transition (asterisked) prevents specific DNA binding activity. MBD4 is a 
mismatch repair protein, which binds CpG deamination products and excises the mismatched base 
pair via the C terminal glycosylase domain (Glycosylase). Kaiso is unique amongst the MBPs as it 
binds DNA through a zinc finger motif (zinc finger) rather than an MBD. Kaiso, mediates transcriptional 
repression through its POZIBTB domain (POZIBTB). 
MeCP2 levels are particularly high in neuronal cells, consistent with the observation that 
mutations in MeCP2 give rise to the human neurological disorder; Rett Syndrome (Amir et 
al., 1999; Nan and Bird, 2001). A mouse deficient for MeCP2 provides a convincing model 
for the disease, presenting postpartum onset of both learning and cognitive impairment 
consistent with the disease phenotype in humans (Guy et al., 2001). Interestingly, a recent 
study indicated that restoration of a functional protein in a transgenic mouse could rescue the 
majority of the diseased phenotype (Guy et al., 2007). This suggests that the in vivo 
localisation of MeCP2 is hard wired into the chromatin allowing MeCP2 to decipher DNA 
methylation and restore wild type gene expression. 
Further to its role as a mediator of transcriptional repression, MeCP2 has been implicated in 
functions such as RNA splicing and chromatin organization (Georgel et al., 2003; Nikitina et 
al., 2007; Young et al., 2005). The fact that endogenous gene expression levels across the 
whole genome are only modestly affected by MeCP2 deficiency suggests that it may possess 
additional, as yet, uncharacterised cellular functions (Tudor et al., 2002). A recent study 
investigating global MeCP2 occupancy indicated preferential localisation to expressed gene 
promoters in a human neuronal cell line (Yasui et al., 2007). This finding is somewhat at 
odds with the historical role of MeCP2, and will require further investigation to determine its 
biological significance. 
MBDI 
MBDI is a transcriptional repressor comprising an MBD, TRD and two or three conserved 
cysteine rich CXXC domains (discussed in chapter 3;(Cross et al., 1997b; Hendrich and 
Bird, 1998)). MBDI colocalises to heterochromatic genomic foci but the localisation is not 
perturbed in DNMT deficient cells (Hendrich and Bird, 1998; Jorgensen et al., 2004). This 
methylation independent affinity is facilitated by the CXXC-3 domain which binds 
nonmethylated sequences in vitro and in vivo (Jorgensen et al., 2004). Accordingly, 
transcriptional repression can be achieved from both methylated and nonmethylated DNA 
templates (Fujita et al., 1999; Jorgensen et al., 2004). Human MBDI has been shown to 
associate with the histone methyltransferase SETDB 1 and transiently with chromatin 
assembly factor (CAF1) during S phase. Ablation of MBDI in HeLa cells, leads to the 
hyperacetylation of certain target gene promoters (Sarraf and Stancheva, 2004). These 
findings indicate the existence of a coordinated propagation mechanism between DNA 
methylation and histone modification. This would suggest that newly deposited nucleosomes 
are methylated on H3K9 in response to DNA methylation via an indirect PCNA interaction 
(Sarraf and Stancheva, 2004). The formation of this complex may be regulated by the 
posttranslational modification of MBDI by the small ubiquitin like modifier (SUMO; (Lyst 
et al., 2006)). 
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MBD2 and 3 
MBD2 and MBD3 are the most closely related amongst the MBD proteins showing an 
overall amino acid sequence conservation of approximately 70% (Hendrich and Bird, 1998). 
MBD2 can bind methylated DNA in vitro and in vivo but a tyrosine to phenylalanine 
substitution has ablated specific DNA binding for MBD3 (Fraga et al., 2003; Hendrich and 
Bird, 1998). Both MBDs associate with the Nucleosome Remodeling and Histone 
Deacetylase (NuRD) corepressor complex (Bowen et al., 2004; Muchardt and Yaniv, 1999; 
Zhang et al., 1999). Initial results indicated that the two family members resided within the 
same repressive complex (Zhang et al., 1999). Genetic analysis has indicated that the MBD2 
and MBD3 are not functionally redundant which has subsequently led to the biochemical 
purification of MBD2 and MBD3 specific NuRD complexes (Hendrich et al., 2001; Le 
Guezennec et al., 2006). This discovery may indicate that these MBDs play a role in distinct 
transcriptional repression in response to different physiological conditions or cellular 
processes. 
MBD2 deficient mice are viable, fertile and present only a mild maternal nurturing defect 
(Hendrich et al., 2001). Molecular analysis has indicated that MBD2 deficiency results in 
slight de-repression of the XIST transcript and ectopic expression of a panel of genes in the 
colon (Barr et al., 2007; Berger et al., 2007). Conversely, MBD3 deficiency is embryonic 
lethal prior to implantation, suggesting that MBD3 is essential for completion of the 
developmental program (Hendrich et al., 2001). This phenotype appears to be mediated by 
an inability to repress the expression of specific pluripotency markers in the absence of a 
functional MBD3/NuRD complex (Kaji et al., 2006; Kaji et al., 2007). 
Whilst DNA methylation is essential for mammalian development, it represents a significant 
mutational burden (Li et al., 1992; Okano et al., 1999). 5MeC is hyper-mutable as it is prone 
to spontaneous deamination to thymine (Bird, 1980). Indeed approximately 1/3' of human 
genetic disease have been attributed to such deamination events (Cooper and Krawczak, 
1990). MBD4 can bind to both fully and hemimethylated CpG sites but has elevated affinity 
for T/G mismatches which are the product of rneCpG  deamination (Hendrich et al., 1999). 
Furthermore, MBD4 possesses a carboxy terminal glycosylase domain which can excise 
thymine and uracil when paired with a guanine base in vitro (Hendrich et al., 1999). 
Consistent with this observation, MBD4 deficiency results in a three fold over representation 
of CG to TA transition mutations (Millar et al., 2002). Deficient mice show an elevated 
tumour burden and increased mortality when crossed onto an APCTh1  background (Millar et 
al., 2002). Mismatch mutations can disrupt genomic integrity characteristic of cancers which 
present a microsatellite instability phenotype. Accordingly, human cancers of this type have 
a significant association with mutations in the endogenous MBD4 gene, although recent 
evidence suggests that this may be consequential rather than causative (Bader et al., 2000; 
Pinto et al., 2008; Riccio et al., 1999). This is strong evidence that MBD4 functions as a 
mismatch repair protein in vivo and has evolved to combat the intrinsic mutability imposed 
by a heavily methylated genome. 
Further to this well characterised function, more recent evidence has suggested that like its 
kin, MBD4 can also act as a transcriptional repressor (Kondo et al., 2005). This study 
indicated that transcriptional repression was mediated by interaction with Sin3A and 
HDAC1 (Kondo et al., 2005). Further investigation will be required to determine if this 
observation translates into a genuine regulatory function at endogenous loci. 
Kaiso 
Kaiso is an MBP of the BTB/POZ transcription factor family which bears no sequence 
similarities with the MBD proteins (Prokhortchouk et al., 2001). DNA binding is achieved 
through the recognition of two symmetrically methylated CpGs or a nonmethylated 
consensus site through interaction with aconserved zinc finger domain (Fig. 1.2-7) (Daniel 
et al., 2002; Prokhortchouk et al., 2001)). Transfection assays identified Kaiso as a methyl 
specific repressor in Xenopus and ablation of the protein facilitated precocious transcription 
of a panel of developmental genes (Ruzov et al., 2004). It is unclear whether the affinity for 
the nonmethylated motif in mammalian cells can also direct sequence specific, methylation-
independent transcriptional repression (Daniel et al., 2002). Kaiso associates with the HDAC 
dependent NCoR corepressor complex through interaction between the N terminal POZ 
domain of Kaiso and the RDI domain of hNCoR. A functional kaiso/NCor complex is 
required for repression of endogenous MTA2 expression (Yoon et al., 2003). Disruption of 
the complex by siRNA depletion of NCoR or Kaiso, leads to derepression of the MAT2 and 
concomitant histone hyperacetylation and the loss of H3K9 methylation (Yoon et al., 2003). 
A degree of redundancy between the MBPs is suggested by their functional and mechanistic 
similarities. This proposal is supported by the mild phenotype presented by MBD2 
deficiency and the weak genetic interaction observed between MBD2 and 3 (Hendrich et al., 
2001). However, the observation that MBPs have different in vitro sequence preferences 
suggests that they are not completely functionally equivalent (Table 1.2-I). Interestingly, the 
single member of the family lacking methyl CpG binding (MBD3) is embryonic lethal which 
suggests its function extends beyond sensing the methylation state of DNA alone. The 
various MBPs seem to have evolved to capitalize, decipher and protect the DNA methylation 
mechanism. For an insight into the evolution of DNA methylation and the MBD protein see 
review by Colot and Rossignol and references therein (Colot and Rossignol, 1999). 
There is evidence indicating that MeCP2, MBD24 and Kaiso are HDAC dependent 
transcriptional repressors. Furthermore the majority of MBPs have been associated with 
H3K9 methyltransferase activity, a histone mark known to associate with inactive chromatin 
(Bernstein et al., 2007). These findings indicate that modulation of chromatin structure is a 
primary mechanism employed by MBPs, but that this does not exclude a secondary role in 
the steric hindrance of transcription factor binding (Fig. 1.2-2). 
Table 1.2-1. Sequence bindinq affinity for Methvl-Bindinci Proteins 
Methylation Binding 
MBP Binding site Statusa Domain Reference 
MeCP2 CpG+AIT[;~:4] M MBD (Klose et at., 2005; Nan et at., 1993) 
(Hendrich and Bird, 2000; Jorgensen et al., 
MBD1 CpG M/N MBD/CXXC 2004) 
(Hendrich and Bird, 1998; Klose et at., 
MBD2 CpG M MBD 2005) 
(Fraga et at., 2003; Hendrich and Bird, 
MBD3 NA NA NA 1998) 
(Hendrich and Bird, 1998; Millar et at., 
MBD4 C/U/TpG M/H!M MBD 2002) 
CpGpCpG or (Daniel et al., 2002; Prokhortchouk et al., 
Kaiso TCCTGCNA M/N Zinc Finger 2001) 
aMethylation status of binding sequence are indicated as either methylated (M), nonmethylated (N), 
hemimethylated (H) or non applicable (NA). 
1.2.8 Mammalian X-inactivation - An Epigenetic Paradigm 
One of the best characterised examples of the functional importance of DNA methylation is 
mammalian X-inactivation. In mammals, sex determination is mediated by a pair of 
heteromorphic sex chromosomes. X inactivation is the process whereby females, bearing two 
X chromosomes, compensate for the genetic imbalance between the sexes. To equalize X-
linked gene expression levels between males and females a single X chromosome is 
inactivated during early development (Heard et al., 1997). Interestingly, during the first five 
cell divisions of female embryogenesis, the paternal X chromosome (Xp) is inactivated. 
Subsequently, features of early imprinted X-inactivation are lost in the inner cell mass 
allowing random X-inactivation to proceed in the epiblast (Okamoto et al., 2004). DNA 
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methylation plays a central role in X-inactivation as disruption of DNMTI leads to severe 
perturbations in X inactivation inducing ectopic silencing of the active X chromosome (Xa; 
(Norris et al., 1994; Panning and Jaenisch, 1996)). Furthermore, transient depletion of DNA 
methylation, following 5AzaC treatment can reactivate the PGK-1 gene located on the Xi in 
hybrid mammalian cells (Hansen and Gartler, 1990). 
The molecular process of random X inactivation, proceeds through a reversible initiation 
stage and then culminates in the irreversible repression of a single X chromosome (Wutz and 
Jaenisch, 2000). The Xic (X-inactivation centre) encodes Xist, a large ncRNA, which is 
essential for the initiation of X-inactivation (Penny et al., 1996). Xi specific expression of 
Xist follows inactivation choice, and initiates chromosome-wide repression in cis (Brown et 
al., 1991; Clemson et al., 1996; Wutz and Jaenisch, 2000). The restricted pattern of Xist 
expression is mediated by the Tsix antisense ncRNA, which is expressed from the Xa and is 
required for Xist repression (Luikenhuis et al., 2001; Sado et al., 2002). Furthermore, Xist is 
regulated, at least in part, by differential DNA methylation of its promoter region which is 
hypomethylated and hypermethylated on The Xi and Xa respectively in somatic cells (Norris 
et al., 1994). In support of this scenario, DNMTI deficiency was shown to reactivate Xist 
expression form the Xa, and elicit ectopic X inactivation (Norris et al., 1994; Panning and 
Jaenisch, 1996). Xist RNA physically coats the Xi, which facilitates transcriptional 
repression which occurs very shortly after Xist transcription is initiated (Clemson et al., 
1996; Keohane et al., 1996). Interestingly, Xist stabilization is important for this process with 
the half life of the RNA transcript being significantly higher in somatic relative to ES cells 
(Sheardown et al., 1997). Interestingly, recent evidence suggests that early paternal specific 
X inactivation corresponds to specific gamete-derived DNA methylation patterns within the 
Xic, analogous to autosomal imprinting (Boumil et al., 2006). Unlike imprinting however, 
these methyl-marks are erased in the inner cell mass to allow subsequent random X-
inactivation. 
Following Xist mediated initiation events; subsequent inactivation involves the formation of 
facultative heterochromatin which occurs in response to Xist localisation. Artificial 
differentiation experiments provided much of the information pertaining to temporal order of 
these events (Brockdorff, 2002). Following the accumulation of Xist, the Xi becomes 
methylated at H3K9 and hypoacetylated on H3K9 and H3K4 (Heard et al., 2001; Mermoud 
et al., 2002). This corresponds with a shift to late replication of the Xi during S-phase 
(Keohane et al., 1996; Priest et al., 1967). Subsequent to asynchronous replication, histone 
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H4 tails become hypoacetylated which may contribute to the stabilization of inactivation 
required for the transition between initiation and maintenance (Heard et al., 2001; Keohane 
et al., 1996). The H2A1.2 histone variant is deposited on the Xi, although interestingly this 
was found to be reversible if Xist was depleted in MEFs (Csankovszki et al., 1999). 
Consistent with this result, depletion of Xist in ES cells prior to 72 hours was shown to 
reverse X-inactivation with the concomitant loss of early chromatin modifications. Once ES 
cell differentiation extends beyond this point, inactivation becomes stable and independent 
of Xist expression (Wutz and Jaenisch, 2000). However there is evidence that Xist can 
contribute, in part, to the maintenance of X inactivation (Csankovszki et al., 2001). Synthetic 
depletion of Xist in MEFs results in partial relief of transcriptional silencing on the Xi. The 
same study indicated that efficient maintenance of the inactive state requires Xist, DNA 
methylation and hypoacetylation of histone tails for efficient transcriptional repression 
(Csankovszki et al., 2001). 
Further to the modifications already discussed, polycomb repressive complexes play a 
central role in X inactivation. Components of both PRCI and PRC2 complexes associate 
with the Xi very shortly after Xist expression (de Napoles et al., 2004; Plath et al., 2003; 
Silva et al., 2003). Concurrently, histone H2AK9 is ubiquitinated and histone H3K27 is 
methylated (de Napoles et al., 2004; Plath et al., 2003; Schoeftner et al., 2006). The PRC2 
complex, and H3K27me2 and me3 \were found to be indispensable for Xi gene silencing. 
Moreover, H2A ubiquitination was found to be independent of PRC2, despite the fact that 
H3K27 methylation is known to recruit PRC1 (Schoeftner et al., 2006). Moreover PRC1 
components could be recruited to DNA in an Xist dependent and PRC2 independent manner 
(Schoeftner et al., 2006). Alternatively, disruption of DNA methylation led to mislocalisation 
of the PRC1 component BMI1, but did not affect H3K27methylation (Hernandez-Munoz et 
al., 2005). These data suggest that H3K27methylation, DNA methylation and Xist may have 
an overlapping role in PRC I recruitment. 
Maintenance of transcriptional repression corresponds with promoter-CGI methylation and 
hypoacetylation on the Xi (Gilbert and Sharp, 1999; Norris et al., 1991; Tribioli et al., 1992; 
Weber et al., 2005; Wolf et al., 1984; Yen et al., 1984). Despite the fact that CGI 
methylation correlates with transcriptional repression, data suggests that it is required for 
stable maintenance rather than initiation of repression. This is supported by the observation 
that Xi genes are already repressed prior to the acquisition of DNA methylation at these sites 
(Keohane et al., 1996). Interestingly, analysis of allelic methylation suggests that intergenic 
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regions are relatively hypomethylated on the Xi, although the biological relevance of this is 
unclear (Gilbert and Sharp, 1999; Weber et al., 2007; Yen et al., 1984). One hypothesis is 
that gene-body methylation associated with genes of the Xa, may serve to prevent spurious 
transcription from internal cryptic promoters or transposable elements. Such internal 
expression has been proposed to interfere were correct transcription as previously discussed 
(Suzuki and Bird, 2008). However analysis of Xa specific gene body methylation indicated 
no correlation with genes bearing internal repetitive elements (Hellman and Chess, 2007). 
Alternatively, this may simply represent the global hypomethylation of the inactive X-
chromosome relative to its active counterpart (Viegas-Pequignot et al., 1988; Weber et al., 
2005). 
Gene repression on the Xi is not ubiquitous as many genes avoid repression and are 
biallelically expressed form both chromosomes (Brown and Greally, 2003; Carrel et al., 
1996; Carrel and Willard, 2005). Active genes located on the Xi are generally localised to 
the region that is homologous with the Y chromosome. It is therefore possible that these 
represent genes which can opt out of inactivation due to equal dosage between the sexes 
(Brown et al., 1991). Alternatively, genes escaping X-inactivation have been shown to 
correlate with more recent acquisition to the sex chromosome, via autosomal translocation. 
This would suggest an alternative hypothesis, where selective pressure has not yet dictated 
the inactivation of these genes (Graves, 2006). The mechanism by which these genes remain 
transcriptionally active is unclear. A recent microarray study investigating the DNA 
methylation status of human gene promoters indicated that promoters of genes which escape 
inactivation were hypomethylated relative to their inactivated counterparts, consistent with 
previous reports (Carrel et al., 1996; Weber et al., 2007). This is particularly interesting, 
since it has been posited that these genes contribute to sexual dimorphic traits (Carrel and 
Willard, 2005). Furthermore, escaping genes are somewhat variable between individuals, 
which may consequently provide female specific phenotypic heterogeneity (Carrel and 
Willard, 2005). These findings suggest a possible role for DNA methylation in establishing 
or propagating these polymorphic traits. 
Haploinsufficiency occurs when a diploid organism transcribes a gene from only one allele, 
such that expression is insufficient for correct gene function. Consequently, X inactivation 
represents a paradox, as it appears to impose this fate by creating X chromosome specific 
monosomy, which results in Turner Syndrome in humans (Zinn and Ross, 1998). However, 
there is recent evidence to suggest, that mammalian cells avoid this deleterious effect, by 
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specifically up-regulating the Xa, following zygote formation (Nguyen and Disteche, 2006). 
The mechanisms facilitating this process are unclear at present, but this represents an 
unanticipated aspect of mammalian dosage compensation. 
1.3 CpG Islands 
The mammalian genome is globally methylated at the majority of CpG sites with 
methylation being localised to gene bodies, endogenous repeats and transposable elements 
(Eckhardt et al., 2006; Ehrlich et al., 1982; Weber et al., 2005). However, this methylated 
landscape is punctuated by CpG rich non-methylated sequences, called CGIs (Bird et al., 
1985; Cooper et at,, 1983; Gardiner-Garden and Frommer, 1987). CGIs have an increased 
G+C content and are enriched for CpG dinucleotides, although this CpG density alone is 
insufficient to account for the elevated GC composition. Suppression of CpG, characteristic 
of the majority of the genome, is not observed in these regions due to the lack of DNA 
methylation and the consequent absence of deamination. The existence of CGIs resolves the 
apparent discrepancy whereby 15% of CpG sites localise to approximately 2% of the 
mammalian genome (Antequera and Bird, 1993; Ehrlich et al., 1982). 
This human CGI fraction was first identified by digesting genomic DNA with the methyl-
sensitive restriction endonuclease HpaII (Antequera and Bird, 1993; Cooper et al., 1983). 
This preparation preserved the majority of the genome as high molecular weight DNA, 
whilst generating a small proportion of highly restricted products termed HTFs (HpaII Tiny 
fragments; (Antequera and Bird, 1993; Cooper et al., 1983)). Based on the characterisation 
of these initial digestion products, CGIs were defined as sequences longer than 200bp which 
have a G+C composition of more than 50% and a CpG[o/e]  in excess of 0.6 (Gardiner-
Garden and Frommer, 1987; Larsen et al., 1992). These parameters have been refined based 
on data generated by the human genome project, however this definition is still widely used 
for sequence based CGI prediction (computational CGI prediction will be discussed later; 
(Hackenberg et al., 2006; Lander et al., 2001; Ponger and Mouchiroud, 2002; Takai and 
Jones, 2002; Waterston et al., 2002)). 
CGIs are, on average, one kilobase in length and notably overlap the promoter regions of 
approximately 60-70% of all human genes (Bird et al., 1985; Lander et al., 2001; Larsen et 
Vil The actual number is likely to be closer to 60% as CGIs are used to predict gene 
promoters. Therefore, annotated genes will be artificially biased towards the promoter CGI 
category Saxonov, S., Berg, P., and Brutlag, D.L. (2006). A genome-wide analysis of CpG 
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al., 1992; Saxonov et al., 2006; Weber et al., 2007). Preliminary chromatographic 
purification of these sequences was driven by their utility in mapping cDNA (cloned DNA) 
sequences to their 5' regulatory elements (Cross et al., 1994). Specifically, CGIs have been 
shown to colocalise with the promoters of all housekeeping genes and approximately 40% of 
those displaying a tissue restricted expression profile (Larsen et al., 1992). The more 
ubiquitously expressed CGI promoters appear to define a class of transcription start sites 
which can initiate from multiple positions within the promoter. The more tissue restricted 
class on the other hand is generally associated with a single well defined initiation site and a 
TATA consensus (reviewed in (Sandelin et al., 2007)). Promoter association accounts for the 
uneven distribution of CGIs in the genome, showing preferential localisation to gene rich 
regions (Craig and Bickmore, 1994; Lander et al., 2001). A combination of molecular and 
computational mapping methodologies have determined that there are between twenty and 
thirty thousand CGIs in the haploid human genome (Antequera and Bird, 1993; Ewing and 
Green, 2000; Lander et al., 2001; Takai and Jones, 2002). 
Consistent with promoter association, CGIs are characterised by a transcriptionally 
permissive chromatin state (Bird, 1987; Larsen et al., 1992; Tazi and Bird, 1990). These 
findings suggest that CGIs may provide a means to distinguish gene promoter regions from 
the large proportion of transcriptionally irrelevant intergenic chromatin. This would suggest 
that CGIs facilitate the correct association of ubiquitous transcription factors to their cognate 
sites within regulatory sequences. Support for this idea was provided by an early study 
investigating the distribution of transcription factor binding sites in a small panel of human 
genes (Prestridge and Burks, 1993). Whilst binding sites were slightly enriched in promoter 
proximal sequences, they were also highly abundant throughout the genome (approximately 
16 sites per lOObp). This study concluded that the presence of binding sites alone was 
insufficient to identify promoters, which supports the idea that CGIs may serve as TF 
'landing lights' in the darkness of the nucleus (Bird, 1995; Prestridge and Burks, 1993). 
CGIs do not always localize to annotated transcriptional start sites of protein coding genes. 
However, is interesting to note that previous detailed investigation of intergenic, 'orphan 
CGIs', has subsequently led to the identification of previously unanticipated promoters 
(Gardiner-Garden and Frommer, 1994; Kleinjan et al., 2004; Macleod et al., 1998). This 
suggests that all CGIs may represent sites of transcriptional initiation which have thus far 
dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc 
Nati Acad Sci U S A 103, 1412-1417.. 
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remained unidentified. Indeed it is possible that certain alternative start sites are utilised in a 
highly tissue restricted fashion, and as such have escaped annotation. Indeed several genes 
which are transcribed from intragenic CGIs have been found to be expressed during highly 
specific developmental stages (Kleinjan et al., 2004; Macleod et al., 1998). 
1.3.1 The Origin and Maintenance of CpG Islands 
The characteristic clustering of CpG sites is a consequence of CGI immunity against de novo 
methylation during the earliest stages of mammalian development. However the mechanism 
by which CGIs remain hypomethylated during the period of global de novo methylation 
remains unclear. A simple suggestion would be that they are intrinsically refractive to de 
novo methylation by preventing the action of the DNMTs. This seems unlikely however, as 
CGIs contain a substantially elevated density of CpG sites, the preferred substrate of the 
DNMT enzymes (Ramsahoye et al., 2000). Moreover, CGIs located on the female inactive X 
chromosome and those of certain cultured mammalian cells readily acquire DNA 
methylation (Antequera et al., 1990; Weber et al., 2005). 
A plausible alternative is that bound transcription factors sterically preclude the activity of 
DNMTs at CGI sequences (Cuadrado et al., 2001). Evidence for such a mechanism is 
supported by mouse transgenic experiments in which ablation of binding sites for the 
ubiquitous transcription factor Spi was shown to facilitate de novo methylation of the APRT 
promoter CGI (Brandeis et al., 1994; Macleod et al., 1994). Consistently, c-globin which is 
transcribed in the embryo contains a promoter CGI whilst the related, transcriptionally silent, 
3-globin gene does not (Daniels et al., 1997). Moreover, analysis of a panel of genes 
expressed during mouse embryogenesis found that 93% are associated with a 5' CGI (Ponger 
et al., 2001). A global characterisation of histone modifications in mouse ES cells identified 
islands of H3K4me3 at almost all CGIs (Mikkelsen et al., 2007). These data suggest that 
CGIs are footprints of the basal transcription machinery localised during embryogenic de 
novo methylation. However, this model does not account for the observation that CGIs are 
intrinsically sensitive to nuclease digestion and therefore more accessible than the majority 
of the genome (Antequera et al., 1989; Tazi and Bird, 1990). Moreover, the majority of CGIs 
remain hypomethylated in terminally differentiated cells irrespective of gene association and 
transcriptional activity (Eckhardt et al., 2006; Larsen et al., 1992; Weber et al., 2007). 
A third possibility is that CGIs are targeted by a DNA demethylation mechanism, which 
specifically removes the methyl moiety from the cytosine base. Various protein factors, 
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including CGBP (CpG Binding Protein) possess a CXXC domain, which can specifically 
bind to non-methylated CpG sites (Carlone et al., 2002; Voo et al., 2000). This protein has 
been shown to associate with the MLL complex, which mediates the formation of 
transcriptionally permissive chromatin via histone modifying activities (Ansari et al., 2008). 
It is possible, that an equivalent recruitment mechanism could target a demethylation activity 
to CGIs. However, no such demethylase activity has thus far been identified in somatic 
tissues. 
Recent evidence suggests a rather speculative alternative involving the methyltransferase 
like factor DNMT3L. As previously discussed, this protein can associate with, and facilitate 
the action of the de novo methyltransferases (Gowher et al., 2005; Hata et al., 2002; Jia et al., 
2007; Suetake et al., 2004). However, this protein cannot bind to chromatin in which the 
Historic H3 tails are tn-methylated at the lysine 4 position (Ooi et al., 2007). A recent 
investigation indicated that the majority of protein coding gene promoters were occupied by 
RNA polymerase II and trimethylated at H3K4 even in the absence of transcriptional 
elongation (Guenther et al., 2007). The presence of this active mark at CGI-promoters may 
prevent de novo methylation via repulsion of DNMT3L. Moreover, the persistence of these 
modifications in somatic tissues where transcription levels are below detection may still 
prevent accumulation of methylation through the same mechanism. Indeed, one study 
indicated that tissue specific genes may be expressed at very low levels, but are nonetheless 
active (Cuadrado et al., 2001). This model is speculative at this point and requires 
experimental scrutiny to determine its validity. 
High density clustering of CpG sites alone does not account for the atypical G+C 
composition of mammalian CGIs. Moreover, it is unlikely that the basal transcription 
machinery alone could generate a I kilobase footprint characteristic of CGI sequences. 
Interestingly, several vertebrate CGIs are found to associate with origins of DNA replication 
(Delgado et al., 1998; Phi-van and Stratling, 1999; Rein et al., 1997). This led to the proposal 
that both elevated G+C composition and lack of DNA methylation could arise through the 
association of CGIs with altered DNA metabolism at these sequences (Antequera and Bird, 
1999). The unique looping of DNA during replication initiation in combination with the 
replication apparatus may provide an alternative means by which DNA methylation could be 
precluded from these sites (Antequera and Bird, 1999). 
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Several of these models are likely to be involved in the establishment of CGIs and the 
hypomethylation which persists during subsequent differentiation. High throughput analysis 
of chromatin modifications; transcriptional activity; transcription factor binding and global 
methylation analysis will likely provide further insight into the origin of CGIs in the future. 
1.3.2 Aberrant CpG Island Methylation 
Knudson's 'two hit hypothesis' dictates that incremental mutations are required for the 
conversion of 'normal' cells into highly proliferative cells characteristic of cancer. In this he 
stated that two or more mutational events were required to disrupt cellular regulation and 
consequently facilitate cancer formation (Knudson, 1971). At this stage cancer was 
considered as a genetic disorder, resulting from mutations in the underlying DNA sequence 
itself. However, more recent data suggests that epigenetic abnormalities also play an 
important role in the etiology of neoplasia (reviewed in (Jones, 2002; Jones and Baylin, 
2007; Ting et al., 2006)). 
Cancer cells and transformed cell lines are often characterised by a global paucity of DNA 
methylation (see for example (Rodriguez et al., 2006; Weber et al., 2005)). This has been 
implicated in genome instability, and subsequent genetic abnormalities such as chromosomal 
rearrangements and aneuploidy (Fukasawa, 2005; Rodriguez et al., 2006). Alternatively, 
there is extensive evidence indicating that unscheduled de novo methylation of CGIs 
associated with tumour suppressor promoters is a frequent hallmark of many cancer cells 
(Huang et al., 1999; Weber et al., 2005; Yan et al., 2002; Yan et al., 2000). Consequently, 
epigenetic silencing (epimutation) of tumour suppressor genes has been suggested as a 
primary event leading to unchecked proliferation associated with metastasizing cells. 
Interestingly, a similar phenomenon has been reported in permanent cultured cell lines, 
where CGIs associated with non-essential gene promoters are frequently de novo methylated 
(Antequera et al., 1990). 
Is cancer specific CGI methylation a random stochastic event or a more targeted 
phenomenon directed towards particular DNA sequences? Evidential support for the former 
comes from the observation that several DNA sequences aberrantly acquire DNA 
methylation during the process of aging in mammalian cells (Issa et al., 1996; Kwabi-Addo 
et al., 2007; Oakes et al., 2003; Toyota et al., 1999). A study of epigenetic variation in 
monozygotic twins, determined that global and regional methylation levels varied more 
extensively within older (>28) twin pairs (Fraga et al., 2005). This phenomenon could result 
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in an accumulation of meCpG at promoter CGIs inadvertently invoking gene silencing of 
tumour suppressors and provide a selective growth advantage to these cells. However, these 
studies are based on a small numbers of candidate loci or are relatively low resolution with 
respect to individual CpG sites. Consequently changes in DNA methylation levels as a 
function of age, has proven to be contentious. A large scale bisulfite sequencing analysis of 
512 human CGIs failed to identify significant methylation differences between two panels of 
tissues of disparate age (mean ages of 26 and 68; (Eckhardt et al., 2006)). Moreover, there is 
evidence to suggest that cancer specific methylation is distinct from that associated with 
human aging (Toyota et al., 1999). Analysis of a panel of colorectal cancers indicated that 
CGI methylation occurred in both metastatic cells and adjacent parenchyma in an age 
dependent fashion. However, certain CGIs were found to be methylated specifically in a 
subset of cancer cells and were distinct from those found in normal parenchyma. This 
phenomenon was termed the CpG Island Methylator Phenotype (CIMP; (Toyota et al., 
1999)). This finding alone does not however, rule out the possibility of random CGI 
methylation, and clonal selection and expansion. More recently several studies have 
identified a link between chromatin modifications and CGIs which acquire aberrant 
methylation in cancer (Keshet et al., 2006; Ohm et a]., 2007; Schlesinger et al., 2007). 
H3K27me3 is a repressive histone modification associated with the promoters of many 
developmental genes during the early stages of embryogenesis. Interestingly, islands which 
were found to be aberrantly methylated in cancer cells and cell lines were found to be tightly 
associated with genes marked by this modification in ES cells (Keshet et al., 2006; Ohm et 
al., 2007; Schlesinger et al., 2007). These studies concluded that DNA methylation may 
serve to lock in a pseudo pluripotent stem cell like state, which facilitates cellular 
proliferation. These findings suggest an "instructive" mechanism whereby this chromatin 
modification directs cancer specific methylation; although it is unclear whether this is the 
only mechanism giving rise to aberrant CGI methylation (Keshet et al., 2006; Ohm and 
Baylin, 2007; Ohm et al., 2007; Schlesinger et al., 2007). 
1.3.3 'Normal' CpG Island Methylation 
Despite this wealth of data pertaining to the methylation status of CGIs in cancers, relatively 
little attention has been paid to the equivalent phenomenon in 'normal' cells. Indeed, a small 
but significant proportion of CGIs does acquire methylation during human development, and 
is implicated in functionally important processes such as X-inactivation (previously 
discussed) and parental imprinting (Reik, 2007). CGI methylation at imprinted loci is 
generally chromosome specific and has a functional role in the regulation of monoallelic 
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expression (Li et al., 1993; Sleutels et al., 2002; Wutz et al., 1997)). A CGI located at the 
IGF2R/H19 locus serves as an insulator element, which can either promote or repress the 
expression of IGF2R in a methyl-dependent manner. Moreover, the non coding RNA Air is 
paternally expressed from the differentially methylated intragenic CGI of murine IgJ2r, and 
represses transcription of the maternally expressed gene cluster (Sleutels et al., 2002; Wutz 
et al., 1997). The importance of correct methylation at this CGI has been illustrated by the 
complete repression of certain IGF2R isoforms, as a consequence of biallelic methylation 
during aging and carcinogenesis in human cells (Issa et al., 1996). A third class of 
methylated islands has been characterised, and these associate with the promoter regions of 
germ line specific genes which are silenced in somatic tissues (De Smet et al., 1999; Shen et 
al,, 2007; Weber et al,, 2007). Genes of the MAGE (Melanoma Antigen Encoding Genes) 
family are silenced during embryogenesis primarily through the methylation of CpG rich 
promoter sequences (De Smet et al., 1999). Accordingly, promoter demethylation correlates 
with ectopic expression in various cancer cells (Honda et al., 2004). 
Several studies have identified additional methylated CGIs (Eckhardt et al., 2006; Kitamura 
et al., 2007; Strichman-Almashanu et al., 2002; Weber et al., 2007; Yamada et al., 2004). A 
digestion based cloning strategy identified 43 hypermethylated CGIs in human somatic 
tissues (Strichman-Almashanu et al., 2002). Interestingly, detailed analysis determined that 
approximately half of these sequences were hypermethylated in germ-line derived cells from 
both parents, indicating that these sequences do not represent imprinted loci (Strichman-
Almashanu et al., 2002). This finding was unexpected as methylation during this 
developmental stage is likely to result in heritable depletion of CpG sites through 
spontaneous mutation of methyl-cytosine. Methylation analysis of all predicted' CGIs (149) 
on the q arm of human Chromosome 21 determined that 22% were heavily methylated in 
peripheral blood DNA (Yamada et al., 2004). 
More recently, high throughput analysis has provided a more comprehensive view of the 
human CGI methylome (Eckhardt et al., 2006; Weber et al., 2007). Weber and coworkers 
screened the majority of human gene promoters by probing oligonucleotide arrays with DNA 
prepared using the MeDIP technique (Weber et al., 2005; Weber et al., 2007). Interestingly, 
Viii Prediction was based on the formal CGI criteria proposed by Gardiner-Garden and 
Frommer, with an increased stringency for CGI length (>400bp) and repeat masking 
Gardiner-Garden, M., and Frommer, M. (1987). CpG islands in vertebrate genomes. J Mol 
Biol 196, 261-282, Yamada, Y., Watanabe, H., Miura, F., Soejima, H., Uchiyama, M., 
Iwasaka, T., Mukai, T., Sakaki, Y., and Ito, T. (2004). A comprehensive analysis of allelic 
methylation status of CpG islands on human chromosome 21q. Genome Res 14, 247-266.. 
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relatively few CGIiX  promoters were found to be methylated (-3%) in somatic tissues and 
primary cell lines (Weber et al., 2007). These finding were consistent with those of an 
independent study, which identified 4% of CGT promoters as hypermethylated in whole 
peripheral blood leukocytes (Shen et al., 2007). Alternatively, promoters with relatively 
reduced CpG content were frequently found to be methylated in these cells (Weber et al., 
2007). This finding is consistent with the observation that a methylated fraction purified 
from human whole blood was found to be enriched for sequences with a CpG density 
intermediate between CGIs and bulk genomic DNA (Brock et al., 1999). High resolution 
bisulfite sequencing analysis was carried out for 2,524 regions of human chromosomes 6, 20 
and 22 in a panel of 12 tissues (Eckhardt et al., 2006). This study identified 9.2% of 
predicted CGIs as methylated at more than 80% of CpG sites in one or more somatic tissues 
(Eckhardt et al., 2006). The discrepancy between the observed numbers from these two 
studies likely arises due to two key experimental factors. 1). Eckhardt and colleagues 
partitioned methylation into 3 categories including those sequences presenting intermediate 
levels of methylation (>20 and <80% "CpG). 2). The bisulfite analysis assayed CGIs 
irrespective of promoter association, and therefore may reflect an altered tendency towards 
methylation of these sequences (Eckhardt et al., 2006; Weber et al., 2005). Consistently, only 
2.1% of promoter associated CGIs were identified as hypermethylated (>80%) by bisulfite 
sequence analysis (Eckhardt et al., 2006). Furthermore, both studies confirmed that many 
CGIs in sperm are hypomethylated with respect to those in somatic tissues (Eckhardt et al., 
2006; Weber et al., 2005). 
A small proportion of CGIs presented tissue specific differential methylation levels 
(Eckhardt et al., 2006). This finding is particularly interesting as it is conceivable that 
differential CGI methylation could function in tissue specific gene regulation. Consistently, 
candidate analysis of the CpG rich promoter of the human gene MASPIN identified tissue 
specific methylation. Promoter methylation levels were shown to correlate with 
transcriptional inactivity (Futscher et al., 2002). RLGS (Restriction Landmark Genomic 
Scanning) analysis of DNA methylation in five somatic tissues and mature sperm in mice 
indicated that as many as 5% of CGIs associated with tissue specific methylation profiles. 
Analysis of 14 candidate loci determined that the majority were specifically hypomethylated 
IX  CGIs in this study are referred to as HCPs (High CpG Promoters) whereas other lOPs 
(Intermediate CpG Promoters) have a sequence composition intermediate to that of CGIs 
and bulk genomic DNA Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., 
Rebhan, M., and Schubeler, D. (2007). Distribution, silencing potential and evolutionary 
impact of promoter DNA methylation in the human genome. Nat Genet 39, 457-466.. 
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in sperm, although one COT associated with the promoter of Gata2 was specifically 
methylated in liver consistent with low level transcription in this tissue (Song et al., 2005). 
Interestingly a recent study identified a panel of methylated promoters in murine ES cells, of 
which, approximately 3% were associated with CGIs (Fouse et al., 2008). These included 
members of the Reproductive homeobox (rHOX) class of transcription factors. The 0.7Mb 
rHOX cluster has been shown to associate with lineage specific methylation patterns which 
dictate the expression of the respective genes in the embryonic lineages (Oda et al., 2006). 
Analysis of DNMT mutants confirmed that these genes are primarily silenced by DNA 
methylation (Fouse et al., 2008; Oda et al., 2006). Minimal overlap between genes repressed 
by DNA promoter methylation and those targeted by PcG and Nanog / Oct4 suggests that 
there are multiple complementary regulatory mechanisms which maintain correct expression 
in the preimplantation embryo (Fouse et al., 2008). 
These recent investigations have provided tantalising insights into distribution of 
methylation across this functionally important fraction of the genome. However, there are 
many remaining questions. Do tissue specific methylation patterns have a mechanistic role in 
hard wiring expression patterns in terminally differentiated cells? Does differential COT 
methylation occur between equivalent healthy cells in different individuals? These questions 
must be addressed before we can begin to understand the role of this epigenetic phenomenon 
in transcriptional regulation and consequently the aberrant events associated with cancer. 
1.4 PhD Objectives 
The purpose of this PhD is to provide better insight into the distribution and methylation 
status of CpG islands in normal somatic tissues. This will be approached by two related 
chromatographic methodologies. In the first instance a novel purification technique will be 
developed to enrich for sequences containing clusters of nonmethylated CpG sites. This will 
be applied to the generation of a CGI set from whole human blood genomic DNA. 
Characterisation of this library will be used to determine the spatial distribution of CGIs 
relative to protein coding genes and with those identified by sequence based prediction 
algorithms. Subsequent analysis will focus on methylated CGIs in normal human tissues, as 
this remains a relatively poorly defined fraction of the genome. To this end, methylated CGIs 
will be purified from total genomic DNA using MAP chromatography (Brock et al., 1999; 
Cross et al., 1994). A microarray representing the entire CGI set will be probed with MAP 
fractions prepared from blood, brain, muscle and spleen DNA. Microarray results will be 
MIJ 
validated using conventional techniques, and then used to assess genomic distribution, tissue 
variability and gene association of these sequences. It is hoped that these results will provide 
insight into previously unanticipated biological processes involving methylation of CGIs. 
The majority of data presented in this thesis has been published and can be found in 
Appendix I (Illingworth et al., 2008). 
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Chapter 2: 	Materials and Methods 
2.1 	Materials and Reagents 
All material and reagents were stored at room temeperature (nt) unless otherwise stated. 
Standard Molecular Biological reagents will not be referred to here 
2.1.1 DNA Manipulation 
Orange G loading buffer (6x): 0.198% (w/v) orange G, 12% (w/v) Ficoll, 120mM 
EDTA pH8.0, 4.2% (w/v) SIDS. Stored at —20°C (long-term) or nt (short-term). 
Proteinase K stock solution: 20mg/mi proteinase K, 100mM EDTA pH 7.5, 2% 
(w/v) SDS. Stored at —20°C. 
DNA Sequencing Buffer (2.5x): 20mM Tris HC1 (p118) and 5mM MgC12. 
TAE electrophoresis buffer (lx): 40mM Tris-acetate, 1mM EDTA 
TBE electrophoresis buffer (lx): 45mM Tris-borate, 1mM EDTA 
Bisulfite modification solution (pH of 5.0): 3.8g sodium hydrogen sulfite 
(NaHS03) was dissolved in 5m1 dH20 and 1.5ml 2M NaOH (protected from light). 110mg 
hydroquinone was dissolved in imi dH20 at 55°C for ten minutes. The sodium bisuiphite 
and the hydroquinone solutions were then mixed. Bisuiphite modification solution was 
prepared immediately prior to use. 
TE buffer pH7.5: 10mM Tnis HCI p7.5, 1mM EDTA 
RCL Buffer (Red Cell Lysis): 150mM Ammonium Chloride (NH4C1), 10mM 
Potassium Hydrogen Carbonate (KHCO3) and 0.01% (w/v) EDTA. 
Eli 
SL Buffer (Sperm Lysis): 6M Guanidinium Hydrochloride, 30mM Sodium Citrate 
(pH7), 0.5% (w/v) Sarkosyl, 0.2mg/mi proteinase K, 0.2mg/ml RNase A and 0.3M - 
mercaptoethanol. 
2.1.2 RNA Manipulation 
lOx MOPS buffer: 400n-LM MOPS, 100mM NaOAc, 10mM EDTA. pH adjusted to 7.0 
with NaOH. 
RNA loading buffer (3x): 60% (v/v) deionised formamamide, 8% formaldehyde, 0.5x 
MOPS buffer, 0.4% (w/v) bromophenol blue and 1mg/mi ethidium bromide. Stored at 
—20°C. 
2.1.3 Protein Manipulation 
Sodium Phosphate Buffer [pH8]: 6.8m1 1M Sodium dihydrogen phosphate 
(NaH2PO4) and 93.2 ml IM di Sodium hydrogen phosphate (Na2HPO4). 
PBS (lx): 140mM NaCl, 3mM KC1, 2mM KH2PO4, 10mM Na2HPO4 
Chelating Sepharose wash buffer [pH4]: 0.02 M NaOAc and IM NaCI. 
NlO buffer: 50mM sodium phosphate buffer pH8.0, 300mM NaCl, 10% (v/v) glycerol, 
10mM Imidazole, 15mM -mercaptoethano1 and 0.5mM PMSF. J-mercaptoethano1 and 
PMSF were added immediately prior to use. Stored at 4°C 
N20 buffer: As per N10 buffer but with 20mM Imidazole. 
N250 buffer: As per N10 buffer but with 250mM Imidazole. 
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CEA buffer (Cation Exchange A): 20mM HEPES (pH7.9), 0.1% (v/v) Triton X-100, 
10% (v/v) Glycerol, 0.5mM PMSF and 0.5mM -mercaptoethanol. J3-mercaptoethanol and 
PMSF were added immediately prior to use. Stored at 4°C. 
CEB buffer (Cation Exchange B): As per CEA buffer with the addition of IM NaCl. 
Coomassie Brilliant Blue R-250 staining solution: 50% (v/v) methanol, 10% 
(v/v) glacial acetic acid, 0.1% (w/v) Coomassie Brilliant Blue R-250. Filtered through a 
Whatman number 1 filter. 
Coomassie destain solution: 50% (v/v) methanol and 10% (v/v) glacial acetic acid. 
CNBr coupling buffer (pH8.3): 0.1M NaHCO3 and 0.5M NaCl. 
SDS PAGE loading buffer (2x): 100mM Tris HCI pH6.8, 4% (w/v) SDS, 20% (v/v) 
glycerol, 200mM DTT, 0.2% (w/v) bromophenol blue. Stored at —20°C. 
SOS PAGE separating gel: 8-15% (w/v) 29:1 acrylamide:bis-acrylamide, 0.1% (w/v) 
SDS, 390mM Tris HC1 pH8.8, 0.08% (v/v) TEMED, 0.1% (w/v) APS. Prepared immediately 
prior to use. 
SDS PAGE stacking gel: 5% (w/v) 29:1 acrylamide:bis-acrylamide, 0.1% (w/v) SDS, 
129mM Tris HC1 pH6.8, 0.1% (v/v) TEMED, 0.1% (w/v) APS. Prepared immediately prior 
to use. 
Tris-glycine electrophoresis buffer: 25mM Tris, 250mM glycine, 0.1% (w/v) SDS. 
Bandshift binding buffer (5x): 30 mM Tris-HCI (pH8), 750 mM NaCl, 5 mM DTT, 
30 mM MgC12, 15% (v/v) Glycerol, 50 ng/p.l BSA, and 0.05 pg/pJ of poly(dAdT) 
(Amersham). 
2.1.4 Bacterial Media 
Me 
Ampicillin stock solution: 50mg/mi ampicillin in dH2O. Filter sterilize (0.2j.im filter) 
and stored at —20°C. Added to LB medium to a final concentration of 50j.tg/ml. 
Kanamycin stock solution: SOrng/ml kanamycin in dH2O. Filter sterilize (0.2.im 
filter) and stored at —20°C. Added to LB medium to a final concentration of 50tg/ml. 
Choramphenicol stock solution: 34mg/mi chloramphenicol in 96% (v/v) ethanol. 
Stored at —20°C protected from light. Added to LB medium to a final concentration of 
34 jig/mI. 
IPTG stock solution: IM 1PTG (Isopropyl--D-thiogalactoside) in dH20. Filter 
sterilize (0.2j.tm filter) and stored at —20°C. 
X-gal stock solution: 40mg/ml X-gal in dimethylformamide (DMF). Protect from light 
and stored at —20°C. 
Blue/white selection LB agar plates: LB / antibiotic plates were spread with 40j.tl 
100mM IPTG, and 40j.tl 40mg/ml X-gal and dried at 37°C. Prepared on day of use. 
LB medium: lOg/I Bacto tryptone (Difco), 5g/l Bacto yeast extract (Difco), lOg/l NaCl. 
pH adjusted to 7.0 with NaOH. 20g/i Bacto agar (Difco) added if making LB agar then 
autoclaved. LB agar plates (20m1 volume) were stored inverted at 4°C and LB broth was 
stored at r/t. 
NZY+ medium: lOg/l casein hydrolyaste, 5g/l yeast extract and 85mM NaCl. Adjust pH 
to 7.5 with NaOH and autoclaive. Prior to use add 12.5m1 of 1M MgCl2, 12.5mi of 1M 
MgSO4 and 20ml 20% (w/v) glucose per 11 of autoclaived media. 
Competent cell buffer A: 100mM RbCI, 50mM MnCl2, 30mM KOAc, 10mM CaCl2, 
15%(v/v) Glycerol. Adjusted pH to 5.8 and filter sterilize (0.2jim filter). 
Competent cell buffer B: 10mM MOPS, 10mM RbCl2, 75mM CaCl2, 15%(v/v) 
Glycerol. Adjusted pH to 8.8 and filter sterilize (0.2jim filter). 
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Miniprep solution 1: 25mM Tris HCI pH8.0, 10mM EDTA, 50mM glucose. Stored at 
4°C. 
Miniprep solution 2: 200mM NaOH, 1% (w/v) SDS. Prepared immediately prior to use. 
2.1.5 Bacterial Strains 
DH5cc 
Genotype: supE44 AlacU169 (80 IacZAM15) hsdR17 recAl endAl gyrA96 thi-1 relAl. 
Laboratory stock. 
XU-Blue 
Genotype: recA l endA I gyrA96 thi- 1 hsdR 17 supE44 relA I lac [F proAB lact'ZAM 15 
TnlO (Tet1 )]. Laboratory stock. 
XI-10-Gold 
Genotype: Tetr A(mcrA)183 A(mcrCB-hsdSMR-mrr)173 endAl supE44 thi-1 recAl gyrA96 
relAl lac Hte [F proAB lacIqZAMl5 TnlO (Tetr) Tn5 (Kanr) Amy]. Stratagene 
TOP1OF' 
Genotype: F'{Iaclq TnlO (TetR) mcrA A(mrr-hsdRMS-mcrBC) b801acZAM15 AlacX74 
recAl araD 139 A(ara-leu)7697 galU galK rpsL endAl nupG. Invitrogen. 
131-21-CodonPlus (DE3)-RIL 
Genotype: E. coli B F— ompT hsdS(rB— mB—) dcm+ Tetr gal endA Hte [argU ileY 
leuWCamr]. Stratagene 
BL21(DE3)pLysS 
Genotype: E. coli B F— dcm ompT hsdS(rB— mB—) gal X(DE3) [pLysS Camr]. Stratagene 
StrataClone Solo Pack Competent Cells 
Genotype: E. coli B F— lacZAM15 [pSC-A-amp/kan] endA recA tonA. Stratagene 
2.1.6 Microarray Reagents 
MH buffer (Microarray hybridization): 2xSSC, 50% (v/v) deionised formamide, 10 
mIvI Tris-HCI [pH7.5], 5% (w/v) dextran sulphate and 0.1% (v/v) Tween 20. 
MHu buffer (microarray humidifier): 2xSSC, 50% (v/v) deionised formamide, 10 
mM Tris-HC1 [pH7.5] and 0.1% (v/v) Tween 20. 
SSC (Saline Sodium Citrate - 20x): 3M Sodium Chloride (NaCl) and 0.3M Sodium 
Citrate. Adjusted to [pH7] using 1M HC1. 
MWA buffer (Microarray Wash A): lx PBS and 0.05% (v/v) Tween 20. 
MWB buffer (Microarray Wash B): IxSSC. 
2.1.7 CXXC and MAP Affinity Purification reagents 
BW1 buffer (Beads Wash 1): 20mM HEPES [p117.9], 10% (v/v) Glycerol, 0.1% (v/v) 
TritonX-100, 100mM NaCl, 0.5mM PMSF and 10mM -mercaptoethanol. 1-
mercaptoethanol and PMSF were added immediately prior to use. Filter sterilized (0.2.1), 
degassed and stored at 4°C. 
BW2 buffer (Beads Wash 1): As for BWI buffer + 10mM Imidazole. 
CA buffer (Column buffer A): 20mM HEPES [pH7.9], 10% (v/v) Glycerol, 0.1% 
(v/v) TritonX-100, 0.5mM PMSF and 10mM f3-mercaptoethanol. 3-mercaptoethanol and 
PMSF were added immediately prior to use. Filter sterilized (0.2ji), degassed and stored at 
4°C. 
CB buffer (Column buffer B): As for CA buffer + 1M NaCl. 
2.1.8 Oligonucleotides 
All custom oligonucleotides were purchased from Sigma-Genosys. Oligonucleotides were 
resuspended in dH20 to lOOp.M (except where stated). Working stocks were diluted in dH20 
to 10l.tM. Resuspended oligonucleotides were stored at —20°C. 
M. 
Table 2.1-1. Genomic DNA PCR Primers 
Primer 
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Table 2.1-2. Bisulfite Primers 























































Table 2.1-3. Quantitative RT PCR orimers 
Primer 
Seq ID Names 	Sequence Forward 	 Sequence Reverse 
GAPDH 
G' P DH Fl/Ri RT TGGTATCGTGGAAGGACTCATGAC 	ATGCGAGTGAGCTTCGCGTTCAGC 
SEC31 B 
C31 B FA/RA AT CCACCTGAGAAGATGGAAAG 	GCTTCTCATATAGATACTCCAG 
Table 2.1-4. Sundry Oligonucleotides 
Oligonucleo 
Seq ID tide Name Sequence Forward Sequence Reverse  
Adaptori 
MseI GGT CCA TOG AAC CGA TOT 1 m M Stock 
Adaptor2 
Msei (p)TAA GAT GGG TTG GAT GGA cc 1 m M Stock 
Universal 
ImPOR Primer GGT CCA TCG AAC CGA TOT TA NA 
MBD MBD77-1 67 CGGHCATAACCATATGGCTTCT CGGAAGTCAAAGAATTCTCATCAGTG 




All methods were carried out at RIT unless otherwise stated. Some standard techniques will 
not be outlined here. 
2.2.1 DNA Manipulation 
Human Samples and DNA extraction 
Whole blood and sperm was collected from voluntary donors and anonymized, linked only 
with minimal sample information (Age, sex etc.). Donors were aware of, and consented to, 
its use for preparation of DNA. 
Monocyte and granulocyte cells were prepared from whole human blood using Ficoll 
gradient centrifugation. Whole blood (3ml) was layered onto an equivalent volume of 
Histopaque-1077 Ficoll (Sigma-Aldrich) and sedimented at 400g for 30min according to 
manufacturers instructions. Granulocyte cell pellets were resuspended in lOmis of RCL 
buffer and centrifuged at 1200g for lOmins (repeated twice to remove red blood cells). 
Monocyte and granulocyte cells were rinsed and sedimented twice in PBS at 1200g. Cells 
were visualised using standard reverse field microscopy. Pelleted cells stored at -80°C until 
required. All centrifugation steps were carried out in a swing bucket Allegra X-22 Series 
Benchtop Centrifuge (Beckman Coulter). 
Whole human blood, monocyte and granulocyte DNA was extracted using the Genomic-tip 
500/G (Qiagen 10262) genomic DNA purification kit as described by the manufacturer. 
Sperm DNA was prepared as described by Hossain and collegues (Hossain, et al., 1997). 
Briefly, 2m1 total ejaculate was centrifuged at 5000g for 5mm. Cell pellets were resuspended 
in lOmi PBS and sedimented as above with three repetitions to remove seminal material. 
Cell pellets were resuspended in SL buffer and incubated for 4hrs at 55°C. DNA was 
precipitated by addition of 20m1 of Isopropanol (Propan-2-ol) and then spooled out into 70% 
ethanol. The DNA was air dried for —5mins or until glassy in appearance and resuspended in 
500p1 of TE buffer. 
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Brain, Musice and Spleen DNA were purchased (Ambion) and supplied at a concentration of 
500pg/pl in TE. 
Measurement of DNA concentration 
DNA solutions were measured at OD260nm and OD280nm using a Nanodrop-I000 
spectrophotometer. An automated reading of DNA concentration was calculated using 
Beer's law (Concentration_ng/ul 	(Absorbance_OD260nm x Extinction 
coefficient_dsDNA_50ng/pl/cm) I pathlength_cm). DNA purity was determined using 
OD260nm:OD280nm ratio, with >-1.8 indicating the absence of residual protein or phenol 
contaminants from the sample. 
Restriction digestion 
DNA digest were carried out as per manufacturers instructions (NEB). Briefly, DNA was 
diluted in appropriate digestion buffer, supplemented with 100 p.g/ml Bovine Serum 
Albumin where appropriate and digested with 6U of restriction endonuclease per g of 
DNA. Reactions were typically incubated at 37°C for I -2hours. 
DNA Electrophoresis 
DNA was resolved by agarose gel electrophoresis using the Sub-cell system (Bio-Rad). 0.8-
2% (wlv) agarose gels were used depending on the DNA fragment(s) size to be resolved. 
Agarose gels were prepared with TAE (or TBE for fragments < 300bp) containing 0.5p.g/ml 
ethidium bromide, a DNA intercalating agent that fluoresces in ultraviolet (LW) light. DNA 
samples and appropriate size ladder (100bp-12kb; Invitrogen) prepared in orange G loading 
buffer were loaded into the wells of the gel. Agarose gels were run at constant voltage (75-
1 1OV) in TAE (or TBE) electrophoresis buffer and visualised under UV light. Where 
electrophoresed DNA was to be further manipulated, UV exposure was kept to a minimum 
to prevent damage. 
Gel Extraction 
Gel extraction was used to purify a homogeneous population of DNA fragments for cloning 
or probe preparation. Fragments were resolved by agarose gel electrophoresis, cut out and 
extracted using the Perfectprep Gel Cleanup Kit (Eppendort) according to manufacturers' 
instructions. 
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In vitro methylation 
DNA was methylated using the cytosine methyltransferase M.SssI (NEB). Methylation was 
carried out in a volume of 200.tl containing 0.5-2tg, DNA, 2j.il M.SssI (8U), reaction buffer 
2 (NEB), and supplemented with 1601iM SAM. After an ON incubation at 37°C the reaction 
was supplemented with a further 2il M.SssI and 1 tl SAM (32mM) and incubated for 2hrs 
prior to reaction clean up. 
End labeling 
DNA was radiolabelled by kienow incorporation of a32P-dCTP. Labeling was carried out in 
a total volume of 50 t1 containing 200-800ng DNA, 5111  10mM dNTPS (-dCTP), 2 11j al2p_  
dCTP (GE Healthcare), 2u1 klenow large fragment (NEB) and reaction buffer 2 (NEB). The 
labeling reaction was incubated at 37°C for 2 hours and then DNA was extracted using a 
nucleotide clean up kit (Qiagen). 
Oligo Annealing 
Oligos Al and A2 at a concentration of 1mM were annealed by incubation at 100°C for 
lOmins and then cooling for 5 hours to R/T. Final adaptor concentration of 500tM. 
DNA ligation 
Standard DNA ligation reactions were performed in a total of 20j.ils containing bOng 
linearised vector, insert DNA (3x molar excess), T4 DNA ligase buffer and lul T4 DNA 
ligase (NEB; equivalent to 6 Weiss units) and incubated ON at 16°C. 
COT library cloning was performed in a total volume of 1 .2ml containing 1/3' of the CXXC 
purified COT fraction, 600ng pGEM5zf-(gel extracted), 40pJ of T4 DNA ligase (240 Weiss 
units) and T4 DNA ligase buffer. The ligation reaction was incubated at 16°C for 24hours. 
MAP array linker ligation for 1mPCR. 10111 universal adaptor (50011M), 8111  T4 DNA ligase 
(48 Weiss Units) and T4 DNA ligase buffer was added to 50g of MseI digested genomic 
DNA to a total volume of 500111 and incubated at 16°C ON. A further 4 hour incubation was 
carried out after the addition of 4u1 of T4 DNA ligase (24 Weiss units). Ligation reactions 
were cleaned up using a PCR clean up kit (Qiagen) according to manufacturer's instructions. 
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DNA sequencing 
DNA sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing kit 
(Applied Biosystems). Sequencing reactions contained 21.11  BigDye Terminator v3.1, 5pmol 
primer, 41i1  DNA sequencing buffer and 10-150ng DNA template in a lOp] volume. The 
reactions were incubated under the following conditions: initial DNA denaturation at 96°C 
for lOsecs, then 24 cycles of DNA denaturation at 96°C for 30s, primer annealing at 50°C 
for 20s, and extension at 60°C for 4mm. Sequencing reactions were cleaned up and were run 
on an ABI 3730 capillary sequencer by the School of Biological Sciences Sequencing 
Service. Sequence data was quality controlled and analysed using Chromas Lite and 
Lasergene software respectively. 
The CGI library was sequenced at the Wellcome Trust Sanger Institute in Hinxton, 
Cambridge. The clone set was arrayed into 384 well plate format and sequenced using a 
modified alkaline lysis method. Cells were lysed in glucose, Tris, EDTA (pH 8) buffer plus 
NaOH and SDS and spun through Millipore Montage filter plates followed by DNA 
precipitation and resuspension in dH20. In all 172,800 clones were sequenced forward and 
reverse using T7 and 5P6 primers and BigDye V3.1 chemistry, under the following 
conditions: 30sec at 96°C, followed by 44 cycles of 92°C 8sec, 55°C 8sec, 60°C 2mm. 
Samples were resolved using a 3730 XL sequencers (Applied Biosystems). Extraction was 
performed using sequence analysis v3.1, and base-called using Phred. DNA sequences were 
identified and mapped to the human NCBI build 36 and annotated on the ENSMBL Genome 
Browser (http://www.ensembl.org/index.html).  
Polymerase Chain Reaction (PCR) 
PCR was employed to amplify specific target DNA molecules from a DNA template. 
Typical reactions were 251.il, containing DNA template (0.1-10ng), 400nM forward and 
reverse primers, 4001..tM dNTPS, Red Hot PCR buffer (ABgene), 2.5mM MgC12, 1.5U Red 
Hot DNA polymerase (ABgene). A negative control reaction with dH20 and no template and 
a positive control with template and conditions previously shown to yield a product were 
included. PCR cycling conditions were as follows: an initial denaturation at 94°C for 2n-ii 
followed by 30 cycles of denaturation at 94°C for 40sec, primer annealing at 	for 50sec, 
primer extension at 72°C for SOsec and an additional 72°C primer extension phase for 7mm 
to amplify any incomplete DNA molecules. Specific primer annealing temperatures (T n) 
were generally calculated to be the lowest primer melting temperature minus 2°C. 
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Depending on the purpose of the PCR some or all of the product was resolved by agarose gel 
electrophoresis. Supplementing the PCR reactions with 3% DMSO or Betaine or increasing 
the MgC12 concentration was routinely employed to amplify very GC rich target sequences. 
Whole genome amplification for microarray labelling was achieved using linker mediated 
(lm)PCR. Reactions were carried out in a volume of 500 containing adaptor ligated DNA 
template (10-100ng), 400uM dNTPS, 5001iM MgCl, supplement (GC Rich PCR system; 
Roche), 400nM ImPrimer, 5 p1 GC Rich supplement (GC Rich PCR system - Roche), 
reaction buffer (GC Rich PCR system - Roche) and 0.5 p1 polymerase (2.5U; GC Rich PCR 
system - Roche). PCR cycling conditions were as follows: an initial denaturation at 95°C for 
3min followed by 20 cycles of denaturation at 95°C for 50sec, primer annealing at 58°C for 
50sec, primer extension at 72°C for 4min and an additional 72°C primer extension phase for 
7mm. Amplified DNA was purified using a PCR clean up kit (Qiagen). 
Quantitative PCR 
Quantitative PCR was used to accurately quantify a target region in a DNA sample. SYBR 
Green I is a cyanine dye that absorbs light at a Xmax of 488 nm and emits light at a 2ma x of 522 
nm when complexed with double stranded (ds) DNA. Measurement of emitted light (522nm) 
directly allows the real-time quantification of duplexed DNA as it is synthesised. Each PCR 
reaction was prepared in a total volume of 20 p1, including DNA template (I-Song), SYBR 
Green supermix (hot start iTaq, sybr green dye and dNTPS; Biorad) and 300nM forward and 
reverse primers. Reactions were cycled on an iCycler iQ (Bio-Rad) according to 
manufacturer's instructions. Cycling conditions were as follows: an initial denaturation step 
of 95°C for 2.5mins then 45 cycles of denaturation at 95°C for 30sec, primer annealing at 
for 30sec, primer extension at 72°C for 30sec and data collection. After cycling, a single 
denaturation step at 95°C for Imin is followed by a 35°C to 94.5°C ramp spanning 20min in 
119 in 0.5°C incremental steps. The final temperature range generates the product melting 
curves. 
iCycler iQ software assigns a baseline fluorescence measurement based on the standard 
deviations calculated for cycles 2-10. This baseline bisects the fluorescence curves from each 
PCR in the linear amplification phase and indicates the cycle threshold value for that 
reaction (CT). An arbitrary measure of DNA quantity (Q) can be calculated using: 
= 2-Ct 
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Target sequences were quantified within and between DNA samples when calculated as a 
ratio to a reference sequence or sample. In order to ensure that quantifications were 
significant each PCR was carried out in triplicate and standard deviations were calculated for 
each quantification. 
Cloning 
DNA sequence corresponding to the CXXC and MBD domains were introduced into the 
pet30b His-tagging vector (Novagen). Briefly, DNA sequence corresponding to the hMBD 
and mCXXC domains were PCR amplified from cDNA. Forward and reverse primers 
complementary to the coding sequence, included an NdeI and EcoRI site respectively. NdeI 
introduces an ATG translation start site in frame with the cloned coding sequence. To 
incorporate a Histidine tag, the forward (N terminal) or reverse (C terminal) primer included 
an additional 18 nucleotides coding the 6xHis. Gel extracted PCR products were digested 
with EcoRI(NEB) and NdeI(NEB) according to the manufacturers instructions and ligated 
into the corresponding sites in the MCS of pet30b. 
PCR fragments generated by Taq DNA polymerase were gel extracted and cloned using the 
StrataClone PCR Cloning Kit (Stratagene) according to manufacturers' instructions. 
Abundant PCR products were cloned using half reactions including only 50% of the 
template, vector mix, buffer, competent cells and bacterial growth media. All incubation 
steps were carried out according to manufacturers' instructions. 
Exonuclease 1/Phosphatase treatment 
To prepare PCRs for sequencing 0.25tl (SU) exonuclease I (NEB), 1.tl (5U) Antarctic 
phosphatase (NEB) and I l.75p.l of dH20 was added to 151.il of PCR product. Exonuclease 
degrades ssDNA (single stranded DNA) primers and phosphatase removes the phosphate 
groups from the dNTPS preventing these residual PCR components from interfering with the 
subsequent sequencing reaction. 
Bisulfite Genomic Sequencing 
Genomic DNA (2-5 jig) was digested with a restriction endonuclease (cleaved outside the 
region of interest) and precipitated. DNA was resuspended in 25jil TE buffer, transferred to a 
siliconised tube and denatured at 100°C for 5min before returning to ice. To aid 
denaturation, 2.5ji.l of freshly prepared 3M NaOH was added to the DNA and incubated at 
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37°C for 20mins. 270tl of bisulfite modification solution was added to the DNA then 
overlayed with 200j.tl of mineral oil. The bisulfite reaction was incubated at 55°C for Shours 
protected from light prior to isopropanol precipitation (including 50ig glycogen carrier; 
Roche). DNA was resuspended in 25iil and desulfonated by the addition of 2.5jil of freshly 
prepared 3M NaOH and incubation at 37°C for 15mm. The DNA was EtOH / NH40AC 
precipitated and resuspended in 40.il of TE. 
2j.tl bisulfite-treated DNA was used in a standard Red Hot PCR reaction supplemented with 
3% DMSO and containing primers specific for bisulfite-converted DNA. PCRs were 
resolved by agarose gel electrophoresis (TAE), gel extracted and PCR cloned. The cloning 
reaction was transformed into StrataClone Solo Pack Competent Cells (Stratagene) 
according to the manufacturer's instructions. Transformed cells were spread onto blue/white 
selection ampicillin lb agar plates. Colonies harboring plasmids containing inserts were 
identified by blue/white screening (insertion into the cloning site disrupts the (x-fragment of 
-galactosidase). Inserts were PCR amplified from single colonies by transferring some cells 
with a pipette tip into a 20il Red Hot PCR reaction containing primers flanking the vector 
insert site. Spi of each PCR was resolved by agarose gel electrophoresis to confirm that 
cloned fragments were of the correct size. PCRs corresponding to validated insert were 
Exonuclease JlPhosphatase treated and then sequenced using one of the flanking primers 
from the colony PCR. 
Bisulfite genomic sequencing data was analysed using the BiQ_Analyzer software package 
(Bock et al., 2005). Much of the cloning, colony selection and DNA sequencing was carried 
out by Dina DeSousa and Elaine Evans. 
Cyanine Labeling 
Florescent labeling of DNA for microarray hybridization. Bioprime random primer mix 
(Invitrogen) was added to DNA samples (100-300ng) to a final volume of 130.5j.il, 
denatured at 100°C for 10min and then immediately chilled on ice. On ice, 15p1 of dNTP 
mix (I mM dCTP, 2 mM dATP, dTTP and dGTP), I .Spi Cyanine 3 or 5-dCTP (depending 
on dye swap orientation; GE Healthcare) and 3pi of klenow (120U; Invitrogen) was added to 
each reaction. These were incubated at 37°C for 4hours (protected from light). Labelled 
DNA was purified using the Purelink PCR cleanup kit (Invitrogen) according to 
manufacturers instructions and elute in lOOul elution buffer. Cyanine incorporation was 
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calculated using a Nanodrop spectrophotometer and labeled samples were stored short term 
at -20°C. 
2.2.2 RNA Manipulation 
RNA extraction 
Monocyte and Granulocyte RNA was extracted using Tri reagent (Sigma-aldrich). Tn 
reagent contains phenol and guanidine isothiocyanate and serves to maintain RNA integrity 
during cell disruption and dissolution of cell components. Addition of chloroform and 
centrifugation allows biphasic separation such that RNA may be retrieved from the aqueous 
phase whilst DNA and protein remains in the organic phase. Monocyte and Granulocyte cell 
preparations from 3mls of whole blood (prepared as outlined in Human samples and DNA 
extraction) were resuspended in I ml of Tri reagent (Sigma-aldrich) and incubated at nt for 
5min to disrupt nucleoprotein complexes. Following the removal of insoluble material by 
centrifugation (10min at 12,000g at 4°C) 200111 chloroform was added, mixed vigorously and 
incubated for 10min at R1T. The aqueous phase (RNA) was resolved from the organic phase 
(DNA and proteins) by centrifugation for 15min at 12,000g at 4°C. To precipitate the RNA 
the aqueous phase was transferred to a tube containing 500j.il of isopropanol, mixed and 
allowed to stand for 10min at nit. RNA was pelleted by centrifugation (10min at 12000g at 
4°C), washed with 70% EtOH, air dried and resuspended in 50tl of nuclease free water 
(Ambion). RNA was resolved by RNA gel electrophoresis (see RNA electrophoresis) to 
address the quality of the preparation as indicated by sharp bands representing the 28S and 
18S ribosomal RNA. RNA was stored until required at -20°C. 
cDNA synthesis 
Prior to cDNA synthesis, contaminating DNA must be removed from the RNA preparation 
to avoid artefactual results. RNA (-SOOng) was treated in a total volume of 401.11 containing 
3u1 (6U) DNAse I (DNA-free kit; Ambion) in DNAse I reaction buffer (DNA-free kit; 
Ambion) and incubated for 30min at 37°C. DNase I was inactivated according to the 
manufacturers instructions. 
Prior to reverse transcription the RNA was denatured at 65°C for 5mmn and snap chilled on 
ice. 250ng of the RNA was prepared in a total volume of 25111 containing 5j.tM random 
hexamers (Roche), 1mM dNTPs (Abgene), 40U RNasin (RNase inhibitor; Promega), 200U 
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of M-MLV reverse transcriptase (RNase H minus; Promega) and MLV reverse transcriptase 
reaction buffer (Promega). In addition a minus (-)RT reaction was set up in parallel 
containing all the components except for the reverse transcriptase to control for DNA 
contamination by PCR. The reactions were cycled 4x each each for 8min at 20°C, 8min at 
25°C and 30min at 37°C followed by final heat inactivation at 70°C for 15mm. The 25tl RT 
reactions were stored at —20°C. lp.l of cDNA was used in each PCR in parallel with the 
respective (-)RT control. 
RNA Electrophoresis 
RNA was resolved using the Sub-cell system (Bio-Rad). To remove ribonucleases, gel 
apparatus was washed with 0.4M NaOH and thoroughly rinsed with filtered dH20 prior to 
electrophoresis. RNA samples and size marker (281bp-6.58kb; Promega) were denatured in 
RNA loading buffer for 10min at 70°C and chilled on ice. These were then loaded onto a 
1.5% (w/v) non denaturing agarose gel containing 0.5 jig/mI ethidium bromide. Agarose gels 
were run at constant voltage (80V) in TAE buffer and visualised under UV light. 
Quantitative PCR 
Relative RNA transcript levels were determined using quantitative PCR essentially as 
described for DNA. Each PCR contained ipi  of cDNA or (-)RT except when quantifying an 
abundant transcript such as hGAPDH when the starting material was diluted by 1:10. 
2.2.3 Protein Manipulation 
Preparation of bacterial whole cell lysate 
Bacterial cells were pelleted at 4200rpm for 30min at 4°C and washed with cold PBS. The 
cell/PBS suspension was then pelleted at 11 starting culture per tube and stored at -80°C. The 
bacterial pellets were resuspended in cold NAL buffer containing lmg/ml lysozyme (disrupts 
the bacterial cell wall) and incubated on ice for 30mm. The lysates were sonicated (Branson 
sonifier 250) at a duty cycle of 30% and an output setting of 5 for 5min on ice to sheer the 
bacterial DNA and aid downstream purification. The lysate was then centrifuged at 17,000g 
for 40min at 4°C and the clarified soluble material transferred to a clean tube and stored at - 
80°C. 
Nickel affinity chromatography 
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All stages of this protocol were carried out at 4°C unless otherwise stated. Nickel beads were 
prepared by incubating chelating sepharose FF(GE Healthcare) in 0.2M NiSO4 for 10mm. 
The charged beads were washed with 5 volumes of dH20, 5 volumes of chelating 
sepharose wash buffer, rinsed with dH2O and stored until required in 20%(v/v) EtOH. 
Nickel beads were equilibrated with 2 volumes of cold Nl0 buffer and added to the clarified 
bacterial lysate at 0.5ml of beads per litre of initial bacterial culture. The beads were agitated 
for 2hours to ensure maximal protein adsorption and then pelleted at 500g for 5min after 
which the unbound supernatant was removed. The beads were washed twice with 10 bed 
volumes of cold N20 buffer. A third wash was transferred to a disposable chromatography 
column (GE Healthcare) and allowed to flow through the column. Tagged protein was eluted 
from the column by competition with the histidine analogue Imidazole. One bed volume of 
N250 buffer was added to the beads and equilibrated for 10min and then allowed to flow 
from the column. This process was repeated 7 times. Samples of the soluble lysate, unbound 
material, wash and eluted fractions were resolved by SDS PAGE to assess the efficiency of 
the purification procedure. Fractions containing appreciable quantities of purified proteins 
were pooled and dialyzed in a slidealyzer cassette (7kDa cut off; Pierce) overnight in 
2x2litres cold NAL buffer to remove imidazole. 
Cation Exchange Chromatography 
Nickel affinity purified protein was dialyzed in a slidealyzer cassette (7kDa cut off; Pierce) 
overnight in 2x2litres of 100mM NaCl cation exchange buffer (90%CEA and 10%CEB). 
The protein was bound to a Mono-S strong cation exchange column (Methyl sulfonate active 
groups; GE Healthcare) and eluted into lml fractions spanning a 0.1-1M NaCl gradient using 
an AKTA purifier liquid chromatography system (GE Healthcare). Samples of the input, 
unbound material, wash and eluted fractions were resolved by SDS PAGE to assess the 
efficiency of the purification procedure. Fractions containing appreciable quantities of 
purified proteins were pooled, dialyzed into cold NAL buffer and stored at -80°C. 
Coupling Protein to Cyanogen Bromide Sepharose beads (CNBr beads) 
All stages of this protocol were carried out at 4°C unless otherwise stated. 500mg of 
lyophilised CNBR-activated sepharose (GE Healthcare) was resuspended in 5m] of 1mM 
HCl (pH3; 500mg equivalent to I .75m1 of swollen media). The beads were transferred to a 
disposable chromatography column (Econo-Pac; Biorad) and washed with 100 bed volumes 
of 1mM HC1 (pH3). CNBr beads were then equilibrated with 10 bed volumes of cold CNBr 
coupling buffer. 40mg of purified recombinant protein was dialyzed in a slidealyzer cassette 
(7kDa cut off; Pierce) overnight in 2x2litres cold CNBr coupling buffer. Protein was added 
to imi of pre-equilibrated media and coupled for 2hours with agitation. Samples of input and 
unbound protein were measured by Bradford assay to assess the coupling efficiency. 
Coupled beads were then rinsed in 90%CA / 10% CB buffer prior to column preparation. 
Protein Concentration measurement 
The Bio-Rad Protein Assay was used to determine the concentration of protein preparations. 
The assay works on the principle that the Xmax of Brilliant Blue G-250 dye shifts from 465 
nm to 595 nm when complexed with protein. A range of protein standards (lysozyme or 
BSA) were incubated with a 1:5 dilution of the dye reagent (Biorad) for 5mins and the 0D595 
measurements used to plot a standard curve. Unknown protein concentrations were 
determined using 0D595 measurements substituted into the equation describing the standard 
curve. 
Bandshift Assay 
A Bandshift assay (also gel shift of EMSA) determines the specificity of protein DNA 
binding. Radiolabeled DNA probes are incubated in the presence of protein and then 
resolved by gel electrophoresis. Protein:DNA binding is indicated by reduced mobility 
through the gel matrix. Recombinant MBD and CXXC (0-1000ng) was incubated with 0-
2.tg poly(dA.dT) (non-specific competitor DNA; Sigma) and binding buffer at nt for I 0mm. 
15pmol of radiolabeled methylated or nonmethylated CGII probe and 0.1%(w/v) 
bromophenol blue was added to the reactions and incubated for a further 25min at nt. The 
bandshift reactions were loaded onto a pre-cooled 1.3%(w/v) 0.5x agarose TBE gel and run 
at 120V for 3hours. Bandshift gels were placed onto 2 layers of DE81(Whatman) and 2 
layers of 3M Whatman (VWR) paper and dried at 80°C for 2hours using a speed vac. Dried 
gels were incubated in a Phosphor screen for 2-5hours and imaged using a Storm 860 
scanner (GE Healthcare) and analysed using ImageQuant software (GE Healthcare). 
Protein Electrophoresis 
SDS polyacrylamide gel electrophoresis (SDS PAGE) was used to resolve proteins based on 
molecular weight. Both the Mini-PROTEAN 3 system (Bio-Rad) and Sci-Plas system (Sci-
Plas) were utilised depending on the application. Stacking gels contained 5% (w/v) 
acrylamide and separating gels between 8 to 15% (w/v) acrylamide depending on the 
molecular weight of the proteins of interest. Protein samples, prepared in protein loading 
buffer, and Pre-stained broad range protein markers (6-175kD; NEB) were incubated at 
100°C for 5n-fin to aid SDS coating and to disrupt quaternary structures. Samples were then 
chilled on ice and loaded into the wells of the stacking gel. Electrophoresis was carried out 
at 25mA (Mini-PROTEAN 3 system) or 65mA (Sci-Plas system) in Tris-glycine 
electrophoresis buffer. 
SDS PAGE gels were Coomassie stained by incubation in Coomassie Brilliant Blue R-250 
staining solution with agitation for 20mm. Gels were de-stained by immersion in Coomassie 
destain solution until background was reduced sufficiently. A final rinse in dH20 at 100°C 
was included to remove the last traces of non-specific staining. Gels were scanned and then 
dried between two sheets of clear cellulose film (Biorad). 
2.2.4 Bacterial Preparation 
Bacterial Conditions 
Bacterial transformations were streaked onto LB agar plates containing the appropriate 
antibiotics, inverted and incubated at 37 °C overnight. Single colonies ere picked with a 
sterile loop and transferred to LB broth with appropriate antibiotics and incubated at 37 °C 
overnight. 
Competent Cells 
5ml of LB culture was grown overnight at 37°C and then diluted 1:100 into a final volume of 
500m1. The culture was incubated at 37°C until reaching an 0D600 of 0.5 and transferred to 
2x sterile prechilled centrifugation bottles and incubated on ice for 10mm. Cells were 
pelleted at 2400rpm for 15 at 4°C and then resuspended in 165m1 of cold competent cell 
buffer A. After incubation on ice for 45min the cells were pelleted as before and resuspended 
in 40m1 of cold competent cell buffer B. Cells were incubated on ice for 15min and then 
snap frozen in liquid N2 in 200p1 aliquots. Competency was calculated through a 
transformation titration of 0,1,10 andlOOng of plasmid DNA. Efficient competent cells 
should yield >106  colonies per jig of plasmid DNA. 
Transformation 
Calcium chloride competent cells can be heat shocked to induce uptake of naked DNA 
molecules. b- bOng of plasmid DNA or 2j.tl of a ligation reaction was incubated with lOOj.il 
of competent cells for 25min on ice. The cells were incubated at 42°C for 45sec and returned 
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to ice for 2mm. 900j.tl of 37°C NZY+ media was added to the transformation and were then 
incubated with agitation for Ihour at 37°C. Depending on the starting quantity of plasmid 
DNA and the expected efficiency of transformation, 25-500W of the cells were plated on an 
appropriate lb/antibiotic plate, inverted and incubated at 37°C overnight. 
Bacterial Expression of recombinant proteins 
The B121 E. coli strain and its derivatives were used for over-expression of target genes 
under the control of a T7 promoter. B121 cells and the pet30b cloning vector (Novagen) both 
encode the lacI repressor protein and B121 also encodes bacteriophage T7 RNA polymerase 
under the control of the lac promoter/lacO system. On addition of IPTG to the culture media, 
the lacl repressor protein complexes with the 1PTG and prevents binding to the lac operator. 
This allows expression of T7 RNA polymerase and in turn induces the expression of the 
recombinant protein from the T7 promoter. The CXXC construct was expressed in B121 
pLysS which expresses nominal levels of T7 lysozyme. This binds to and inhibits T7 RNA 
polymerase preventing leaky expression of cytotoxic proteins. 
An overnight culture of B121 transformed with the desired construct was diluted 1:100 into 
lb media and the appropriate antibiotics. The culture was then incubated at 37°C until 
reaching an 0D600 of 0.45-0.6. 1 m JPTG was added to the media to induce recombinant 
protein expression and was incubated for a further 2-3hours. When expression of a protein 
prone to degredation, induction was carried out at 30°C for Shrs. 
Isolation of plasmid DNA 
Plasmid DNA was prepared from X110 Gold, DH5a and Xli Blue E.coli strains. Each of 
these strains is endonuclease deficient (endA) and recombination deficient (recA) which 
helps stable maintenance of the insert sequence. 
For general plasmid preparations for applications such as probe production or restriction 
digestion the following protocol was used. 2m1 0/n bacterial culture pelleted at 12,000g for 
1mm, and the cell pellet was resuspended in lOOi.il Miniprep solution 1 with lOOjig/ml 
RNase A. The cells were then lysed by the addition of 200tl Miniprep solution 2, and then 
neutralised with the addition of lSOp.l SM KOAc pH4.8. Insoluble cell debris were removed 
by centrifugation at 14,000rpm for 5mm. Plasmid DNA was then recovered from the 
supernatant by ethanol precipitation, and was resuspended in 50jtI TE buffer. Plasmid DNA 
was stored at —20°C. 
Where plasmid DNA was to be used for sequencing, cloning or if larger quantities were 
required, DNA was prepared using plasmid isolation kits (Qiagen) according to 
manufacturers instructions. 
2.2.5 CAP and MAP Purification 
Preparation of MBD and CXXC Chromatography columns 
50-60mg of recombinant CXXC or MBD was dialyzed into NAL buffer and bound to lml of 
nickel charged sepharose at 4°C for 2 hours. The beads were washed with 10 column 
volumes (cvs) of BWI buffer, 10 cvs of BW2 buffer and IOCVs of BWI buffer. The beads 
were packed onto a Imi chromatography column (Tricorn 5/50; GE Healthcare) at a constant 
imi/min linear flow rate. Once assembled, the chromatography column was equilibrated 
with a 200ml linear NaCl gradient (0.1-tM; gradient formed between CA and CB buffers) at 
a imi/min flow rate on an AKTA purifier (GE Healthcare). This equilibration serves to pack 
the beads and remove any bacterial DNA from the matrix. 
CAP and MAP Chromatography 
All chromatography steps were carried out on either an FPLC or an AKTApurifier (GE 
Healthcare) at a linear flow rate of lml/min and a maximum backpressure of 0.3MPa. 
Fragmented DNA (25-100.tg) was EtOH precipitated and resuspended in 500pl of 100mM 
NaCl column buffer (90% CA and 10% CB). DNA was bound to the chromatography 
column by injection. Bound DNA was then eluted over an increasing NaCl gradient of 0.1-
IM by mixing CA and CB buffers. 3ml fractions were collected across the gradient. 250 tl 
of each fraction was precipitated and resuspended in 40tl TE buffer for fractionation 
analysis. 
2.2.6 Microarray Procedures: 
Microarray experiments were carried out using custom designed arrays generated by 
Cordellia Langford and colleagues at the Wellcome Trust Sanger Institute. CGI amplicons 
were amplified from the CXXC library to include 5' primary amine groups. These were 
coupled to amine binding slides and denatured to remove non-coupled DNA molecules. The 
resulting array consists of 28.8k features representing of 17,387 unique single stranded CGIs. 
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Hybridization and washing 
Cyanine labeled MAP and Input DNA and lOOjig of human Cot-i DNA (Invitrogen) were 
EtOH precipitated (protected from light). In parallel a prehybridisation mix containing 
lOOpg of human Cot-] DNA (Invitrogen) and 40jig of Sonicated herring sperm DNA 
(Sigma-Aldrich) was prepared and precipitated. Both the hybridization and prehybridisation 
mixtures were resuspended in 60il of MH buffer, denatured at 100°C for lOmins and 
snap chilled on ice. 
The prehybridization was then incubated at 70°C for lOmins and applied the surface of a pre-
chilled coverslip. A prechilled microarray was lowered onto the coverslip until adhesion with 
the hybridisation mix lifted it onto the array surface. Once the coverslip was orientated 
across the full arrayed area and any air bubbles had been expelled, the array was transferred 
to a humidified chamber containing lml MHu buffer and incubated for 1 hour at 37°C. The 
coverslip was then carefully removed by submerging the array in MWA buffer. The array 
was washed twice in MWA buffer for 10mm, one in MWB buffer and rinsed twice in dH20. 
Microarrays were centrifuge dried at 500g for Imin in 50ml disposable tubes such that the 
ID label was at the bottom of the tube. 
The hybridization mix was incubated for 1 hour at 37°C and then applied to the microarray 
as for the prehybridisation. Hybridisation was carried out for 48hrs at 37°C. Once the 
coverslip was removed the microarrays were washed four times for 10min in 37°C MWA 
buffer, three times for 10min in 52°C MWB buffer, twice for 10min in nt MWA and finally 
rinsed twice in dH20, before being dried by centrifugation (500g). Hybridised microarrays 
were protected from light and moisture and scanned within 24 hours. 
Scanning and Data acquisition 
Arrays were scanned with a 2 laser GenePix Autoloader 4200AL (Axon). Arrays were 
scanned such that approximately —5% of features were saturated. Microarray scans 
representing Cyanine 3 and 5 signals were processed using the GenePix Pro 6.0 (Axon) 
software package. Prior to calculating the signal intensity values, all spots were manually 
checked and flagged for later analysis. 
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2.2.7 Biointormatic Analysis 
Microarray analysis, figure generation, and Gene Ontology (GO) analysis weas carried out 
by R Illingworth. The majority of gene mapping and genome wide database searching was 
carried out by the WTCCB Bioinformatician, Dr Alastair Kerr. 
Microarray analysis 
Analysis was carried out with the LIMMA package in the R statistical environment. Flagged 
CGIs were removed from the analysis and features with poor signal-to-noise ratios were 
stabilised using a minimum capped value of 1000 for background subtracted intensities. Cy3 
and Cy5 signals were transformed into M values (log2 [red/green]) and normalised by print-
tip loess. Each biological variable analysis was represented by four microarrays comprising 
two independent replicates with two respective dye swap hybridisations. Processed values 
were averaged through linear modeling and used to determine the relative enrichment of 
MAP DNA relative to Input. An M value of 21.5 was designated as the threshold for 
hypermethylation as determined by Quantitative PCR and bisulfite genomic sequencing. 
This threshold was confirmed as significant by calculation of a t-statistic by Bayesian 
modeling and BH multiple testing correction. Differential methylation was deduced when 
features displayed an M value 21.5 in one or more tissues and a differential of 0.75 between 
tissues (upper boundary capped at M = 2.5). CGIs which failed to satisfy these criteria but 
which had an M value 21.5 in one or more tissues were classified as 'uncharacterised' as it 
was not possible to conclude the methylation status in the remaining tissues. To avoid 
complications due to X chromosome inactivation, CGIs on sex chromosomes were excluded 
from the analysis of tissue specific methylation. In addition, spots that gave no signal on the 
microarray (NA values) and spots containing DNA in which CpG[o/e] values were <0.5 
were excluded. All microarray data is available in MIAME compliant format in Array 
Express (http://www.ebi.ac.uk/microarray-as/ae/) accession number: E-MEXP- 1391 
(01/07/2008). 
Significance testing 
Data distribution was determined using a Shapiro-Wilk test of normality. Data conforming to 
a parametric distribution were analysed using a Welch Two Sample t-test. For non 
parametric data sets, significance was determined using either a two sample Kolmogorov-
Smirnov tests or a Wilcoxon rank sum test as indicated. 
Genome mapping and data mining 
Physical mapping of sequences to the human genome was carried out by Dr Alastair Kerr. 
CGIs that mapped within 1.5kb of annotated genes were considered to be gene-associated. 
This window takes into account mis-annotation of transcription start sites within poorly 
defined 5'UTRs. Genic association was broken down into 4 categories. Promoter associated 
was designated as +1- 1.5kb from the most 5' end of an annotated gene. 3' associated was 
designated as +1- 1.5kb from the most 3' end of an annotated gene. Intragenic was designated 
as overlapping an annotated gene internal to the most 5 and 3 extremities whilst not being 
within 1.5kb of them. Intergenic was designated as not within 1.5kb of an annotated gene. 
Where multiple alternative transcripts were reported for a given gene the largest was used for 
analysis. 
Chapter 3: 	CXXC Affinity Purification 
3.1 Introduction 
3.1.1 CpG Islands 
The methylated, CpG deficient, mammalian genome is punctuated by discrete 
nonmethylated DNA sequences called CGIs. These G+C rich islands are approximately 1 
kilobase in length and show little CpG suppression relative to bulk genomic DNA. CGIs co-
localize with approximately 56% of human gene promoters and as such are overrepresented 
in R bands (Antequera and Bird, 1993; Craig and Bickmore, 1994; Larsen et al., 1992). 
Despite 25 years of investigation the exact functional role of CGIs remains unclear. 
Transfection studies have shown that transcription from a CpG island promoter can be 
extinguished with the introduction of DNA methylation (Stein et al., 1982). Conversely, 
genome wide demethylation induced by the drug 5AzaC has been shown to activate CGI 
genes that were previously methylated (Hansen and Gartler, 1990). Aberrant CGI 
methylation associated with neoplastic cells is also known to correlate with gene silencing, 
although it is unclear whether this is causal. Nonmethylated CGIs are generally 
transcriptionally permissive and associate with all constitutively expressed 'housekeeping 
genes' (Larsen et al., 1992). Accordingly, mutagenesis of Spi binding sites from the mouse 
APRT promoter CGI results in de novo methylation and transcriptional repression (Brandeis 
et al., 1994; Macleod et al., 1994). In addition to gene promoter association, several 
mammalian CGIs have been identified as initiation sites of DNA replication (Delgado et al., 
1998; Phi-van and Stratling, 1999). This is consistent with elevated G+C levels which is not 
solely accounted for by lack of CpG suppression within these regions (Antequera, 2003; 
Antequera and Bird, 1999). As such, the distinct sequence characteristics of CGIs represent a 
unique genomic landmark, which are of significant value for gene mapping and the 
elucidation of genome function. 
3.1.2 The number of CGIs in the human genome 
CGIs were initially discovered by restriction digestion of vertebrate genomic DNA with the 
methyl-sensitive restriction endonucleases Hpal I (CCGG). Cleavage patterns indicated two 
distinct genomic fractions based on CpG density and DNA methylation status. High 
molecular weight DNA, refractive to digestion, was methylated and CpG deficient. The 
second fraction, composed of very highly fragmented DNA, represented a small proportion 
of the genome which was nonmethylated and CpG rich (HTFs; (Bird et al., 1985; Cooper et 
al., 1983)). HTFs were found to originate from 1kb regions enriched at gene promoters and 
were subsequently renamed CpG islands (CGIs) to better suit their sequence composition 
(Bird, 1987; Gardiner-Garden and Frommer, 1987). This procedure was quantified to allow 
the prediction of the total number of CGIs, estimating haploid complements of 44,000 and 
37,000 in human and mouse respectively (Antequera and Bird, 1993; Bird et al., 1985). The 
human figure was later corrected for bulk genomic DNA contamination to suggest a more 
modest 26,300 CGIs (Ewing and Green, 2000). 
As genome sequence has become available, CGI identification has moved increasingly 
toward in silico prediction methods. The first sequence prediction effort utilized CpG island 
sequences associated with promoters annotated in GenBank. Characterization of these 
sequences led to the first purely sequence based description of CGIs, stating that they must 
be at least 200bp in length, 50% G+C and have a minimum CpG[o/e]  density of 0.6 
(Gardiner-Garden and Frommer, 1987). This study predates the completion of the human 
genome project and these criteria have since been embodied in sequence prediction 
algorithms to identify CGIs (Ioshikhes and Zhang, 2000; Lander et al., 2001; Lee et al., 
1998; Ponger and Mouchiroud, 2002; Waterston et al., 2002). However, the wealth of data 
has also highlighted the extraneous inclusion of non CGI sequences due to false discovery. 
Artifacts of sequence prediction are inevitable as they rely on arbitrary thresholds which are 
prone to oversimplifying biological data. The major cause of this overestimation comes from 
the incorrect identification of CpG and G+C rich repetitive elements as CGIs. As such, 
predicted CGI sets often contain spurious DNA sequences such as young Alu elements 
(Hellmann-Blumberg et al., 1993; Larsen et al., 1992; Rubin et al., 1994; Schmid, 1996; 
Takai and Jones, 2002). To combat this problem, algorithm prediction methods have been 
refined in two ways. 
The first refinement investigated the threshold values for CGI length, CpG density and G+C 
composition. Contiguous 200bp sequences, identified by a sliding widow algorithm, were 
combined to generate entire predicted CGIs. Applying this method to a range of threshold 
values indicated that increased stringency reduced the identification of repetitive elements. 
A minimum length, CpG[o/e]  and G+C composition of 500bp, 0.65 and 55% respectively, 
BE 
significantly reduced the number of contaminating Alu elements identified by the algorithm 
(Takai and Jones, 2002). The increased stringency saw a reduction in the number of CGIs by 
approximately 92%. However, a reduced number of gene promoter associated islands, Zn 
suggesting that bona fide CGIs were inadvertently being discarded. 
The second refinement addressed the problem more directly, by a process called repeat 
masking. Repetitive elements and low complexity sequences are removed by screening 
against a comprehensive database of such elements (Repbase; (Jurka et al., 2005)). 
Preliminary analysis of the human genome sequence indicated that there were 50,267 
islands, of which only 28,890 were identified as being unique (Lander et al., 2001). Masking 
is subject to iterative improvements due to the periodic increase of the Repbase repertoire 
(Jurka et al., 2005). Indeed reanalyzing the human CGI complement saw a further reduction 
of 1,890 CGIs, to give a more conservative estimate of 27,000 (Waterston et al., 2002). 
Clarification by repeat masking can be illustrated for a low copy repetitive element related to 
the adenovirus sequence. Located on Chromosomes 4 and 19, these elements are identified 
as single or tandem repeated CGIs by the ENSEMBL and NCBI prediction algorithms 
(Epstein et al., 1987). These sequences are recognized by repeat masker and eliminated. 
Table 3.1-1. Details of CGI prediction algorithms 
Database / CpG 
Prediction 	Length 	G+C [ole] 	RMa 	Comments Ref 
ENSEMBL 	~!400 	2~50% ~:0.6 	N 	stringent length constraint (Birney et al., 2004) 
NCBI relaxed 2!200 2!50% ~0.6 N Total CGIs = 307,193 
NCBI strict 	2!500 	2!50% 2!0.6 	N 	Total CGIs = 24,163 
USCSb 	>200 2~50% >0.6 Y Total CGIs = 28,226 (Karolchik et al., 2008) 
EMBOSS 	UDC 	UD UD 	NA 	Variable parameters (Rice et al., 2000) 
(Ponger and 
CpGProD 	>500 	>50% >0.6 	Y 	Total CGIs = 76,793 Mouchiroud, 2002) 
CpGcluster NA NA NA N Clustering. Total = 197,727 (Hackenberg et al., 2006) 
aRM = Repeat Masked. Y=Yes N=No, NA=Non Applicable. 
bParameters used for CGI identification for the ENCODE project although totals vary due to repeat 
masking differences between hg17 and hgl8 builds (Birney et al., 2007). 
CUD = User Defined. 
All major genome browsers employ CGI prediction algorithms based on these parameters 
and utilize repeat masking as a means to reduce the false discovery rate. The absolute 
numbers of CGIs is highly variable depending on the exact thresholds applied (Table 3.1-1). 
NCBI Mapview employs two different permutations of these parameters to provide a relaxed 
X Chr4: Location (bp) 132864773 to 132905671 and Chr19: Location (bp) 41448637 to 
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and stringent identification of islands (Table 3.1-1). NCBI strict predicts 24,163 unique CGIs 
whereas there relaxed criteria identifies more than 307,000. Such variability arises from the 
following observations: 1) the use of arbitrary thresholds, 2) no account taken for the 
heterogeneity of CGIs (Fig. 3.1-1) and 3) all sequence based prediction methods necessarily 
ignore methylation status. 
These limitations may be addressed in the future by the incorporation of multiple layers of 
information into prediction methods, including methylation status and epigenetic 
modifications. Studies have shown that CGIs generally incorporate active histone marks and 
this can distinguish them within their long range chromatin context (Roh et al., 2005; Tan 
and Bird, 1990; Weber et al., 2007). Genome wide epigenetic information will allow the 
refinement of prediction methods such that arbitrary sequence based predictions are 
supported by contextual biological information (Bock et al., 2007). 
Figure 3.1-1. Schematic 
representation of an average 
CGI gene promoter. 
The plot shows the distribution of 
start and end positions for all CGls 
located within 1 k of a gene 
promoter (as annotated on the 
ENSEMBL genome browser). The 
average CGI (red bar; 1172bp) is 
indicated relative to the transcription 
start site (arrowed) and the 1st exon 
(dark blue bar). The boxplot indicates 
values for the median (central black 
line), 1st  and 3rd  quartiles (extremes 
of the blue box), maximum and 
minimum non outlying values 
(extremes of the dashed lines) and 
outliers (open circles). Data generate 
by Dr A. Kerr 
3.1.3 Isolation of CpG Islands 
As previously discussed, CGIs were initially identified through methyl sensitive restriction 
of genomic DNA. This procedure served as an analytical tool for the identification of CGIs 
but was necessarily destructive, and unsuitable for the isolation of intact CGIs. However an 
initial attempt to prepare and clone CGI sequences was through the isolation of larger 
digestion products (Shiraishi et al., 1995). Total genomic DNA was digested with a cocktail 
of restriction endonucleases which cut infrequently in CGIs'. The digested DNA was then 
resolved by denaturing gradient gel electrophoresis. Fragments with a high GC composition 
X  MseI (TTAA), Tsp5091 (AATT), Mal (CATG) and Bfal (CTAG). 
were resolved whereas bulk genomic DNA was denatured and removed. Cloning and 
analysis of G+C rich fragments identified approximately 50% that were derived from CGIs. 
However the procedure was technically challenging and took no account of CpG clustering 
or lack of methylation, two important qualifiers for the identification of CGIs (Shiraishi et 
al., 1995). 
Discovery of a nuclear protein with specific affinity for DNA sequences bearing methylated 
CpG dinucleotides facilitated an alternative means of CGI preparation (Lewis et al., 1992). 
Cross and Colleagues prepared a DNA affinity matrix by coupling a recombinant MBD from 
rat MeCP2 to a Nickel sepharose matrix (Cross et al., 1994). The MBD column was shown 
to selectively purify DNA fragments containing a high density of methylated CpG sites. 
Total human genomic DNA was digested with the restriction endonuclease MseI (TTAA). 
This had the effect of restricting bulk genomic DNA into small fragments (predicted average 
length of I 23bp) while leaving CpG islands relatively intact (predicted average length of 
625bp). This DNA was applied to the MBD column and eluted across an increasing NaCl 
gradient. Nonmethylated CGIs behaved as a poor ligand for the MBD, and eluted from the 
column at relatively low salt concentration. Methylated, CpG dense fragments were retained 
by the matrix and stripped from the DNA prior to further purification. Low affinity 
fragments including CGIs were fractionated a further twice prior to being fully methylated 
using the CpG methyltransferase, M.SssI. These were then reapplied to the column and 
fractionated. High salt fractions, containing the artificially methylated CGIs, were pooled 
and rechromtographed. High affinity DNA sequences were precipitated and cloned into 
pGEM Szf- (Promega). Characterization of the cloned DNA fragments indicated that they 
were CpG and GC rich. Furthermore, they represented low copy number sequences with the 
exception of rDNA repeats (12.5%) which also resemble the sequence composition of CGIs 
(Bird et al., 1985; Bird and Taggart, 1980; Cross et al., 1994). It was confirmed that a 
significant fraction of the clones associated with the 5' ends of annotated genes. 80% of the 
library had significantly elevated CpG and G+C content suggesting that the cloned library 
represented a comprehensive CGI set. 
This MBD technology has subsequently been applied to the purification of CGI from Mouse 
(Cross et al., 1997a), Chicken (McQueen et al., 1996) and Pig (McQueen et al., 1997). CGI 
libraries were also generated from human BACs, PACs and flow sorted chromosomes to 
allow detailed analysis of the relationship between CGIs and genes (Cross et al., 1999; Cross 
et al., 2000). 
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The original human CGI library was prepared, primarily, as a means of promoter 
identification. The purpose being to identify the transcription start sites and regulatory 
elements of cloned cDNAs prior to the availability of whole genome sequence. However, as 
the functional and regulatory significance of CGIs has become more apparent the utility of 
the library has increased. Novel estrogen responsive elements (EREs) were identified 
through screening the library with a recombinant Estrogen receptor (Watanabe et al., 1998). 
Subsequently, microarray probing technology has yet furthered the applications of the 
library. The arrayed CGI set has been used to screen CpG island methylation profiles in both 
normal and cancer tissues (Huang et al., 1999; Weber et al., 2005; Yan et al., 2001; Yan et 
al., 2002). Chromatin Immunoprecipitation (ChIP) has allowed the identification and 
characterization of transcription factor binding sites (Mao et al., 2003; Weinmann et al., 
2002). To facilitate these applications, the entire library was re-sequenced and mapped to the 
human genome (Heisler et al., 2005). In total, 20,736 CGI clones were sequenced 
representing 9595 unique genomic loci. After justification and filtering the non-redundant 
proportion of the library represented 7184 unique CGI sequences, although this number 
contains some ribosomal repeats and non-specific contaminating DNA (Heisler et al., 2005). 
The utility of the CGI library as a set of regulatory elements is clear. However represents less 
than 1/3 rd  of the human complement. This is partially due to the cumbersome nature of the 
purification process which resulted in the loss of some sequences. In addition, elevated GC 
density, a prerequisite for CGI sequence, is intrinsically difficult to sequence using 
conventional technology. As this library represents a biologically relevant set of regulatory 
elements, it would be of extreme value to generate a more comprehensive CEll set. 
3.1.4 Aim 
A limitation in many studies investigating the role of human CGIs has been uncertainty 
concerning their identification. As previously discussed, the criteria for designating a 
sequence as CGI-like are currently exclusively bioinformatic in nature, relying on the 
differences in the base composition and CpG frequencies (observed/expected) between bulk 
genomic DNA and CGIs. This obviates the need for a more biologically relevant method for 
CGI identification. 
This chapter described the development and application of a novel chromatographic 
technique to fractionate CGIs and create a resource for future analysis. This technique, 
termed CXXC Affinity Purification (CAP), selectively enriches for nonmethylated CpG rich 
sequences from bulk genomic DNA, and serves as an elegant preparative and analytical tool. 
3.2 Results: CXXC Affinity Purification 
The CXXC domain (PF02008) was first identified in the N-terminal region of the 
mammalian maintenance DNA methyltransferase, DNMTI (Bestor, 1992). Removal of the 
N' terminal region of DNMT1, containing this motif, was shown to induce ectopic de novo 
methyltransferase activity (Bestor, 1992). Alignment has subsequently identified several 
additional mammalian proteins which carry homologous sequences. These include MLL 
(mixed lineage leukemia; also known as All-1 and HRX), MBD1 (Methyl CpG Binding 
protein 1, also known as PCMI), JHD1B (also known as FbllO or JEMMA) and CGBP (Fig. 
3.2-la, (Cross et al., 1997b; Koyama-Nasu et al., 2007; Ma et al., 1993; Voo et al., 2000)). 
BLASTp alignment to a protein database (refseq) indicates that nine human proteins have 
sequences which bear significant homology to the archetypal DNMT1 CXXC (Altschul et 
al., 1997) 
The domain is characterized by a cysteine rich motif with the bipartite consensus sequence; 
CX2CX2CXCX2CX2C (Bestor, 1992; Cross et al., 1997b; Ma et al., 1993). The two triplet 
cysteine repeats coordinate two Zn2 ions to form a crescent like structure (Allen et al., 2006; 
Lee et al., 2001). NMR determination of the MLL CXXC showed that the secondary 
structure contains two short alpha-helices which form the basis of the zinc coordination 
module. All 6 cysteines are essential for DNA binding (Allen et al., 2006). 
Alignment of homologous genes, show that the CXXC is highly conserved at the amino acid 
level. Paralagous CXXC3 domains of human and murine MBDI show 100% sequence 
conservation. In addition orthologous CXXCs found in various mouse proteins display high 
levels of sequence conservation out with the core cysteine residues ((Carlone et al., 
2002);Fig. 3.2-1b). 
The majority of CXXC domains can bind DNA, and do so by interaction with a single 
nonmethylated CpG site. In vitro studies have indicated that CpG is both necessary and 
sufficient for binding and that this is ablated when the cytosine is methylated (Birke et al., 
2002; Jorgensen et al,, 2004; Lee et al., 2001). Evidence suggests, however, that CXXC can 
also bind to hemimethylated CpGs, although with significantly reduced affinity (Birke et al., 
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Figure 3.2-1. Conservation of the CXXC domain. 
(a) Scale schematic representations of mammalian proteins bearing the conserved CXXC domain 
(filled gold ovals). Additional domains identified by the pfam protein database are illustrated and colour 
coded as per the legend. (b) Amino acid alignment of CXXC domains from various mammalian 
proteins. Conserved and partially conserved amino acids are shaded (black and grey respectively). 
The six essential core cysteine residues are emboldened. 
domain, it is interesting to note that the CXXC domains I and 2 of mammalian MBD 1 have 
no DNA binding affinity (Jorgensen et al., 2004). In addition, binding activity has not been 
reported for the DNMT1 CXXC and In vitro experiments suggest that it is non functional in 
this regard (unpublished observations). 
The CXXC domain appears to act primarily as a DNA binding module. Mammalian MBD1 
cannot localize to, or inhibit transcription from, nonmethylated promoters when lacking a 
functional CXXC3 domain (Fujita et al., 2000; Fujita et al., 1999; Jorgensen et al., 2004). 
CXXC Mutagenesis experiments showed complete loss of promoter transactivation in 
murine MLL (Ayton et al., 2004). In contrast however, DNMT1's CXXC does not bind 
DNA but is associated with a domain known to affect the specificity of the methyltransferase 
activity (Bestor, 1992). Mammalian MBD1 isoforms containing all 3 CXXC domains also 
seem to indicate a role outwith DNA binding. Two of the CXXC domains are incapable of 
DNA binding, but have been shown to interact with Ringib, a component of PRC1. The 
third domain has been implicated in interaction with another PRC 1 component; hPc2 
(Sakamoto et al., 2007). Although data is limited, it appears that the CXXC motif may 
function as an important protein:protein interphase in addition to its well characterized role 
in nonmethylated DNA binding. 
3.2.1 Recombinant CXXC expression and purification 
The pET30-CxxC-3 expression plasmid was constructed by cloning the coding sequence of 
murine Mbdla (amino acids 344 to 439) into the pet30b protein tagging vector (Novagen). 
The construct, encoding the entire third CXXC domain, was inserted into the EcoRl and 
Hind 111 sites of the multiple cloning site (MCS). The CXXC was cloned, in frame, with an 
N' terminal 6x histidine tag, thrombin cleavage consensus (endolytic serine protease), S tag 
and an enterokinase cleavage consensus (serine protease; Fig. 3.2-2, construct generated by 
Dr Helle Jorgenesen (Jorgensen et al., 2004)). 
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Figure 3.2-2. Cloning schema for the CXXC construct. 
(a) Schematic representation of mMBdla indicating the locations of the MBD (green) and CXXC (Red) 
domains. The location of the protein fragment cloned is indicated (aa344-439) and the DNA coding 
sequence corresponding to this site cloned into the Hind-111 and EcorRi sites of the pet30b protein 
tagging vector. The multiple cloning site (MCS, heavy black arrow), open reading frames (grey bars) 
and origin of replication (grey arrow) are indicated. (b) Sequence of the recombinant protein (red box). 
Eneterokinase cleavage site (green arrow head), S Tag (green box), thrombin cleavage site (blue 
arrow head) and the Histidine tag (6xH). 
pET30-CxxC-3 was transformed into BL21(DE3)pLysS chemically competent E.coli cells, 
and the clonal cell culture was expanded to 8 liters. Recombinant CXXC expression was 
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induced by 3 hour incubation in the presence of 1mM IPTG at 37°C. CXXC induction was 
assessed by SDS PAGE (Fig. 3.2-3b). 



























Figure 3.2-3. Purification of the recombinant CXXC3 domain of mMbdla. 
(a) Recombinant CXXC was purified from bacterial whole cell extract (WOE) by using the indicated 
two-step purification scheme (Ni-Affinity and MonoS). Chromatography buffers used for Nickel Affinity 
(Nb, N20 and N250) and Mono S (CEA and CEB) are indicated. Fractions pooled from each step are 
bracketed. (b) CXXC induction and Nickel affinity purification, indicating protein content of uninduced 
bacterial culture (UI), IPTG induced culture (I), WOE, unbound protein (UB), wash (W), elutions (E1-6) 
and broad range marker (Marker, sizes indicated; Fermentas). Fractions to be further purified 
(bracketed) and the CXXC degradation product (red asterisk) are indicated. (c) Mono S cation 
exchange purification. Partially purified CXXC was bound to a imI Mono S chromatography column 
and eluted over an increasing NaCl gradient. Samples of input, Unbound (UB), elutions (100-600mM 
gradient) and size markers (not shown; indicated by labeled arrows) were resolved by SIDS PAGE. 
Pooled fractions and the CXXC degradation product are indicated as for (b). 
Whole bacterial cell extract was prepared and bound to Nickel charged sepharose at 4°C in 
the presence of 10mM imidazolexil  for 2hours. The CXXC adsorbed beads were washed in 
low Imidazole concentration buffer and then eluted across 8 successive fractions by 
XII 6x polyhistidine binds strongly to divalent nickel ions by coordination between the 
imidazole group and the Ni2 ions. Binding in the presence of low concentration Imidazole 
reduces non-specific binding of bacterial proteins with an inherent affinity for divalent cations. 
Proteins bound with high affinity can be eluted by competition with high concentration 
Imidazole or a reduction in buffer pH. 
competition with high Imidazole concentration. SDS PAGE analysis of the fractions 
indicated that the nickel affinity purification had highly enriched a protein corresponding to 
the expected size of the recombinant CXXC (16.4kDa; Fig. 3.2-3b). However, contaminating 
proteins were still evident in the preparation so additional purification was required. 
The basic nature of the CXXC construct (p1 of 9.35) meant that it would be ideally suited to 
purification by cation exchange chromatography. Fractions containing large quantities of the 
purified CXXC (Fig. 3.2-3a & b; bracketed) were pooled and dialysed into 100mM NaC1 
cation exchange buffer. These fractions were bound to a lml Mono-S' cation exchange 
column (GE Healthcare) and fractionated across a 0.1-IM NaCl gradient. CXXC purity was 
assessed by SDS PAGE (Fig. 3.2-3c). At this stage recombinant CXXC was deemed pure 
enough for application to DNA chromatography. It is worth noting that recombinant CXXC 
always co-purified with a 2nd  protein fragment presumed to be a degradation product (Fig. 
3.2-3b and c - asterisk). Additional attempts to remove this degradation product were 
unsuccessful or resulted in unacceptable loss of total CXXC. 
3.2.2 Activity and affinity of recombinant CXXC 
The CXXC3 domain of mMbla has been shown to bind to a single nonmethylated CpG site 
which is both necessary and sufficient for DNA binding. It has also been shown that binding 
affinity is lost when the cytosine base of the CpG is methylated (Jorgensen et al., 2004). To 
confirm the activity and specificity of the purified CXXC construct, DNA binding was 
characterized by bandshift assay. 
A titration of recombinant CXXC was incubated with a methylated or nonmethylated, end 
labeled DNA probe containing 27 CpG sites. Binding assay reactions were resolved by 
agarose gel electrophoresis and imaged by phosphorlmager. Increasing amounts of CXXC 
was shown to induce a gel mobility shift when incubated with the nonmethylated form of the 
probe but not when incubated with the methylated probe (Fig. 3.2-4). This confirmed that the 
recombinant CXXC had non-methyl specific binding with no detectable affinity for DNA 
containing only methylated CpGs. It is interesting to note that the protein:probe complex 
XIII Mono S chromatography media is composed of the methyl sulfonate group (strong cation 
exchanger) conjugated to a highly crosslinked polystyrene matrix. 
XIV To reduce the degradation observed the CXXC construct was prepared such that all the 
media contained Zn + ions and full protease inhibitors as this had previously been shown to 
stabilize constructs coordinated by metal ions. This however had little effect on the 
appearance of the degradation product Kelly, S.M., Pabit, S.A., Kitchen, C.M., Guo, P., 
Marfatia, K.A., Murphy, T.J., Corbett, A.H., and Berland, K.M. (2007). Recognition of 
polyadenosine RNA by zinc finger proteins. Proc NatI Acad Sci U S A 104, 12306-12311.. 
formed, is not a discrete band suggesting that multiple CXXC domains can associate with 
each 135bp probe. This is an important observation and will be discussed later. 
CG1I 	 MeCGI1 
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Figure 3.2-4. Purified CXXC specifically binds nonmethylated DNA. 
Bandshift assay showing the CXXC complexed with a DNA probe containing 27 non-methylated CpG 
sites. Non-methylated probe DNA (CG1 1) or methylated probe (MeCG1 1) were incubated with 0, 250, 
500, 1000 or 2000ng of recombinant CXXC protein. 
3.2.3 Preparation of a CXXC chromatography column 
The purified CXXC construct was dialysed into a sodium phosphate buffer". and coupled to 
ImI of nickel sepharose. Following removal of unbound protein, the beads were washed in a 
low concentration of imidazole (lOmfvI) to remove weak affinity contaminants. The beads 
were then re-equilibrated to remove the iniidazole and packed onto a imi chromatography 
column (Tricorn 5/50; GE Healthcare). The column was saturated with CXXC, containing 
approximately 45mg of CXXC, as determined by measurement of protein concentration in 
the input and unbound fractions. Prior to calibration, the CXXC column was equilibrated 
with a 0.1-I M NaCl gradient at imI/min. This pre-equilibration step ensured that the beads 
were thoroughly packed and that any residual bacterial DNA was eluted from the column 
(data not shown). 
3.2.4 Plasmid fragment calibration 
The resolution of affinity column chromatography techniques can be affected by a range of 
factors including matrix bed volume, the nature of the ligand and the amount of the affinity 
construct. As such it was necessary to calibrate the CXXC column in order to determine its 
efficacy for DNA chromatography. In order to do this, DNA fragments of varying length, 
CpG density and CpG methylation status were resolved across an increasing NaCl gradient. 
xv HEPES, the buffering component for cation exchange, has an amine group which can 
reduce nickel resin. 
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The pABS plasmid, containing the CpG island for the mouse APRT gene, was linearised and 
restricted into 3 fragments using the endonucleases, EcoRl and Hind 1 11 (Macleod et al., 
1994). The digestion products generated were 1.4, 2 and 2.7kb in length with CpG 
densitiesxi of 0.22, 0.5 and 1.0 respectively (Fig. 3.2-5a). 
1.tg of the fragmented plasmid was treated with the CpG methylase M.Sssl and 500ng 
aliquots of the methylated and nonmethylated DNA were end labeled with cL32P-dCTP. The 
CXXC chromatography column was attached to an FPLC system (Pharmacia) and pre-
equilibrated with 100mM NaCl running buffer. The nonmethylated fragments were bound to 
the column in 100mM NaCl buffer and then eluted across a 30m1, 0.1-IM salt gradient (Fig. 
3.2-5b). This process was repeated for the methylated fragments, and 113 rd of each fraction 
was ethanol precipitated. 
A relative measure of DNA content in each fraction was obtained by measuring the 
incorporated label using a Tri-Carb 2100TR liquid scintillation counter (Perkin Elmer). 
Fractions were then resolved by agarose gel electrophoresis to determine the specific elution 
profile of the methylated and non-methylated fragments across the NaCl gradient. 
All three methylated fragments eluted at 400mM NaCl concentration irrespective of CpG 
density. At this low NaCl concentration the CXXC matrix showed retention of all non-
methylated DNA fragments. Unlike the methylated DNA fragments however, increasing the 
NaCl concentration resolved nonmethylated DNA as a function of CpG density. The CpG 
deficient fragment (CPG101e1 of 0.22) eluted at 550 to 600mM NaCl whereas 800-900mlVI 
NaCl was required for the elution of the CpG dense fragments (Fig. 3.2-5b). When 
methylated and nonmethylated fragments were pooled and fractionated the CXXC column 
could selectively resolve the nonmethylated CpG rich DNA fragments from CpG deficient or 
methylated DNA fragments (data not shown). 
The DNA binding calibration indicated that all DNA fragments bound to the CXXC affinity 
matrix but that methylated DNA did so with reduced affinity. Nonmethylated DNA retention 
was shown to be CpG density dependent with increased CpG content binding at a higher 
NaCl concentration. This suggested that the CXXC matrix formed multiple contacts with 
CpG density was determined by calculation of the CpG[observed/expected] ratio. 
Expected values were calculated using the equation: Expected = ((number of 












each DNA fragment and that CpG dense fragments represented higher affinity ligands for the 
affinity colunm. This was consistent with the observation that the bandshift probes were 
complexed with multiple CXXC domains. This result confirmed that CAP could selectively 
enrich for nonmethylated sequences from a low complexity pool of CpG deficient and 
methylated DNA fragments. However, to determine if CAP could effectively purify CGJs 
from total genomic DNA further calibration was necessary. 
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Figure 3.2-5. Nonmethylated DNA binding is dependent on CpG density 
(a) Schematic representation of the pABS plasmid and three restriction products. TheCpG [0/el values 
are indicated (at right of fragments), CpG (top strand) and GpO (lower strand) are indicated by black 
strokes. The length of each fragment is indicated by the scale (above the upper most fragments, base 
pairs (bp). (b) The upper panel indicates the elution profile of methylated (dashed red line) and 
nonmethylated (dashed blue line) fragments across the NaCl gradient (solid black line). All methylated 
fragments elute at low NaCl concentration (-0.4M) whereas nonmethylated fragments don't elute until 
(0.6M) with the most CpG dense fragments being retained by the CXXC matrix until (0.9M). Size 
markers, as determined by the lkb+ DNA ladder (Invitrogen, not shown) are indicated (black arrows 
and corresponding sizes). CPM (counts per minute) represents an arbitrary measure of radiolabeled 
DNA. 
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3.2.5 CAP Genomic DNA calibration 
To determine if CAP could specifically enrich for nonmethylated CGI sequences, total 
human genomic DNA (male and female) was restricted with the endonucleases Msel 
(TTAA) and fractionated over the CXXC column. The rationale behind this digestion has 
previously been discussed (Cross et al,, 1994). Msel restriction was utilized as it cuts AT-
rich genomic DNA into small fragments, whilst leaving CGIs relatively intact. Bulk genomic 
DNA has a CpG on average every 100 base pairs so the majority of Msel fragments have 
insufficient CpGs to be retained by the CXXC matrix. CGIs on the other hand, with one CpG 
per approximately 10 base pairs, will give rise to long CpG rich fragments with high affinity 
for the CXXC column. 
The NaCl gradient was optimized to incorporate a 600mM NaCl wash to increase the 
separation between the methylated and non-methylated DNA fragments (Fig. 3.2-6a). Eluted 
fractions were interrogated by PCR using primers specific for a range of known CGIs and 
non-COT sequences (Fig. 3.2-6b). The non-methylated COT of the P48 gene eluted at high 
salt. The X-linked monoamine oxidase (MAO) gene eluted as a single high salt peak from 
male genomic DNA (where it is nonmethylated), but as two separate peaks at low and high 
salt when female DNA (with one methylated and one nonmethylated allele) was fractionated. 
The CGI associated with the testis specific antigen gene NYESO (somatically methylated) 
eluted from the CXXC column at low salt as predicted (Fig. 3.2-6c; (De Smet et al., 1999)). 
The data confirms that CAP can effectively purify nonmethylated CGIs from total genomic 
DNA. 
The CXXC column was used infrequently, and as such it was difficult to determine the 
lifespan of the matrix. DNA fractionations were consistent across a six month period; 
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Figure 3.2-6. CAP enrichment of nonmethylated CGI sequences 
(a) A typical elution profile of bulk genomic DNA (blue line) from a CXXC affinity chromatography 
column. Genomic DNA (1 OOp.g) was applied to the CXXC affinity matrix (see Methods) in low salt (0.1 M 
NaCI) and eluted with a gradient of increasing NaCl (red line). Eighteen fractions were interrogated by 
PCR (blue lines). The bracket above indicates fractions that were found to contain non-methylated 
CGIs. (b) Sequence characteristics of specific CGIs of known methylation status (NYESO, P48 and 
MAO). The direction of transcription (red box) is arrowed. Msel fragment assessed for column binding 
(dashed green line) and the region amplified by PCR (blue line) are indicated. (C) Elution of specific 
CCI sequences of known methylation status. Methylated CGIs (NYESO and MAO in females) coelute 
with bulk genomic DNA (see bracket and equivalent fractions in (a) whereas non-methylated CGIs 
(P48 and MAO) elute at high NaCl concentration. 
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3.3 Results: Generation of a novel CGI set 
3.3.1 CXXC affinity purification of a human blood CGI fraction 
Having demonstrated the functionality of the CAP procedure it was applied to the 
purification of a complete CGI library. To this end, we prepared whole blood DNA from 
three healthy male donors. Blood was used in preference to sperm, as it is known that CpG 
rich repeats and GC rich telomere proximal regions are unmethylated in sperm and would 
represent an unacceptable contamination of the CGI fraction (Brock et al., 1999; Kochanek 
et al., 1993). Genomic DNA was Msel digested and applied to the CXXC column. The DNA 
was eluted across an increasing NaC1 gradient and the high salt fractions (0.8-IM) pooled Z-- 
and re-chromatographed for a second time. This additional wash was introduced to ensure 
efficient removal of bulk genomic DNA contaminants from the CGI fractions. CGIs 
retention was confirmed by PCR validation of the first and second column runs. Pooled CGI 
fractions were precipitated and cloned into the Ndel site of the pGEM5zf- (Promega) 
plasmid vector to generate a CGI library. 
A panel of 181 cloned Msel fragments was sequenced using the Sanger dideoxy method 
(Sanger et al., 1977). The sequences were aligned against the human genome to determine 
the origin of the cloned Msel fragments. 145 of the Msel inserts were derived from human 
genomic sequence, 94% (136) of which showed elevated CpG[o/e] and/or G+C composition 
relative to the genome average (Fig. 3.3-1a). Full details of the alignment are summarized in 
Table 3.3-1. The insert length were also increased relative to the expected Msel fragment 
size for bulk genomic DNA (123bp; Fig. 3.3-lb dashed line). The sequence composition of 
the clones was highly suggestive of a library enriched for CGI fragments. Furthermore, none 
of the cloned sequences showed redundancy (with the exception of rDNA repeats), which 
suggests comprehensive library coverage. 
Table 3.3-1. Pilot sequence characteristics of the CGI library 
Sequence characteristic Number of Inserts 
Failed Sequence 19 
Cloning vector sequence 8 
E co//genomic sequence 	 - 9 
Human: Non CGI sequence 9 
Human: CGI sequence 126 
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Figure 3.3-1. CAP enriches for sequences with classical CGI sequence properties. 
(a) A panel of CAP purified CGI inserts show elevated CpG and G+C content compared to bulk 
genomic DNA (black dot). The majority of inserts fulfill the minimum sequence criteria of ~! 50% G+C 
(vertical dashed line and CpG [ole] of ~! 0.6 (horizontal dashed line) commonly used to identify CGI 
sequences (Gardiner-Garden and Frommer, 1987). (b) Cloned inserts are longer than that expected for 
bulk genomic DNA (123bp, dashed line) consistent with reduced TTAA recognition sites in G+C rich 
CGls. 
3.3.2 Sequencing the CGI library 
The optimized libraryx was sequenced to redundancy by the sequencing facility at the 
Welcome Trust Sanger Institute. In total approximately 172,000 colonies were sequenced 
with paired end reads, representing 119,487 genomic templates. Sequences which mapped to 
unique genomic locationsx were aligned to 28,013 unique Msel fragments. Plots depicting 
insert length versus either G+C content or CpG[ole] indicated elevated CpG and G+C 
composition of the cloned fragments (Fig. 3.3-2a,b). Despite these general characteristics, a 
population of smaller inserts resembled the sequence characteristics of bulk genomic DNA 
(Fig. 3.3-2a,b dashed line). To determine if these short fragments represented library 
contamination or genuine CGI sequences, a panel of inserts (<5 l2bp) were tested for CXXC 
binding. Human male DNA was MseI digested and fractionated using the CXXC column. 
Primers, complementary to short MseI fragments, were used to identify these sequences by 
PCR amplification from input and CXXC bound DNA (Fig.. 3,3-2c). Each MseI fragment 
was then allotted to a quadrant determined by a G+C vs. CpG plot (Fig. 3.3-2d). Only 
fragments satisfying both elevated G+C (>50%) and CpG[o/e] (>0.6) criteria were retained 
by CAP and represented genuine nonmethylated CGI inserts. As such, Msel fragments 
xv!iAn efficiency of >2million colonies per pGEM ligation was required for library coverage. 
Human genome assembly NC13I36. 
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shorter than 5 l2bp with a G+C content of <50% and/or a CpG[p/e] of <0.6 were filtered out 
of the CGI set (filtered islands are represented as grey dots in Fig. 3.3-2a.b). Remaining 
sequences were compiled into complete CGIs by knitting together contiguous fragments. Z- 
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Figure 3.3-2. CGI sequences characteristics and CAP binding 
Plots of fragment length versus G+C content (a) and CpG[o/e} (b) for 28,013 unique Msel inserts. 
Fragments shorter than 512bp with a G+C content = <50% and a CpG[ole] = <0.6 (grey dots) are 
indicated. The dashed line indicates the base composition (a) and CpG o/e (b) of bulk genomic DNA. 
(C) Investigation of CAP binding to short DNA inserts. PCR interrogation of short CGI library sequences 
from input (I) and CAP retained (B) DNA. Regions amplified are indicated by numbers or, in the case of 
positive (ATPSBS and cFOS) and negative (XIST and CATHEPSIN) controls, as gene names. (d) 
Sequence characteristics of short inserts which bound (+) or did not bind (black points) the CXXC 
column. 
Longer CGI inserts were not filtered from the set, as reduced CpG and G+C density for these 
fragments likely resulted from the cloning of fragmented CGIs. These sequences were 
retained due to their utility in localizing genuine CGIs. The final refined set contained 
17,387 unique CGIs with sequence composition consistent with classical CGIs (Fig. 3.3-3). 
XIX 
Fragments were combined if contiguous fragments were separated by :5 1 OObp. 
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This set can be viewed via the 'CPG island' DAS track hosted by the ENSEMBL genome 
browser (http://www.ensembl.org/ Homo_sapiens/index.html; (B irney et at., 2004), Dataset 
I). Elevated G+C content of the CGI set hindered DNA sequencing, such that only 
approximately 70% of clones were identified. This suggests that the total number of CGIs 
may be in excess of 25,200. 
CGI Insert G+C vs CpG ole 
20 	40 	60 	80 
G+C 
Figure 3.3-3. A CAP purified library represents a comprehensive CGI set. 
A filtered insert set representing 17,387 CGIs, show a discrete distribution that is distant from bulk 
genomic DNA (black dot). 
3.3.3 Distribution of the CAP CGI library 
Studies have indicated that CGIs are not distributed evenly throughout the human genome 
(Craig and Bickmore, 1994; Lander et al., 2001). To investigate this further, all CGIs were 
plotted against the 24 human chromosomes to generate a physical map of CGI location (Fig. 
3.34a). The schematic obviates gene rich chromosomes such as 19, which is 
overrepresented in the CGI set containing one CGI every 57kb. Conversely, gene deficiency 
on chromosomes 13 concords with a paucity of CGIs represented by an average density of 
one island every 303kb. Genome wide comparison identifies a striking correlation between 
CGI density and gene distribution (R=0.96; Pearson's correlation; Fig. 3.3-4b). Whereas, 
physical length of the chromosomes correlates far less with CGI density (R=0.58; Pearson's 
correlation; Fig. 3.3-4b). These findings are consistent with the co-localization of CGIs with 
0ene promoters and regulatory elements. 
a) CGI library Physical Map 
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Figure 3.3-4. Genomic distribution of the CGI set. 
(a) The distribution of cloned CGIs (red strokes) on human chromosomes. The number of CGIs on 
each chromosome is shown (right) and centromeres are denoted by blue dots. (b) A plot indicating the 
chromosomal length (red points), number of protein coding genes per chromosome (dashed blue line) 
and number of CGIs per chromosome (dashed green line) indicates a correlation between CGI and 
gene densities. (C) A plot depicting the average observed/expected CGI distribution (red line) along the 
autosomal arms indicates a relative enrichment proximal to the telomeres. The plot represents a 
window size and sliding resolution of 5% and 1% of autosomal arm length respectively. Values 
indicated are observed numbers of CGIs / that expected from even CGI distribution [ole]. An [o/e] ratio 
of 1 (dashed line) and centromere position (blue point) are indicated. 
Fluorescence in situ hybridization (FISH) experiments utilizing sequences enriched for 
CGIs, identified high density clustering of CGIs in T bands proximal to telomeres (Craig and 
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Bickmore, 1994). To determine if the CGI distribution indicates a similar trend and 
investigate spatial CGI density along the chromosome arms, an average schematic 
representation of chromosomal distribution was plotted (Fig. 3.3-4c). The representation of 
CGIs per chromosomal region was calculated using sliding windows of 5% with a 
periodicity of 1%. CGI distributions were calculated for all chromosomal arms and 
combined to give an average CGI density map. The observed number of CGIs was 
normalized against 5% of the total set to give a measure of density distribution. This plot 
indicated that while CGI levels approximate that expected along the majority of the 
chromosome, that CGIs are enriched in subtelorneric regions. Interestingly, the inverse is 
true for density surrounding the centromeres. This may be explained by the dearth of CGIs in 
pericentric heterochromatin such as illustrated for chromosomes 1 and 9 (Fig. 3.3-4a). 
In addition to the genome wide distribution, it was of interest to investigate the specific 
association between CGIs and genes. In order to do this, library inserts were mapped relative 
to all genes annotated by the ENSEMBL genome browser. This showed that 76.3% of all 
islands associated with an annotated protein coding gene (see Materials and Methods for 
gene mapping). However it was interesting to note that only 49.5% of these mapped to the 
annotated TSSs of protein coding genes. This suggests that approximately half of all CGIs 
are located distal to promoters and as such may represent unannotated regulatory regions or 
alternative internal transcriptional initiation sites. Furthermore, it is likely that at least a 
proportion of the intergenic 'orphan' islands represent genes which are as yet unannotated, 
due to low level or highly restricted expression patterns. Gene overlap suggests that only 
43.5% of protein coding genes have a CGI associated with their promoter (Table). However 
this likely represents the reduced coverage due to sequence failure. The discord between the 
observed and expected number of CGI gene promoters allowed a refinement of the estimated 
total. The fraction of genes observed to associate with a promoter CGI (43.5%) and the 
Table 3.3-2. Relationship between CGI library inserts and genes. 
Total Overlap 
Gene Genes with CGI Overlap with 
Type of Overlap Biotype (CGIs) (Gene) Percentage CGls (TSS) Percentage 
Gene Overlap: CGI Protein 21384 15118 70.7 9312 435a 
All genesb 31524 15433 49 9529 30.2 
CGI Overlap: Genes Protein 17387 13271 76.3 8491 48.8 
All aenes 17387 13360 76.8 8611 49.5 
a The fraction of genes with promoter CGIs is less than the known fraction (56%) because of 31% 
sequence failure in the CGI set. 
"All genes as classified on the ENSMBL genome browser including; non-coding RNAs, pseudogenes, 
VDJ regions etc. 
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fraction previously determined (56%) would suggest that there are 22,400 (Larsen et al., 
1992). This figure is rather less than the 25,200 previously posited. 
3.3.4 CGI prediction vs. the CAP CGI Set 
CGI prediction algorithms identify CGIs based on three key parameters: CpG density, G+C 
content and sequence length. Most methods, employ a minimum CpG[o/e]  density of 0.6 and 
minimum G+C content of 50%. However, the length of sequence which must satisfy these 
parameters varies between 200 and SOObp, the consequences of which are outlined in the 
introduction. Since, sequence based algorithms necessarily ignore methylation status it 
would be informative to compare bioinformatically identified islands with the more 
biologically relevant CAP CGI set. For this, two of the most commonly applied algorithms 
were compared with the library. The NCBI genome browser suite maintains two such 
algorithms with minimum length requirements of 200bp and SOObp which we formalize as 
NCBI 	and NCBISI  respectively. The total number of CGIs is summarized in table 3.1- 
1. 13,305 (76.5%) CAP CGIs are identified by NCBISCt,  which represents only 56% of all of 
the 24,163 islands predicted by this algorithm. Improved representation is provided by 
NCBIr ,  with 15,799 (90%) of the CAP CGI library being predicted. However despite the 
concordance between the two methods, the CGI library only represents 5.2% of the total 
307,193 predicted. Additionally the overlap between the two prediction methods is minimal 
(7.9%) suggesting that the majority of CGIs detected are false positives. This relatively poor 
representation of the CGI library in the NCBISLCt  set is likely due to library sequence failure. 
However the apparent accordance between predicted numbers of CGIs by these two methods 
masks a significant difference. The CGI library identifies approximately 4,082 CGIs (23%) 
missed by the algorithm. 
Table 3.3-3. Gene association: CoG islands missed by NCBI strict 
Gene overlap 	 Number of CGIs 	 Percentage of CGIs 
5' 	 778 	 19.1 
3' 176 43 
Intragenic 	 1421 	 34.8 
Intergenic 1707 41.8 
Total 	 4082 	 100 
Ill 
All CGIs vs. NCBI Missed-GC b) 
c. 
00 	 I 
1 
0 
All 	NCBI Missed 
All CGIs vs. NCBI Missed-CpG ole 
CL 
All NCBI Missed 
C) 
154520k 154530k 154540i 154550k 154560k 154570k 154580k 154590k 154600k 
Chromosome: 1 
COS 
wi 	 *rirt--i"ri---i----- 
CPC clones 
I 	 I 
NCBI Strict . 
NCBI Relaxed 
I 	I I 11 	11 11 	I II III 	II 	III II t II 	I  
711101, 	7120k 7?301, 	71140k 	71501, 7760k 7?70k 	7801, 	7790k 	780'Ok 
Chromosome: 17 
GElS 
tIW BI11I11I141R -, II nrltll- IHIil1I1lli t c> IIUSHIU' '11 	 ii-) 
2 	crn'tr-II----rr'rhtI> CPG clones 
NCBI Strict 
I U • UI 
NCBI Relaxed 
I 	I 	I Mill 	I 	I 	1 IN 1111 IIUI 	0 	II 
010k 5420k 030k 	 5440k 
Chromosome: 19 





NCBI Strict 3 4 
. 
NCBI Relaxed 




11 	II 	i in 
2000 
I 	Ill 	I,;lillllL.I:4::l' 
3000 4000 	5000 
II 	riP: 	 H 	till! ,::8: 
6H11!IilIlhll 	lltI;til 
1 	1417 
fillI!t P El HIF IU 1 1 1831 11 	liI.[IIIHSJ.I!111i tIilItiI!llhlt I Il1Eihl 	:111 19 llIi!lI 	tIlt 	11111 
11tH 
1::: 	1:111: 	111 tit:l:tl ;:l:lIl;1hUl';1l:tl;11131 	:)lCtiltItl:: 3IlliiIlIl:::l: 	Ell1tlttlI9ll 	ll 	11'P 	110:: 
2-19241 
CG 	l Ill 9 	II 	IlilIlIllIlIlIl :ILIOI:l 	llIllf 't9l] Eli 	Ii:8121I11H 	IifliH 	N II 	H: 	III 	9! 
II ltIlli ljlfl!jh!W 	9119 H 101 9Ht flt'it 1$ Ii 1611111106 ftlllEl; Roll 8IIE0tIItIflI9lth! 1711011111111006811111111901 
3- 11826 
4-1118 
Figure 3.3-5. Sequence characteristics of CGIs missed by NCBlstrict. 
Boxplots of G+C (a) and CpG[ole] (b) indicate that islands retained by CAP but missed by NCBI strict 
have significantly reduced G+C base composition (p.value<2.2e-16) and CpG[ole] (p.value<2.2e-16; 
NCBI-missed and all CGIs n=4082 and 13305 respectively). Boxplots are represented as for Fig. 3.1-1. 
(c) Three random chromosomal regions showing CCI secuences mapped to the human genome 
(green bars). Also shown, are CGIs predicted by the NCBiSI1t  and NCB lre 	algorithms (blue bars). 
The direction of transcription of coding sequences (yellow bars) is arrowed. Numbered CGIs (1-4) 
represent sequences not detected by the NCBI strict algorithm. (d) CpG maps of the four CCI clones 
not predicted by NCBISICI.  Transcription start sites in examples 1, 3 and 4 are indicated by arrows. 
Sequenced Msel fragments (dashed lines) and CpG and GpC sites (black strokes) are indicated. 
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Islands not predicted by this algorithm were, as predicted, weaker with respect to CpG and 
G+C content than the whole CGI set (Fig. 3.3-5a and b). Therefore, to ensure that these were 
not representative of genomic contamination, gene association was compared with the whole 
CGI set. Of four randomly selected islands represented in this category three were found to 
colocalise with the promoter regions of protein-coding genes (Fig. 3.3-5c,d). All CGIs 
(n=4082) retained by CAP but not predicted by NCBI strict were mapped relative to 
annotated human genes'. The majority of non predicted islands are gene associated, 
although with an elevated level of intragenic islands (Table 3.3-3). These findings are 
consistent with the previous observation that intragenic islands are generally weaker than 
those associated with gene promoter regions (Ioshikhes and Zhang, 2000). These findings 
suggest that the 23% of cloned but not predicted islands represent genuine CGIs and that this 
method allows the identification of weaker islands by their lack of methylation. Based on 
this it is unlikely that sequence based algorithms can be significantly refined to include these 
CGIs without introducing large numbers of false positives as illustrated by NCB relaxed. 
3.4 Discussion 
Previous attempts to purify CGIs from genomic DNA were inefficient or cumbersome in 
their application (Cross et al., 1994; Shiraishi et al., 1995). The most comprehensive set of 
human CGIs was prepared using a reverse chromatographic procedure employing the MBD 
domain of rat MeCP2 (Cross et al., 1994). Whilst proving effective, technical limitations 
rendered the resulting library incomplete (Cross et al., 1994; Heisler et al., 2005). This 
chapter describes the development of a novel, preparative and analytical procedure to resolve 
these issues. A recombinant CXXC domain, with In vivo and In vitro specificity for non 
methylated CpG sites was purified and adsorbed onto a nickel sepharose support (Birke et 
al., 2002; Jorgensen et al., 2004; Lee et al., 2001). DNA Chromatography conditions were 
optimized to ensure the efficient removal of methylated and CpG deficient sequences. The 
rusulting affinity matrix permitted the isolation of CGIs from total genomic DNA (Fig. 3.4-
1) in a single, nondestructive fractionation step. 
3.4.1 Purifying and characterizing a Comprehensive CGI set 
A comprehensive set of CGIs would not only further elucidate their role in the genome it 
would also provide an analytical tool representing the promoter and regulatory regions for 
the majority of human genes. Similar clone sets have been applied to the large-scale 
elucidation of DNA methylation profiles and identification of transcription factor binding 
XX  Genes were annotated according to ENSEMBL release 46 of NCBI36. 
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sites ((Huang et al., 1999; Mao et al., 2003; Watanabe et al., 1998; Weber et al., 2005; 
Weinmann et al., 2002; Yan et al., 2001; Yan et al., 2002)). Due to the lack of coverage 
provided by previous libraries a human somatic CpG island set was generated by CAP 
fractionation of male blood genomic DNA. 




/Mm 	-i .............................................................. 
Low NaCl (<600mmM) High NaCl (>600mmM) 
Discarded 	 Retained CGIs 
Figure 3.4-1. CXXC Affinity Purification (CAP). 
Msel digested genomic DNA is bound to the CXXC affinity matrix in low NaCl and then eluted across 
an increasing salt gradient. Bulk genomic DNA containing dispersed methylated CpGs (filled circles), 
interacts minimally with the CXXC domains (green "Cs") and elutes at low NaCl and is discarded. CGIs 
containing clusters of nonmethylated CpGs (open circles) bind strongly to the CXXC matrix and are 
retained, allowing their purification at high NaCl concentration. The nickel sepharose support is 
represented by dark blue ovals. 
Sperm DNA, known to have low levels of genomic methylation, was not the preferred 
material for the generation of this library as CpG rich repetitive elements, such as A1us', 
Xxi Alu elements are represented by approximately 1 million genomic copies in the haploid 
human genome Chesnokov, l.N., and Schmid, C.W. (1995). Specific Alu binding protein from 
human sperm chromatin prevents DNA methylation. J Biol Chem 270, 18539-18542, 
Hellmann-Blumberg, U., Hintz, M.F., Gatewood, J.M., and Schmid, C.W. (1993). 
Developmental differences in methylation of human Alu repeats. Mol Cell Biol 13, 4523-
4530, Rubin, C.M., VandeVoort, C.A., Teplitz, R.L., and Schmid, C.W. (1994). Alu repeated 
DNAs are differentially methylated in primate germ cells. Nucleic Acids Res 22, 5121-5127.. 
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would bind tightly to the CXXC matrix. As such it was considered preferable to sacrifice a 
small proportion of relevant CGIs in favour of background reduction that these elements 
would otherwise represent (Rubin et al., 1994; Weber et al., 2007). 
The CGI fraction was cloned and sequenced to redundancy. After filtering out false 
positives, the clone set had sequence characteristics which epitomized classical CGIs. The 
library, consisting of 17,387 unique genomic loci, was annotated onto the ENSEMBL 
genome browser. CGIs distribution strongly correlated with genome-wide gene density as 
previously shown (Lander et al., 2001). Furthermore gene rich T bands, proximal to the 
telomeres were also found to be overrepresented in the library (Craig and Bickmore, 1994). 
Interestingly, regions adjacent to the centromeres were shown to be relatively depleted for 
CGIs. This may represent unsequenced regions of the human genome, however this is 
unlikely as the CGI deficiency represents a larger proportion of the genome than that lacking 
tenable sequence (Bovee et al., 2008). It is feasible that this phenomenon results from large 
regions of pericentric heterochromatin, which are depleted for transcriptionally permissive 
sequences such as these. 
CGIs were found to associate with 76.3% of protein coding genes, although surprisingly, 
mapping data suggested that approximately half of all CGIs are distal from gene promoters. 
It is possible that these 'orphan' CGIs represent as yet unidentified promoters (Gardiner-
Garden and Frommer, 1987; Macleod et al., 1998). Indeed these may represent 
transcriptional initiation sites for ncRNAs such as TSIX and AIR which both originate from 
CGIs (Panning and Jaenisch, 1996; Sleutels et al., 2002; Wutz et al., 1997). Furthermore, 
non-promoter CGIs are enriched in chromosomal domains associated with homeobox genes. 
These complex gene loci contain multiple internal initiation sites and recent evidence has 
also highlighted the existence of functionally important antisense transcription within these 
regions (Kleinjan et al., 2004; Rinn et al., 2007). This will be discussed further in Chapter 4. 
3.4.2 H3K4me3 and the origin of CGIs 
One possible mechanism by which CGIs remain unmethylated, and by association, CpG rich, 
is steric hindrance of the de novo methyltransferases during global methylation in the early 
embryo (Reik, 2007). Since CGIs are known to colocalise with gene promoters, it is possible 
that steric hindrance could result from the association of the preinitiation complex at actively 
expressed genes in the developing embryo (Bird, 2002). This is consistent with the 
observation that genes with a tissue restricted expression profile which are expressed in the 
embryo possess a promoter CGI whilst others genes for which no transcript can be detected, 
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are associated with CpG deficient promoters (Daniels et al., 1997; Macleod et al., 1998). 
Indeed this is consistent with the induced de novo methylation and inactivation of the murine 
APRT gene resulting from mutation of SpI transcription factor binding sites (Brandeis et al., 
1994; Macleod et al., 1994). This data presents the possibility that early embryonic 
transcription directly propagates and maintains CGIs in a nonmethylated form. 
To test this hypothesis, we compared the CGI set with the pattern of the H3K4me3 in human 
ES cells (Guenther et al., 2007). This histone modification is known to associate with 
transcriptionally active promoters (Barski et al., 2007; Guenther et al., 2007; Weber et al., 
2007). In accordance with this hypothesis, we discovered that 78.2% (13595 of 17387) of all 
CGIs colocalised to sites containing this histone modification. Furthermore, 63.5% (5574 of 
8776) of the islands not overlapping an annotated TSS also mapped to this modification. 
This finding is consistent with CGIs arising from sites of transcriptional initiation in the 
developing embryo. It has been proposed that this histone modification is refractory to 
binding of de novo methyltransferases providing a possible mechanism by which the 
nonmethylated state of CGIs is maintained, even in the absence of somatic transcription (Ooi 
et al., 2007). 
3.43 Comparing the CGI library with prediction algorithms 
The CGI library was generated based on the empirical criterion of clusters of nonmethylated 
CpGs. As such it is unparalleled by sequence based prediction algorithms which do not 
account for DNA methylation status (Hackenberg et al., 2006; Ponger and Mouchiroud, 
2002; Takai and Jones, 2002). The comparison of two commonly used predication methods 
illustrated this fact. Relaxed sequence parameters identify the majority of CGIs in the library, 
whilst greatly overestimating the actual number by more than ten fold. Conversely, 
restricting the parameters significantly reduced the overlap between the two sets but provides 
a much more accurate representation of the total complement of CGIs. However, 23% of 
CAP CGIs are not predicted in the stringent set, which is explained by the reduction of CpG 
and G+C composition of these sequences. Despite this, these islands are still coherent with 
respect to promoter association. This suggests that the prerequisite for lack of CpG 
methylation, allows CAP to identify islands which would otherwise fail to meet the sequence 
criteria for this particular sequence algorithm. 
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3.4.4 Summary 
The CAP technique represents an effective preparative and analytical tool for the purification 
of COT sequences from bulk genomic DNA. The utility of this approach was illustrated by 
the generation and characterization of a complete human somatic CGI set. This 
comprehensive library of islands bears sequence characteristics coherent with classical COTs. 
Whilst providing useful information pertaining to genomic distribution and gene association 
of COTs, the library also represents a useful analytical tool for further investigation of an 
interesting regulatory fraction of the human genome. 
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Chapter 4: 	CGI Methylation Analysis 
4.1 Introduction 
4.1.1 DNA methylation analysis 
Initial studies investigating the role of DNA methylation were limited to determining the 
relative abundance of the methylated base within a given cell population. The 
chromatographic procedures applied had no spatial resolution with respect to the methyl 
base, but provided insight into the abundance and variability of DNA methylation in Toto 
(Ehrlich et al., 1982). However, the role of DNA methylation in a wide variety of biological 
processes has consequently led to the development of techniques to determine its distribution 
within a genomic context. These can be broadly separated into three functional categories 
based on the method of detection. These include methylation-sensitive restriction digestion, 
affinity purification and sodium bisulfite conversion. Each of these can be applied to DNA 
methylation profiling at specific candidate loci or across large genomic regions depending on 
the method used to resolve the information. 
In mammalian systems, DNA methylation is restricted to the cytosine base in the context of 
CpG dinucleotides. Restriction endonucleases which are sensitive to CpG sites containing 
methylated (Hpall, Hhal, BstUl, NotI etc.) or unmethylated (McrBC) cytosine can be used 
to directly determine the methylation status of the recognition sequence. Early studies 
combined this selective digestion with Southern blotting to specifically determine the 
methylation status of cleavage sites within a defined DNA sequence (Bird and Southern, 
1978). Whilst proving effective, this is a rather cumbersome technique and requires a 
relatively large quantity of starting DNA (approximately 10 'g  per digestion). Alternatively, 
PCR amplification of DNA sequences which span methylation sensitive restriction cut sites 
can also be applied to infer methylation status and can be applied to nanogram quantities of 
DNA. 
For global analysis, a combination of various restriction endonucleases coupled with cloning 
and sequencing, or microarray hybridisation have been described. Huang and coworkers 
developed a technology termed Differential Methylation hybridisation (DMH). This process 
employed combinatorial digestion using Msel and the methyl sensitive restriction enzymes 
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BstUl and/or Hpal 1. Methylated sequences resistant to restriction were selectively 
amplified by 1mPCR (linker-mediated PCR) and probed against arrayed CGI amplicons, to 
identify cancer specific methylation events (Chen et al., 2003a; Huang et al., 1999; Yan et 
al., 2002; Yan et al., 2000). A similar technique was developed which employed the methyl 
sensitivity of Smal (CCCGGG) to identify differentially methylated CGI sequences. 
Determination of methylation state was achieved by DNA sequencing cloned inserts and 
subsequently by cohybridisation to COT microarrays (Estecio et al., 2007; Heisler et al., 
2005; Ueki et al., 2001). Restriction Landmark genome scanning, detects differential 
methylation between biological samples, by combining methyl-sensitive digestion with two 
dimensional gel electrophoresis. Restriction products, which are apparent in one sample but 
absent in another are determined visually, and identified by subsequent DNA sequencing 
(Plass et al., 1999; Yu et al., 2005). More recently, virtual RLGS profiles generated from 
standardized preparations and in Silico digestion have been used to expedite sequence 
identification (Matsuyama et al., 2003; Song et al., 2005). This procedure allows 
simultaneous interrogation of all sequences bearing the specific restriction site without the 
prerequisite sequence selection intrinsic to microarray analysis. Alternatively, specific 
restriction products can be size selected and cloned to generate a library of methylated DNA 
sequences. This was successfully applied to the identification of candidate islands that were 
methylated in Wilm's tumour samples (Strichman-Almashanu et al., 2002). Sequencing 
allows an unbiased detection of all methylated loci but is hindered by the presence of high 
copy number CpO rich repetitive elements such as the rDNA spacer (Brock and Bird, 1997; 
Strichman-Almashanu et al., 2002). 
A further limitation of restriction techniques is the specific sensitivity of endonucleases to 
methylated DNA, which limits detection to nonmethylated sequences. Methylation is 
therefore indirectly inferred through an inability to cleave at the cognate recognition 
sequence, and is therefore more prone to systematic procedural artifacts. McrBC cleaves 
sequences containing the recognition motif (G/AmC  (N403)  GIAmC)  when one or more 
cytosines are methylated. Combining the opposing sensitivities of Hpal I and McrBC with 
PCR allows the direct determination of both methylated and nonmethylated sequences. Such 
increased resolution facilitated the detection of 3 monoallelically methylated CGIs in whole 
human blood DNA (Yamada et al., 2004). Schumacher and coworkers applied a similar 
technique, combining restriction with microarray hybridisation to characterise DNA 
methylation in a panel of brain samples (Schumacher et al., 2006). 
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Methyl-sensitive restriction is significantly limited by the fact that detection is confined to 
the available cleavage sites. This is highlighted for RLGS, where identification of 
differential methylation is limited to approximately 20% of human and mouse CGIs bearing 
Noti recognition sites. Furthermore, only a subset of all CpG sites within a sequence context 
is assayable by this method. As such, methyl-sensitive restriction represents a quick but 
relatively low resolution technique for the characterisation of DNA methylation. 
Alternatively, DNA sequences bearing methylated cytosine can be selectively enriched by 
various affinity purification methods. Currently, two reagents are available with specific 
affinity for methylated DNA. The first is the Methyl CpG Binding Domain, common to the 
MBD family of proteins (discussed in the introduction). Various recombinant MBD 
constructs from MeCP2 and MBD2 have been successfully applied to the specific 
recognition of methyl-cytosine in the context of CpG dinucleotides (Brock et al., 1999; 
Brock et al., 2001; Cross et al., 1994; Gebhard et al., 2006a; Gebhard et al., 2006b; Rauch et 
al., 2006). Alternatively detection can be achieved via a monoclonal antibody which 
recognizes the methyl-cytosine base in single stranded DNA (Keshet et al., 2006; Weber et 
al., 2005; Weber et al., 2007; Zhang et al., 2006; Zilberman et al., 2007). 
MBD affinity can be used to selectively enrich for DNA sequences bearing clusters of 
methylated CpG sites from total genomic DNA. The MBD from MeCP2 and MBD2 have 
been used to enrich for methylated sequences which have then been screened for specific 
candidates of interest (Gebhard et al., 2006a; Shiraishi et al., 2002). Alternatively, 
methylated sequences can be cloned and sequenced ((Brock et al., 1999; Brock et al., 2001; 
Selker et al., 2003; Shiraishi et al., 1999)) or hybridised to a microarray of pre-selected 
sequences (Gebhard et al., 2006b; Rauch et al., 2006; Zhang et al., 2006). Specific details 
and applications of MBD affinity technologies will be discussed in the next section. 
The utility of the methyl-cytosine antibody has been demonstrated in a number of global 
methylation studies. The method of immunoprecipitating DNA bearing the methyl mark is 
highly analogous to CUP and is therefore well suited to microarray analysis. The initial 
study describing the technique, demonstrated the efficacy of the antibody for determining 
both global and CGI specific DNA methylation patterns in humans (Weber et al., 2005). It 
has subsequently been applied to the elucidation of DNA methylation profiles in normal 
(Weber et al., 2007) and cancerous (Keshet et al., 2006) human cells as well as the high 
resolution profiling of methylation in the A. thaliana genome (Zhang et al., 2006; Zilberman 
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et al., 2007). Methyl DNA Immunoprecipitation (MeDIP) has been applied to genome wide 
analysis in conjunction with microarray technology. However, PCR amplification of specific 
sequences from enriched DNA illustrates its utility as a candidate approach for DNA 
methylation analysis (Weber et al., 2005; Weber et al., 2007). 
Presently little analysis has been carried out to directly compare the two reagents in terms of 
CpG density requirements, enrichment and selectivity. One study determined that the 
methylcytosine antibody could detect methylation at densities of two CpG sites per lOObp 
(Keshet et al., 2006). Whilst MBD technology is usually applied to the characterisation of 
sequences containing clusters of CpG sites, it remains unclear as to whether adjustment of 
the elution conditions would facilitate a similar level of sensitivity (Brock et al., 1999; Brock 
et al., 2001; Cross et al., 1994; Gebhard et al., 2006b). Indeed one comparison indicated that 
the two techniques gave highly concordant results in an analysis of the small genomed plant 
Arabidopsis. The antibody identified 20% of sites, not detected by MBD affinity, posited by 
the authors to indicate a difference in the CpG density requirements of the two reagents 
(Zhang et al., 2006). It is equally possible however, that this disparity arises from non-CpG 
cytosine methylation characteristic of many plants which would be undetectable using the 
MBD affinity method. 
Affinity techniques are very powerful as they allow simultaneous DNA methylation analysis 
on a genome wide scale, limited only by the microarray platform utilised for detection. They 
do however fail to provide nucleotide resolution provided by techniques such as bisulfite 
genomic sequencing. 
Sodium bisulfite converts all nonmethylated cytosine residues to uracil, but does not affect 
the methylcytosine moiety. Subsequent amplification of the converted DNA results in the 
conversion of uracil to thymine. As such, this method imprints a specific methylation state as 
a characteristic alteration in sequence composition. In its simplest form these changes can be 
identified by specific amplification of target regions followed by DNA sequencing (Frommer 
et al,, 1992). This technique represents the 'gold-standard' in DNA methylation analysis as it 
provides single base resolution for every DNA strand in a mixed population. This was 
illustrated by high resolution mapping of DNA methylation spanning target regions on 
human chromosomes 6, 20 and 22. This provided detailed insight into tissue specific 
promoter methylation at a resolution unparalleled by previous studies (Eckhardt et al., 2004; 
Eckhardt et al., 2006). The cumbersome nature of the technique coupled with the cost of 
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deep sequencing presently limits its application to candidate methylation profiling. This can 
be partially alleviated by replacing conventional sequencing with Pyrosequencing, which 
provides a proportional representation of cytosine and thymine at each assayable CpG 
position (Yang et al., 2004). The reduced requirement for sequence reads is countered by a 
loss of single base resolution. 
Related techniques exist which capitalize on the altered sequence composition resulting from 
bisulfite conversion. Combined bisulfite restriction analysis (COBRA) detects "methylation 
dependent sequence differences" by restriction digestion that discriminates between the 
altered sequences. This method allows a quick and quantitative measure of DNA methylation 
at a specific candidate locus (Xiong and Laird, 1997). Alternatively, coupling bisulfite 
conversion and various PCR based detection methods provides a measure of methylation 
status at pre-selected sequences. Methyl-sensitive single nucleotide primer extension (MS-
SNuPE), employs specific primers which can be used to quantitatively assess the 
methylation status of individual CpG sites (Gonzalgo and Jones, 1997). This technique uses 
methylation state independent amplification and secondary detection methods to determine 
sequence composition and subsequently methylation state. 
Alternatively, various techniques have been developed which determine methylation status 
by sequence specific oligonucleotide primers and probes. MethyLight employs a 
combination of methylation discriminatory primers and probes to quantitatively determine 
the methylation status of a specific DNA sequence (Eads et al., 2000). MethyLight is not 
applicable to global analysis but is suitable for determining the methylation status of specific 
sequences and repetitive DNA regions (Weisenberger et al., 2005). This is particularly 
informative in light of the fact that mammalian genomes are predominantly composed of 
DNA repeats, which are inaccessible by microarray and sequence based techniques. Methyl 
sensitive PCR (MSP) directly infers the methylation state by quantitation of amplicon 
produced from primers specific for the methylated and nonmethylated sequences (Herman et 
al., 1996). This technique is quick and simple and provides an effective means for 
confirming data from a global analysis such as those previously introduced. 
As discussed bisulfite based methodologies can provide very high resolution information 
pertaining to DNA methylation within candidate regions, but is less suitable for genome 
wide profiling. To address this limitation various studies have developed microarray based 
bisulfite detections systems. The principle being to hybridise bisulfite treated DNA against 
122 
an oligonucleotide array containing specific probes for methylated and nonmethylated target 
sequences. A preliminary study showed that a focused array representing a portion of the 
human ERa region could effectively characterise the methylation status at nucleotide 
resolution (Gitan et al., 2002). However, to completely map CpG methylation at high 
resolution on a genome wide scale would require probes representing the methylated and 
unmethylated form of every CpG site in the genome. For human this would represent 6x106 
specific probes, with no feature replication. At present this represents a significant technical 
challenge but with the development of high density array platforms such as Illumina's bead 
arrays, this may represent a realistic goal in the future (Bibikova et al., 2006; Fan et al., 
2006). Bisulfite sequencing is presently limited to focused genomic locations due to cost and 
the necessity for large numbers of region specific primers. However, the development of 
high throughput technologies such as solexa sequencing may allow the simultaneous 
characterisation of all unique CpG sites. Indeed the utility of this technology has already 
been indicated by the high resolution mapping of a range of post translational histone 
modifications (Barski et al., 2007). More recently, highly redundant sequencing of the small 
genomed plant, Arabidopsis thaliana confirmed that solexa sequencing could indeed be 
applied to the generation of global DNA methylation maps (Cokus et al., 2008). 
Global sequencing technologies may provide the means by which entire genomic 
methylornes can be characterised. As such it is hard to imagine that such sequencing will not 
supercede array based technologies. However currently, cost and limited analysis tools 
present a restriction to nucleotide resolution mapping of mammalian genomes. Furthermore, 
it is widely accepted that polymerase based amplification is prone to sequence specific bias, 
and as such extensive characterisation will have to be carried out prior to the realisation of 
this potential. 
4.1.2 MBD Affinity Purification (MAP) 
MAP employs a recombinant methyl binding domain to selectively purify DNA fragments 
containing clusters of symmetrically methylated CpG sites. A recombinant MBD domain is 
covalently coupled to a chromatography matrix such that the binding affinity for methylated 
DNA sequences is preserved. The MBD matrix is subsequently applied to a suitable 
chromatography column to which fragmented DNA is bound under low stringency salt 
conditions. DNA fragments bearing unmethylated or low density CpG sites (1 per 100bp) 
can be eluted from the affinity matrix at low NaCl concentration. Subsequent application of 
an increasing NaCl gradient disrupts the electrostatic forces between the CpG rich 
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methylated DNA fragments and the coupled MBD domain (typically at a NaCl of > 
700mM). This allows the efficient fractionation of DNA based on CpG density and 
methylation status. The affinity matrix is stable under these buffering conditions, allowing 
the elution of DNA whilst maintaining the functional integrity of the chromatography 
column for multiple purifications (Brock et al., 1999; Cross et al., 1994; Cross et al., 1999; 
Selker et al., 2003; Zhang et al., 2006). 
MAP was originally developed for the selective purification of CGI fractions from bulk 
human genomic DNA (discussed in the previous chapter; (Cross et al., 1994)). This 
employed a two phased purification approach, with the initial stripping of CpG rich 
methylated DNA, and the subsequent enrichment of artificially methylated CGIs from bulk 
genomic DNA. The technique was also applied to the purification of CGIs from the genomes 
of mouse, pig and chicken in addition to targeted cloning of CGIs from human BACs, PACs 
and flow sorted chromosomes (Cross et al., 1999; Cross et al., 2000; Cross et al., 1997a; 
McQueen et al., 1997; McQueen et al., 1996). 
More recently, MAP has been applied to the direct purification of methylated CpG rich 
fractions from bulk genomic DNA. The 'normal' methylation profile of DNA prepared from 
whole human blood was determined by sequencing a MAP enriched library. This identified a 
major fraction of methylated sequences derived from GC rich repetitive elements, and a 
unique population of sequences which localize to subtelomeric chromosomal termini (Brock 
et al., 1999). MAP, in conjunction with denaturing gel electrophoresis or subtractive 
hybridisation, was used to identify aberrantly methylated CGIs associated with lung 
Adenocarcinomas and breast cancer respectively (Brock et al., 2001; Shiraishi et al., 1999). 
The utility of MAP was particularly highlighted for the elucidation of methylation profiles 
in, as yet, unsequenced genomes. Isolation of methylated sequences from the filamentous 
fungus; Neurospora crassa, identified sequences which specifically localize to transposable 
elements. This data supported a role for DNA methylation in genome defense (Selker et al., 
2003). 
In addition to preparative applications, MAP can also provide a useful analytical tool for the 
direct inference of methylation state of pre-selected sequences. In the case of cancer samples, 
this application is particularly powerful as it allows methylation analysis to be carried out on 
nanogram quantities of DNA. This is a prerequisite when working with certain histological 
grade tumour biopsies where material is highly limiting. Candidate CGI methylation can be 
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determined directly by specific PCR amplification of sequences from MAP enriched DNA. 
This allows the quick, simultaneous assessment of target sequence methylation across a 
panel of biological samples (Gebhard et al., 2006a; Shiraishi et al., 2002). By extension, 
amplified, MAP-enriched DNA can be probed against a set of target sequences by 
microarray hybridisation. MeCpG Immunoprecipitation', a technique evolved from MAP, 
employs a bivalent MBD:IgG fusion protein and was used to screen aberrant CGI 
methylation events in Myeloid Leukemia (Gebhard et al., 2006b). 
These studies indicate that MAP and its derivatives represent a versatile preparative and 
analytical tool for the elucidation of methylation events in a range of genomic contexts. 
4.1.3 The Methyl-binding Domain 
The MBD (pfam0 1429) is a short peptide motif which has specific affinity for symmetrically 
methylated CpG dinucleotides. It was initially identified as the DNA binding module in the 
mammalian corepressor protein; MeCP2 (Lewis et al., 1992; Nan et al., 1993). The amino 
acid sequence required for rneCpG  binding was determined through DNA binding assay using 
a panel of MeCP2 deletion mutants. This analysis identified a core sequence of 
approximately 85aa's which was sufficient for DNA binding in vitro (Nan et al., 1993). 
Cloning of the cDNA encoding the MECP2 gene subsequently led to the identification of a 
family of proteins containing this highly conserved domain (Fig. 4.1-1; (Cross et al., 1997b; 
Hendrich and Bird, 1998)). In humans and mice there are five characterised members of this 
family, referred to as the MBD proteins. Of this family, four have intact DNA binding 
activity whilst MBD3 cannot bind DNA specifically (for details of the MBD proteins see the 
Introduction; Fig. 1.2-6; (Hendrich and Bird, 1998)). 
Initial insight into the structural aspects of the MBD was provided by the NMR solution 
structure for the MBD of MBD1 in both the free and DNA complexed forms (Ohki et al., 
2001; Ohki et al., 1999). On a gross scale, the MBD forms an amphipathic antiparalle! a / 1 
sandwich structure. This comprises of a four stranded f3-sheet backed against an alpha helical 
turn which is stabilised by a core hydrophobic region (Ohki et al., 1999). The NMR structure 
of MeCP2 was found to be highly similar to that described for MBD 1, adopting the same 
characteristic wedge shaped, a / 3 sandwich conformation (Wakefield et al., 1999). Both 
structures indicated that the COOH terminal loop in conjunction with the turn between f3 
strands (2 and 3), protrude into the major groove to form one of the two DNA interacting 
interfaces (Ohki et al., 2001; Wakefield et al., 1999). A second DNA contact region occurs 
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via the amino terminal loop and a portion of the alpha helix. It is interesting to note, that 
despite the symmetry of the mCpG ligand, the MBD contacts the DNA through two distinct 
DNA interfaces (Ohki et al., 2001; Wakefield et al., 1999). Initial, characterisation of the 
MBD structures indicated that 'CpG recognition was mediated by direct contacts via a 
conserved hydrophobic patch of amino acids. However, the X-ray crystal structure of the 
MBD of MeCP2 suggests that this recognition is indirectly coordinated by static water 
molecules. These are stably associated with the methylated cytosine base located in the 
major groove (Ho et al., 2008). This is supported by the fact that a conserved tyrosine 
residue, involved in water association, is mutated to phenylalanine in the mammalian MBD3 
protein (Fig. 4.1-1; asterisked). Mutagenesis recapitulating the tyrosine at this position 
restores rneCpG  specific DNA binding (Fraga et al., 2003; Hendrich and Bird, 1998; Ho et al., 
2008). 
Interestingly, different in vivo binding specificities for the MBD family members were 
observed. This led to the identification of a preference for a run of A and Ts adjacent to the 
central methylated CpG site. It has been suggested that this introduces a bend in B form 
DNA, resulting in a significant narrowing of the minor groove which facilitates MBD 
binding (Ho et al., 2008; Klose et al., 2005). Footprinting analysis has confirmed that this 
results in the asymmetric binding of MeCP2 to its cognate CpG site. This specificity was 
encoded by the minimal MBD domain, but surprisingly was not observed for the highly 
similar MBD of MBD2 (Fig. 4.1-I ;(Klose et al., 2005; Nan et al., 1993)). 
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Figure 4.1-1. Conservation of the MBD in mouse and human 
Amino acid sequence alignment reveals high levels of conservation between the MBDs of MBD family 
members. Regions of conservation are shaded, and the tyrosine to phenylalanine mutation in the MBD 
of mammalian MBD3 is asterisked. Species are denoted to the left of each sequence indicating human 
(h) and mouse (m). Secondary structure, as determined by the x-ray structure of the MeCP2 MBD, is 
indicated above the alignment with alpha helixes (black helix) and beta sheets (black arrows) indicated 
(figure adapted from (Ho et al., 2008)). 
4.1.4 Differential CGI Methylation 
Despite the fact that the large majority of CGIs are hypomethylated in all mammalian 
tissues, there are some which acquire methylation during cellular differentiation (Eckhardt et 
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al., 2006; Shen et al., 2007; Weber et al., 2007). A small but significant proportion of these 
islands is differentially methylated between tissues (Eckhardt et al., 2006; Futscher et al., 
2002; Imamura et al., 2001; Kitamura et al., 2007; Nguyen et al., 2001; Oakes et al., 2007; 
Schilling and Rehli, 2007; Strichman-Almashanu et al., 2002). Several independent RLGS 
analyses identified tissue specific methylation in murine cells (Oakes et al., 2007; Shiota et 
al., 2002; Song et al., 2005). Approximately 5% of assayed sequences were found to be 
differentially methylated between tissues, although the majority of these occurred between 
testis and other somatic cells (Oakes et al., 2007; Song et al., 2005). An equivalent 
phenomenon was observed in an analysis of human brain, testis and Monocytes. Promoter 
arrays, probed with methylated DNA, enriched by methyl-cytosine immunoprecipitation, 
determined that the majority of differences resulted from testis specific hypomethylation 
(Schilling and Rehli, 2007). These results are consistent with the observation that CpG rich 
sequences which are methylated in somatic cells are frequently hypomethylated in 
mammalian sperm DNA (Brock et al., 1999). An independent microarray study identified 
CGIs which were methylated in human blood DNA. Candidate bisulfite analysis of seven of 
these islands confirmed that they were completely devoid of methylation in sperm DNA 
(Shen et al., 2007). However, despite the paucity of differentially methylated islands 
between somatic tissues, several such islands have been identified. The promoter region of 
MASPIN associates with a weak CGI sequence which was found to be differentially 
methylated in a panel of ten somatic tissues and cell types (Futscher et al., 2002). In rat 
tissues, a short (-200bp) differentially methylated region was identified in the 5' end of the 
promoter CGI of SPHKJ (Imamura et al., 2001). A portion of the CGI associated with the 
promoter of human SLC6A8 was identified as heavily methylated in four out of eight human 
somatic tissues (Grunau et al., 2000). More recently, bisulfite analysis of human 
chromosomes 6, 20 and 22, identified eleven CGIs which were differentially methylated 
between 8 somatic tissues (Eckhardt et al., 2006). 
The increased representation of differentially methylated sequence between the germ line 
and somatic cells may have been selected for their ability to stably silence plunpotency 
genes (Zilberman, 2007). Somatic methylation of gene promoters transcribed specifically in 
cells of the germ line and embryo, could serve to irrevocably silence these genes in all 
somatic tissues. This is illustrated by the promoter methylation of the MAGE genes 
associated with transcriptional silencing in all somatic tissues (De Smet et al., 1999). 
Alternatively, such stable silencing may be too inflexible a mechanism to have a general role 
in the regulation of gene expression, between different somatic cell types (Zilberman, 2007). 
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4.1.5 Aim 
Whilst extensive investigation pertaining to the role and distribution of DNA methylation in 
cancer has been carried out, relatively less attention has been paid to the equivalent features 
in 'normal' human tissues. Recent studies have provided tantalising insights into DNA 
methylation in human cells, although genome wide characterisation of tissue variability has 
yet to be carried out. To this end this chapter will investigate the CGI methylomes in a panel 
of primary human tissues utilizing a combination of MBD affinity purification and the novel 
CGI set introduced in the previous chapter. Whilst, it will be informative to characterise 
tissue specific genome wide methylation, this currently represents a technical challenge that 
has only been addressed for the small genomed plant Arabidopsis thaliana (Cokus et al., 
2008; Zhang et al., 2006; Zilberman et al., 2007). We limit the analysis to CGIs as they 
represent a tractable fraction of the genome with obvious biological significance in both 
normal and disease processes. 
4.2 Results: MBD affinity purification 'MAP' Array 
4.2.1 Preparation of the MBD column 
The MBD construct used in previous studies was generated by cloning the coding sequence 
of the rat MeCP2 MBD domain into the pet6h his tagging vector. The amino terminally 
tagged pet6hMBD construct proved to be an effective reagent for the affinity purification of 
methylated DNA (Cross et al., 1994). However, on expression, the majority of the protein 
was found to be insoluble and formed inclusion bodies (Bird lab unpublished observations). 
Despite attempts to increase solubility and expression"  , protein yields remained low. In 
order to make MAP column production more efficient, an alternative human MBD construct 
was generated. 
The MBD coding sequence from human MeCP2 (amino acids 77-167) was amplified with 
PCR primers which introduced a 5' Ndel site (containing an in frame start codon) and a 
sequence corresponding to 6x histidine tag, two stop codons and an EcoRl site at the 3' end. 
Xxii To increase expression and solubility, induced bacteria were grown for 5 hours at a 
reduced temperature of 30°C. In addition, IPTG and antibiotic concentrations were varied. 
Recombinant MBD was also purified under denaturing conditions, but the protocol is lengthy 
and resulted in low yields. 
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The amplicon was restricted with EcoRl and Ndel and cloned into the MCS of the pet30b 
expression vector (Fig. 4.2-la). With the exception of the orientation of the histidine tag, the 
construct was essentially identical to the original MBD, containing the core amino acid 
sequence of the domain, encoding three conserved beta sheets and a single alpha helix (Fig. 

















Figure 4.2-1. Cloning schema for the C terminally tagged MBD construct. 
(a) Schematic representation of hMeCP2 indicating the position of the MBD domain (green). The 
location of the protein fragment (aas 77-167) is indicated DNA encoding the MBD sequence was 
cloned into the Ndel and EcorRi sites of the pet30b protein tagging vector. The pet30b schematic is 
indicated as for Fig. 3.2-2a. (b) The MBD peptide sequence, indicating the location of the cloned amino 
acid sequence (red box) and the Histidine tag (6xH). Alpha helixes (black helix), beta sheets (black 
arrows) and minimal MBD sequence (blue lettering) are depicted. 
Recombinant MBD was expressed by transforming chemically competent E.coli cells with 
the pet30bMBD construct. The MBD was bacterially expressed as previously described for 
the CXXC domain. SDS PAGE analysis indicated that IPTG treatment induced the 
expression of a protein corresponding to the size of the MBD construct (Fig. 4.2-2a). 
Furthermore, samples of the cell lysate confirmed that a large proportion of recombinant 
MBD was soluble (Fig. 4.2-2a, insoluble pellet (P) and soluble whole cell extract (WCE)). 
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Single step Nickel affinity chromatography efficiently removed contaminating proteins from 
the bacterial cell lysate without need for further purification (Fig. 4.2-2a). 
To ensure that recombinant MBD recapitulated the methyl-specific affinity observed for the 
equivalent rat MBD construct, DNA binding was assayed by bandshift. This was carried out 
exactly as described for the CXXC construct, using both methylated and nonmethylated 
DNA probes to test for DNA binding. Consistent with previous findings, the MBD could 
efficiently bind to a probe containing methylated CpG Sites but not to the same 
nonmethylated sequence (Fig. 4.2-2b). In addition, binding indicated that a single DNA 
probe could complex with multiple MBD domains. This suggested that an MBD affinity 
matrix would have a higher affinity for DNA containing clusters of CpGs as has been 
determined previously for both MBD and CXXC affinity techniques (Brock et al., 1999; 
Cross et al., 1994); Chapter 3). 
Purified MBD was dialysed to remove the iinidazole and then coupled to imI of Nickel 
charged sepharose. Saturated beads contained approximately 50m- of recombinant MBD. 
The affinity matrix was packed onto a imI chromatography column (Tricorn 5/50; GE 
Healthcare) and washed as described for the CXXC. Prior to calibration, the column was 
equilibrated with a I OOml, 0.1-IM, NaCl gradient to remove any contaminating bacterial 
DNA. 
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Figure 4.2-2. Purified MBD binds specifically to nonmethylated DNA. 
(a) MBD induction and nickel affinity purification. Protein content of uninduced bacterial culture (UI), 
PIG induced culture (I), insoluble lysate (P), WCE, unbound (UB), wash (W), elutions (E1-5) and size 
marker (Prestained Broad Range Marker, sizes indicated; NEB). Retained fractions are bracketed. (b) 
Bandshift assay showing the MBD complexed with a DNA probe containing 27 methylated CpG sites 
but not with a probe containing no methylated CpGs. Nonmethylated probe DNA (CG1 1) or methylated 
probe (MeCG1 1) was incubated with 0, 25, 50, 125, 250 or 500ng of recombinant MBD protein. 
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4.2.2 MAP Calibration 
MBD chromatography has been shown to specifically purify DNA sequences containing 
clusters of methylated CpG sites (Brock et al., 1999; Cross et al., 1994). However, variations 
in the column matrix, MBD construct and the utility of the technique necessitated thorough 
calibration prior to its application. For this, a preliminary plasmid fragment calibration was 
carried out as previously described for the CXXC. 
500ng of methylated and nonmethylated pABS fragments were prepared and end labeled as 
described in the previous chapter (depicted in figure 3.2-5a). Nonmethylated plasmid 
fragments were bound to the MBD column in low salt (O.IM NaCI) and eluted across a 0.1-
1M NaCI gradient. This process was repeated for the methylated DNA fragments. The DNA 
content of each fraction was measured using a liquid scintillation counter (Perkin Elmer). 
Fractions were then resolved by agarose gel electrophoresis to determine the specific MAP 
elution profile of methylated and nonmethylated DNA fragments (Fig. 4.2-3a). 
As expected the MBD column had reduced affinity for nonmethylated DNA fragments 
relative to their methylated counterparts. All three nonmethylated fragments eluted at 
approximately 750mM NaCI concentration irrespective of CpG density. Methylated DNA 
fragments however, required higher salt concentration for elution (>850mM NaCI). As 
expected, the smaller CpG deficient fragment eluted at a lower NaCl concentration (850mM) 
than the two larger, more CpG rich sequences (retained until 900mM NaCI; Fig. 4.2-3a). 
This plasmid fragment calibration indicated that MAP could enrich for artificially 
methylated CpG rich DNA from a low complexity pool of DNA fragments. However, in 
contrast to the resolution obtained with CAP, the nonmethylated and methylated sequences 
were distinguished by as little as 200mM NaCl concentration. In order to ensure that this 
separation was sufficient to resolve endogenous methylated CGIs from bulk genomic DNA, 
further calibration was required. 
Human male and female blood genomic DNA (n=3) was restricted with the endonuclease 
MseI (TTAA) and fractionated over the MBD column. The salt gradient was optimized to 
incorporate a wash at 750mM NaCI concentration to increase the resolution between the 
nonmethylated and methylated DNA fragments (Fig. 4.2-3b). This NaCI concentration was 
chosen based on the preliminary MAP calibration which indicated this to be sufficient to 
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ifi 
 remove all nonmethylated DNA. Relative DNA content of MAP fractions indicated that 
bulk genomic DNA was eluted from the affinity matrix at a NaCl concentration of 650-
700mM (Fig. 4.2-3b). PCR was applied to investigate the elution profile in more detail by 
specific amplification of a range of CGI sequences with known methylation status. 
Nonmethylated CGIs (P48 and XIST on the Xi in females) co-fractionated with bulk 
genomic DNA, whilst methylated CGIs (NYESO and XIST in males and Xa in females) 
eluted at a higher NaCl concentrations (800-1000mM). Furthermore, it is interesting to note 
that the NYESO CGI (2168bp containing 96 CpG sites) bound to the MBD affinity matrix 
more tightly than the short XIST CGI fragment (214bp containing 10 CpG sites). This 
confirmed the requirement of multiple CpGs for efficient retention by the MBD affinity 
matrix (Fig. 4.2-3b). 
This calibration indicated that the affinity matrix had selective affinity for methylated DNA 
fragments. Furthermore, although elevated CpG density was not required for efficient 
purification per Se, Msel digestion of CpG deficient bulk genomic DNA would result in 
DNA sequences with insufficient CpG sites to bind the MBD matrix. The resolution of MAP 
is poorer than that of CAP, however introduction of a NaCl wash step at 750mM effectively 
separated methylated CpG rich sequences from bulk genomic DNA. The genomic calibration 
was repeated for each new MBD column constructed to account for variations in 
recombinant MBD and matrix packing density. The elution profiles for each column were 
indistinguishable from one another, although the exact NaCl concentration at which DNA 
fragments eluted from the column varied by as much as 40mM. To account for this, the wash 
step was adjusted to an appropriate salt concentration as defined by bulk genomic elution 
and the affinity of a panel of specific DNA sequences. This adjustment was necessary to 
allow consistent sample preparation for microarray hybridization. 
4.2.3 MBD column stability 
MAP fractionations were carried out over the course of more than twelve months. During 
this time, four MBD columns were constructed, each of which was individually calibrated as 
outlined. After approximately fifty fractionations, repeat calibration indicated reduced DNA 
binding to the MBD affinity matrix (data not shown). This temporal deterioration could have 
resulted from the reduction of the nickel beads, protein degradation or stripping of nickel 
ions. However, it is unlikely to have been reduction of the Ni2 ions as this would have 
XXIII Relative DNA content was determined by measuring UV light absorbance at 260nM using 
the chromatography apparatus. 
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Figure 4.2-3. MAP preferentially binds to methylated CpG rich DNA. 
(a) The upper panel indicates the elution profile of nonmethylated (dashed blue line) and methylated 
(dashed red line) DNA fragments across a NaCl gradient (solid black line). All nonmethylated 
fragments (nMeth) elute at approximately 0.75M NaCl whereas methylated fragments (Meth) don't 
elute until 0.85M with the most CpG dense fragments being retained by the CXXC matrix until 0.95M. 
Figure layout is depicted as for Fig. 3.2-5b (b) MAP fractionation of digested male and female genomic 
DNA. The upper panel is a representative elution profile of bulk genomic DNA (blue line). Genomic 
DNA (50ig) was applied to the MBD affinity matrix (see Methods) in low salt (O.1M NaCl) and eluted 
over an increasing NaCI gradient (red line). Twenty two fractions (dashed blue lines) were interrogated 
by PCR. The bracket above indicates fractions containing methylated CGIs. The lower panel indicates 
the elution profile of specific CGI sequences of known methylation status. Nonmethylated CGIs (P48 
and XIST in females) coelute with bulk genomic DNA, whereas the methylated CGIs (NYESO and 
XIST) elute at high NaCl concentration. 
133 
resulted in the formation of a brown colour which was not observed. Imidazole elution of the 
MBD from the Nickel sepharose matrix indicated no appreciable protein degradation after a 
period of six months (Fig. 4.2-4a). Nickel stripping is the most likely cause of the observed 
deterioration as this is known to affect metal affinity cation exchange, and is usually 
countered by recharging the matrix with nickel. As this was not an option, alternative matrix 
chemistry was applied in an attempt to stabilize MBD adsorption. 
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Figure 4.2-4. Optimisation of the MBD affinity matrix. 
SIDS PAGE analysis indicated that MBD protein stripped from nickel sepharose after six months of 
chromatography (MBD1P)  showed little sign of degradation relative to a freshly purified batch of the 
MBD (MBD). Prestained Broad Range Markers 6-175kDa are indicated (Broad Range Marker; NEB). 
CNBr coupling reduces the affinity and resolution of the MAP procedure. Fractions from CNBr and 
Nickel MBD column purification of female human blood DNA were assayed for specific DNA 
sequences by semi-quantitative PCR. The CNBr column showed m0CpG specific biding as confirmed 
by the increased affinity for the CGI of NYESO (methylated) relative to that of P48 (nonmethylated). 
Despite this, the resolution between methylated and nonmethylated DNA was greatly reduced relative 
to the nickel equivalent. The nonmethylated and methylated peaks of XIST (asterisked; blue and red 
respectively) were separated with less resolution by the CNBr column. Fractions interrogated by PCR 
are indicated (dashed blue line). 
Activated CNBr forms covalent attachments with primary amino groups, facilitating the 
stable coupling of proteins to a sepharose matrix. To investigate the effect of this adsorption 
technique, 40mg of purified MBD was coupled to either 1 ml of CNBr sepharose or I ml of 
Nickel sepharose. Adsorption efficiency was equivalent for both matrices as determined by 
Bradford analysis of input, wash and unbound fractions. To test MAP functionality, 7.5 p.gs 
of Mse 1 digested female genomic DNA was applied to each column and chromatographed as 
previously described. Fractions were subsequently interrogated by PCR amplification of 
control DNA sequences. The Ni-MBD column behaved as previously characterized, 
however the CNBr-MBD column showed reduced affinity for all DNA sequences tested. 
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Methylated CpG dense fragments were bound preferentially, but the resolution of separation 
was deemed insufficient for effective purification of methylated DNA (Fig. 4.2-4b; compare 
blue and red asterisks). 
It is possible that the reduced binding affinity and specificity of the CNBr matrix was due to 
excessive multi-point coupling of the MBD. This would have resulted in the occlusion of the 
active DNA binding site. Therefore, optimisation of binding conditions could yield a 
functionally equivalent column that is more stable than the chemistry currently employed. 
Future investigation will be required to determine if this is the case, however for the purpose 
of this study, the generic Nickel matrix was applied successfully. Deterioration associated 
with this type of column was countered by frequent recalibration, and a maximum functional 
lifespan of 40 MAP runs per column. 
4.2.4 CGI microarray platform 
Whilst it would be highly informative to investigate genome-wide methylation patterns in 
human tissues this is currently beyond our technical abilities. Techniques such as MAP and 
MeDIP are not sensitive to DNA methylation at the CpG density (1 site per lOObp) 
characteristic of bulk genomic DNA (Brock et al., 1999; Cross et al., 1994; Weber et al., 
2005). Furthermore, bisulfite sequencing techniques are not, as yet, applicable to large 
mammalian genomes (Eckhardt et al., 2006). As such this study focuses on the DNA 
methylation status of CGIs which represent an interesting and tractable fraction of the human 
genome, the relevance of which has previously been discussed. Having established the MAP 
chromatography procedure for the fractionation of methylated DNA sequences, global 
analysis required a suitable microarray for CGI identification. 
The microarray was generated from DNA sequences present in the CAP CGI library 
characterised in chapter 3. Amino-link amplicons were prepared by PCR amplification of 
CGI clone inserts with a 5' aminolink oligonucleotide forward primer. Amplicons were 
spotted and covalently coupled to the surface of amine binding glass slides (for full details 
see http://www.sanger.ac .uk/Projects/Microarrays/arraylab/methods/shtml). In total 28,800 
features were spotted onto the arrays, representing 27,666 clone inserts (including 
duplicates) and 1134 negative control spots. 59% of the 17,387 unique CGIs were 
represented by duplicates which represent a combination of equivalent sequence clones and 
contiguous Msel fragment inserts from the same island. 
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During microarray data analysis, duplicates were not merged to give additional technical 
replication due to the fact that not all CGI were represented multiple times. Furthermore the 
two distinct classes of duplicate complicated their utility. However these features provided a 
useful empirical means of verification for all aspects of microarray data analysis. The 
microarray was fabricated entirely by Cordelia Langford and colleagues at the Wellcome 
Trust Sanger Institute Microarray facility. 
This microarray represents approximately 60%' of all CGIs in the human genome which is 
comprehensive when compared with equivalent resources (Heisler et al., 2005). However, in 
the future an exhaustive set of CGIs representing the entire human genomic complement 
would be beneficial. Furthermore, due to the fact that CAP only enriches for CGIs which are 
nonmethylated in blood DNA, those which are fully methylated will necessarily be absent 
from the library (Eckhardt et al., 2006; Weber et al., 2007). This is illustrated for the 
promoter CGI of the cancer testis antigen gene NYESO, which is fully methylated and 
therefore not enriched by CAP (Fig. 3.2-6a; Fig. 4.2-3b; (De Smet et al., 1999)). However, 
despite the absence of these sequences, the array allows the detection of CGIs showing 
fractional methylation or indeed differential methylation between somatic tissues. 
Completion of the CGI set will be discussed later. 
4.2.5 Procedure for MAP array and data normalisation 
A total of 50igs of genomic DNA was pooled from three individuals; Msel digested and 
ligated to adaptors suitable for 1mPCR. The prepared DNA was fractionated by MAP, and 
sequences retained with high affinity were re-chromatographed for a second time. MAP 
enriched and input DNAs were PCR amplified and fluorescently labeled by random 
incorporation of Cyanine 3 or 5 conjugated dCTP using the Klenow DNA polymerase 
fragment. Alternately labeled Input and MAP DNA was then cohybridised to the CGI 
microarray (Fig. 4.2-5). 
DNA from each biological sample was prepared and MAP fractionated in duplicate. The 
MAP probes were then amplified and labeled in both Cy3 and 5 orientations to allow for 
further technical replication (dye swap experiments). The four technical replications were 
introduced to reduce experimental artifacts resulting from cyanine incorporation bias or 
variations in MAP preparations. The microarrays were scanned on an Axon 4200B 
XXIV 60% coverage was estimated based on a total genomic complement of 25,500 CGI, the 
justification for which was discussed in chapter 3. 
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Figure 4.2-5. Schematic showing the isolation of methylated CpG dense DNA sequences form bulk 
genomic DNA. Nonmethylated (open circles) and methylated CpGs (filled circles) are indicated. Red 
bars denote ligated universal adaptors, and green and red lines represent cyanine 3 and cyanine 5 
labeled DNA respectively. 
autoloader and the raw signal intensities and primary quality controls were carried out 
using the Genepix pro software package (Axon). Raw signal intensity values for each 
xxv The primary data generated by the microarray scanner were TIFF images off raw Cy3 and 
Cy5 spot intensities. Each image was visually inspected to determine 'bad' spots and then 
auto flagged to identify weak or absent features. These flag values were then introduced into 
later stages of analysis to down weight or remove 'bad' features. 
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replicate microarray were calculated and then analysed using the limma (Linear Models for 
Microarray Data) package and R statistical environment (Smyth and Speed, 2003). Feature 
intensities were corrected for local background signal and those with very low values 
(1000) were coerced to a minimum value of 1000x.  Relative DNA quantities for all 
quality controlled CGI feature were calculated as a 1092  ratios of Cy5:Cy3 (M value), 
required for further analysis. To remove systematic trends occurring from technical aspects 
of the microarray experiment, the M values were normalized using print tip loess (Smyth and 
Speed, 2003). This fitted the data to a local regression line centering the data on a log ratio of 
zero. A typical data set and the processing involved is illustrated for quadruplicate 
hybridisations of MAP prepared genomic DNA (Fig. 4.2-6). Mean M values across all 
replicate experiments were extrapolated using a linear model fit and then used to determine 
the methylation status of each CGI feature (see Materials and Methods for full details). 
The library represented on the microarray contains a proportion of CGI amplicons which are 
indicative of CGIs but which only contain the periphery of the whole island. As such these 
inserts were informative for the identification and localisation of CGIs but contain too few 
CpG sites to be efficiently retained by the MBD affinity matrix under the elution conditions 
applied. As such all CGI inserts with a CPG10ieI  value of less than 0.5 were removed from 
further analysis. Furthermore, sex chromosomes were trimmed from the dataset (unless 
otherwise stated) to account for the fact that pooled individuals were not all of equivalent 
sex. Methylation analysis, subsequent to the calculation of M values, was carried out on this 
trimmed set representing 14,318 CGI inserts (Dataset 2). 
4.2.6 CGI methylation in Male and Female blood DNA 
A pilot experiment was carried out to characterise the CGI methylation profile in a human 
somatic tissue and to determine the efficacy of the MAP array methodology. Human 
genomic DNA was prepared from male and female whole blood and MAP fractionated as 
previously described. Two independent replicates for each sex were prepared, and these in 
turn were each hybridised as two separate dye-swap pairs to give four individual replicates. 
As expected, the mean M values for each sex were positively correlated (R = 0.865: Pearson 
correlation; Fig. 4.2-7a). 
XXVI Microarray experiments generally produce large numbers of features with low signal 
intensity values which introduce artificial variation between hybridisations. As such, minimum 
capping such as this stabilises the data set and provides more reliable results. 
138 
Un-Normalised 
Replicate 1 	 Replicate 2 	 Replicate 3 	 Replicate 4 
I.. 	 I 




mtedy) 	 ntoe,ayl 	 i,jt 	 o,),lflp,,I 
I 	 I 	 I 
ZI 
IA 
A 	 A 	 A 
Normalised 
Repinc,te I 	 Replicate 2 	 Replicate 3 	I 	 Replicate 4 
JL 
IA 	 ' A 
Figure 4.2-6. Replication and normalisation of MAP array data. 
(a) Un-Normalised intensity data from a MAP array experiment. Plots of Raw signal intensities, M value 
distribution and M vs. A (measure of intensity) highlight the variability between quadruplicate 
experiments (Replicates 1-4). Furthermore, the plots indicate the fact that the majority of features 
present on the microarray have higher input intensity values relative to MAP purified DNA. This is 
consistent with the majority of CGIs being unmethylated and therefore not retained by the MBD affinity 
matrix. A log2 Cy3:Cy5 ratio of zero (dashed black line) is indicated. Boxplots are represented as per 
Fig. 3.1-1 (b) Print tip Loess normalisation centers the data and improves the consistency between 
replicate experiments. Comparison of M value distribution, as highlighted by the boxplots in (a) and (b) 
(as presented in Fig. 3.1-1) indicates the refined distribution of the data by the normalisation process. 
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One of the best characterised examples of CGI methylation is that associated with the 
inactive X chromosome (Heard et al., 1997). As such it was expected that the majority of sex 
specific differences in methylation would affect X-linked CGIs (Weber et al., 2005). To 
investigate this, the relative enrichments for all CGIs on the X chromosome were compared 
with those on chromosome 16. The autosome showed no sex specific difference in 
methylation status, whereas a significant proportion of all of the X-linked CGIs showed 
elevated M values in female relative to male (p value < 2.2 x10 6; Wilcoxen Rank Sum Test; 
Fig. 4.2-7b-d). This comparison was extended, confirming that whilst methylation profiles 
were indistinguishable between the two sexes for all twenty two autosomes, methylation 
levels of CGIs on the X chromosome were elevated in females relative to males (p value < 
2.2 x10 16: Wilcoxen Rank Sum Test, Fig. 4.2-7d). It is interesting to note that specific Y-
linked CGIs are also enriched in females relative to males despite this being significantly 
hindered by the lack of this particular chromosome (Fig. 4.2-7d). The X and Y chromosomes 
are derived from the same ancestral autosome, and despite the evolutionary decay of the 
latter, it still bears significant sequence homology to its ancestral partner (Graves, 2006). 
This suggests that this result is an artifact resulting from cross hybridisation of methylated 
X-linked CGIs with homologous regions on the Y chromosome. 
The process of sex chromosome dosage compensation in mammals, extinguishes the 
expression of the majority of genes on one of the two X chromosomes. A notable exception 
is the XIST transcript, a functionally important ncRNA, which is specifically expressed from 
the inactive X chromosome. XIST activity is inversely correlated with the methylation status 
of its promoter CGI which has been implicated to have a role in its repression ((Panning and 
Jaenisch, 1996), Fig. 4.2-3b). However XIST is not the only gene found to escape X 
inactivation. Studies in human and mouse have identified a panel of X-linked genes which 
are biallelically expressed (Carrel et al., 1996; Carrel and Willard, 2005). 
The negative correlation between XIST expression and promoter methylation coupled with 
the fact that promoter CGI methylation prevents transcription directed the investigation of 
methylation status of these biallelically expressed genes (Hansen and Gartler, 1990; Panning 
and Jaenisch, 1996; Stein et al., 1982). The methylation status of X-linked CGIs associated 
with the promoters' of biallelically (n=14) and monoallelically expressed (n=103) genes 
was compared. As expected, MAP probes representing the inactivated class of CGIs had an 
XXVII ± 1 .5kb of an annotated transcription start site (TSS). 
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Figure 42-7. MAP array identifies female specific CGI methylation on the X 
chromosome 
(a-c) Plots indicating the M values of arrayed CGls MAP enriched from male and female whole blood 
genomic DNA. (a) The enrichment profile of all CGI probes isolated by MAP from female and male 
genomic DNA are positively correlated (R = 0.865; Pearson correlation). (b) CGIs present on 
chromosome 16 (red dots) show a methylation status indistinguishable between male and female MAP 
preparations. (c) MAP probes isolated from male and female genomic DNA indicate female specific 
methylation of X-linked COls (red dots). (d) Boxplots depicting the M values for CGls representative of 
all male (top panel) and female (lower panel) chromosomes indicate X-linked, female specific, CGI 
methylation. Boxplots are depicted as per Fig. 3.1-1 with X chromosome highlighted (dashed box). 
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M value distribution indistinguishable from that of all X-linked CGIs (Fig. 4.2-7d and Fig. 
4.2-8). Conversely, promoter CGIs which escape X inactivation were found to be distinct in 
that they were significantly less enriched (KS test: p.value = l.2X10-5; Fig. 4.2-8). This 
suggested that CGI genes which escape X inactivation have nonmethylated CGIs which are 
permissive to transcription. The specific complement of biallelically expressed genes varies 
between females (Carrel and Willard, 2005), and may represent uncharacterised epigenetic 
polymorphisms with a role in individual and sexual dimorphic traits. 
a) 
MAP enrichment vs. Status of X Inactivation 
Inactivated 	Escaping 
Figure 4.2-8. Relationship between promoter CGI methylation and gene expression 
on the inactive X chromosome. 
MAP array distinguishes promoter CGIs associated with genes which undergo (Inactivated) or escape 
(Escaping) X inactivation. X-linked genes, previously shown to be repressed on the inactive X 
chromosome in females (n=103), are significantly more enriched by MAP relative to those expressed 
from both X chromosomes (n=1 4, KS test; p = 1.2 x 10-5). 
To determine the minimum threshold value which describes CGI methylation, 12 CGI inserts 
spanning a range of M values were amplified from MAP and input DNA (from the female 
purification). Results from triplicate quantitative PCR analysis indicated that an M value of 
1.5 could identify methylated CGIs (Fig. 4.2-9a). Bisulfite genomic sequencing was carried 
out on two randomly selected islands from male and female genomic DNA. The CGI 
I3878' associated with the BEST gene had M values of 0.2 and 0.4 in female and male 
hybridisations respectively and, as predicted, was confirmed to be unmethylated by bisulfite 
genomic sequencing (Fig. 4.2-9b). CGI 119112 spans the R4RLI coding region and has an 
M value in excess of 2. When investigated, this island was found to be heavil' methylated in 
both male and female blood DNA (Fig. 4.2-9c). In combination with additional bisulfite 
CGI nomenclature used throughout this chapter correspond to the microarray feature 
identifiers. 
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genornic sequencing results these findings suggest that an M value of 1.5 was suitable for 
the identification of methylated CGIs (data discussed in the next section). The threshold 
applied to describe CGI methylation is relatively stringent, and as such likely excludes a 
proportion of bona fide methylated islands. However, for the purpose of this study 
constricting the identification of methylated islands served to reduce false positive. 
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Figure 4.2-9. Validation of minimum M value required to determine methylation 
status. 
(a) OT PCR analysis of MAP enrichment for CGI fragments with a range of M values indicates 
appreciable enrichment with M values equal to or greater than 1 .5. Error bars represent standard 
deviation values (SOs) across three replicate experiments. (b and C) Confirmation of methylation 
status indicated by MAP array by bisulfite genomic sequencing. CGI inserts 13878 (b) and 19112 (C) 
were confirmed to be nonmethylated and methylated respectively, as predicted by the MAP array 
results. Open and filled circles represent non-methylated and methylated CpG sites respectively. The 
genomic locus including annotated transcripts and CpG sites (vertical strokes) are shown above each 
profile. Each column represents products of amplification by a single primer pair (location indicated by 
brackets below CpG map). Each line corresponds to a sequenced DNA strand. Black bars indicate the 
location of the Msel fragment cloned in the CGI library. 
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The application of these criteria (p value 0.01'', M value of >1.5) to the male and female 
hybridisation data, confirmed extensive methylation of X-linked CGIs. In contrast, the 
percentage of CGIs methylated on the single male X chromosome was comparable to the 
levels found on the human autosomes, as illustrated for Chromosome 16 (Table 4.2-1). In 
addition, it is clear from this data that not all autosornal CGIs are nonmethylated, which is 
consistent with previous studies (Eckhardt et al., 2006; Shiota, 2004; Shiraishi et al., 2004; 
Song et al., 2005; Strichman-Almashanu et al., 2002; Weber et al., 2005; Weber et al., 2007; 
Yamada et al., 2004). These results confirmed the effective utility of MAP array to identify 
methylated CGIs from bulk genomic DNA. 
Table 4.2-1. Methvlated CGIs on Chrl6 and ChrX in Human Whole Blood DNA 
Chromosome Sex Totala 	Methylated Islands Methylated Islands (%) 
16 Male 569 49 8.6 
16 Female 569 62 10.9 
X Male 357 32 9.0 
X Female 357 151 42.3 
aNumber of CGIs based on the CpG density filtered set (discussed in the previous section) 
4.3 Results: Global Human DNA methylation analysis 
4.3.1 Tissue specific CGI methylation 
Human cellular processes such as genomic imprinting and X-inactivation are known to 
associate with the methylation of CGIs. Further to these well characterised examples an 
increasing number of methylated islands have been identified in other genornic locations 
(Eckhardt et al., 2006; Futscher et al., 2002; Song et al., 2005; Weber et al., 2007; Yamada et 
al., 2004). In the previous section, MAP array was applied to the identification of methylated 
islands in whole blood genorriic DNA. These experiments identified 151 (42.3%) of CGIs 
which were methylated on the X chromosome which was consistent with female X 
inactivation. However a further 910 (6.4%) were identified as methylated on the twenty two 
autosomes. It is unclear, whether these CGIs represent a set of ubiquitously methylated 
islands present in all human tissues or whether there is appreciable variability between cell 
types, consistent with a potential role in tissue specification and gene regulation. Despite this 
xxix Significance was determined by linear modeling of the data, followed by the application 
of an empirical Bayes (eBayes) method. Benjamin Hochberg adjustment was applied for 
multiple testing correction to provide a more stringent measure of significant enrichment. 
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however, the global function and variability of CGI methylation are still poorly defined 
(Eckhardt et al., 2006; Futscher et al., 2002; Shi et al., 2002; Song et al., 2005; Weber et al., 
2007; Yamada et al., 2004). 
To address these uncertainties, MAP array probes were prepared from germ line (sperm) and 
three somatic (Brain, Skeletal Muscle and Spleen) DNAs and hybridised to CGI microarrays. 
MAP fractionation of sperm DNA, repeatedly failed to yield sufficient material for 
microarray hybridisation under the equivalent experimental conditions applied to the somatic 
tissues (see methods). Despite the lack of quantitative data this observation empirically 
confirmed the hypomethylation of germ cell DNA relative to somatic tissues (Eckhardt et al., 
2006; Kitamura et al., 2007; Weber et al., 2007). Signal data from MAP array hybridisations 
of the four somatic tissues (including blood), were extrapolated to give an enrichment profile 
for each (Fig. 4.3-1a). This result indicated that Brain had the smallest proportion of 
methylated CGIs (5.7%) with Muscle showing the most (8.3%). Due to the variability in 
methylation profiles between tissues a total proportion of 11.6% (1,657) of CGIs was 
identified as being methylated in one or more of the tissues tested. 
To refine the comparison, CGIs with an M value in excess of 1.5 and a differential of ? 0.75 
were considered as differentially methylated between the tissues. The result indicated the 
presence of a ubiquitously methylated set of islands representing 2.8% (408) of all CGIs 
(Fig. 4.3-lb and Table 4.3-I). Approximately 5% (711) of all CGIs were methylated in one 
or more but not all of the tested tissues, of which more than half (403) were methylated in 
one tissue alone (Fig. 4.3-1b; Table 4.3-1; Dataset 3). A proportion of the islands could not 
be categoriesed due to the thresholds applied (see methods for details). 
The CGIs set was shown to colocalise with the transcriptional start sites of approximately 
50% of all protein coding genes. Promoter-CGI methylation is known to correlate with 
transcriptional repression, and so gene localisation was compared for all CGIs and those 
found to be methylated in at least one of the tissues investigated. Islands were categoriesed 
into four gene association classes. Promoter associated (±1.5kb of an annotated TSS), 3' 
associated (±1.5kb of the most 3' terminus of the last exon), intragenic (associated with an 
open reading frame (ORF) but not falling into the former two categories) and Intergenic (not 
localising to within ±1.5kb of an annotated gene). Interestingly, methylated CGIs are 
relatively enriched at sites distal to the TSS. This is illustrated by the fact that 8% of all 
arrayed promoter CGIs are methylated relative to 21.7% of those associated with the extreme 
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Figure 4.3-1. MAP array identification of tissue specific CGI methylation. 
(a) Plots indicating pairwise comparisons between MAP CGI probe hybridisations prepared from blood, 
brain, muscle and spleen DNA. Dashed red lines indicate the threshold values applied to determine 
differential methylation. (b) CGI methylation events were subdivided into four different classes 
depending on the tissue specificity across the four tissues. The following categories are represented: 
cGls methylated in all tested tissues (black); CGIs methylated in more than one tissue tested but not 
all (green); cGls methylated in one tissue only (blue); CGIs methylated in one tissue tested but 
unclassified in other tissues (white). 
3' terminus (Table 4.3-2). Indeed all classes of CGIs are at least twice as likely to be 
methylated as those proximal to promoter regions. This pattern is also observed for the 
subclass of differentially methylated islands (Table 4.3-2). 
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Table 4.3-1. CGI Methylation in Human Tissues 
Tissue Tested 
Methylation Status Blood Brain Muscle Spleen 
Methylated in All 408 408 408 408 
Differentially methylated (multiple a)149 135 214 247 
Differentially methylated (single a)50 35 178 140 
Unclassified methylation 303 237 392 381 
Total 910 815 1192 1176 
CGIs 14318 14318 14318 14318 
Percentaae Methvlated 6.4 5.7 8.3 8.2 
alndicates  the number of tissues containing a specific methylated CGI 
Table 4.3-2. Methylated CGI location relative to protein coding genes 
CGI Gene Differentially Differentially 
association All CGIs Methylated Methylated (%) Methylated Methylated (%) 
All CGIs 14318 1657 11.6 711 5 
Genes 11399 1225 10.8 514 4.5 
5' 7926 636 78.0 256 3.2 
3' 765 166 21.7 77 10.1 
Intragenic 3478 536 15.4 230 6.6 
lnterenic 2863 435 15.2 203 7.1 
To confirm these results a panel of seven CGIs identified as differentially methylated 
between the tissues tested, were investigated using bisulfite genomic sequencing (Fig. 4.3-2 
a-d and Fig. 4.3-6). In each case, microarray prediction was corroborated by the bisulfite 
data. CGI 11878 is distal to any annotated gene (>± 1.5kb) and was found to be methylated 
exclusively in muscle and brain (Fig. 4.3-2a). The SEC'31B gene transcribes a protein 
product which has been implicated in vesicular trafficking. Bisulfite analysis identified that a 
promoter CGI (12985) which associates with the transcription start site of SEG31B, is 
compositely methylated in blood and spleen (Fig. 4.3-2b). CGIs 113406 (Fig. 4.3-2c) and 
112175 (Fig. 4.3-6a) are methylated specifically in muscle and overlap the predicted gene 
67313 and the 3' ends of OSRI respectively. 111878 locates to the 5' end of ZNF577 and is 
only methylated in spleen (Fig. 4.3-2d). Interestingly two islands associated with the PAX6 
locus, namely 13654 and 13660, are both differentially methylated between the five tissues 
(Fig. 4.3-6b). CGI 13654, an island associated with the promoter region of an internal 
annotated PAX6 transcript (Q59GD2), was previously shown to contain methylated CpG 
Sites, and was found to be specifically methylated in brain (Nguyen et al., 2001); Fig. 4.3-
6b). The second island is approximately 2kb upstream of the outer most annotated 
transcription start site and is heavily methylated in brain and muscle but devoid of 
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methylation in the other three tissues (Fig. 4.3-6b). Only one of the seven bisulfite-treated 
candidate CGIs directly overlapped an annotated TSS (Fig. 4.3-2b) consistent with the 
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Figure 4.3-2. Confirmation of tissue-specific differential CGI methylation. 
(a-d) Four CGI regions identified as being differentially methylated were assessed for DNA methylation 
by bisulfite genomic sequencing. M values are indicated for each tissue in parenthesis and the regions 
are illustrated as for Fig. 4.2-9b and c and annotated based on genomic build NCBI36. 
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4.3.2 Characterisation of Methylated CGIs 
Previous studies have indicated that islands which are somatically methylated have a 
relatively reduced CpG density with respect to those which are not methylated (Weber et al., 
2007). The assumption is that CpG methylation is concurrent with spontaneous methyl-
cytosine to thymine transitions due to deamination. Consequently this would account for the 
relatively reduced density of the dinucleotide within these islands. In order to ascertain 
whether the methylated islands identified in this study had an altered sequence composition, 
the CpG density and G+C content of all CGIs found to be methylated (n=1,657) were 
compared with those that were not (n=12,661). This comparison identified a small but 
significant (Wilcoxen rank sum test: p-value: 1.022e 11 ) reduction in the CpG density of the 
methylated islands with respect to those not identified (median CpG[o/e] of 0.75 and 0.77 
respectively; Fig. 4.3-3a). Despite the significant reduction in CpG density, the G+C content 
was slightly elevated in the methylated island set although the difference between the two 
sequence populations was again found to be small but significant (approximately 0.5% G+C 
content; Wilcoxen rank sum test: p-value: <1.0 e 3). Median sequence characteristics for all 
CGIs identified as methylated and those that were not are illustrated in Fig. 4.3-3a (blue and 
yellow asterisks respectively; see figure legend). The biological significance, of these small 
differences in sequence composition is unclear and may merely represent preferential 
localisation within the genome (this will be investigated in the next section). The fact that 
these methylated islands are less depleted for CpGs than has previously been reported may 
simply represent the different sets of sequences investigated in the two studies (Weber et al., 
2007). 
Using a panel of CGIs that were previously identified as being methylated by conventional 
methods, Bock and colleagues developed a prediction tool for in Silico identification of 
endogenous methylated CGIs (Bock et al., 2006; Yamada et al., 2004). After investigating a 
range of context specific sequence characteristics, they discovered that the set of methylated 
islands showed positive correlation with specific simple sequence patterns (CACC / GGTG 
and TGTG / CACA), repeat sequences (tandem repeats) and DNA structures. The authors 
stated that there was no single "DNA sequence code" which effectively described the 
methylation status of a CGI sequence (Bock et al., 2006). However, despite the subtle 
contribution of each of the afore mentioned sequence parameters, their combinatorial effect 
allowed relatively accurate prediction when applied to an independent set of methylated 
CGIs (Bock et al., 2006; Eckhardt et al., 2004). 
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Figure 4.3-3. Comparison of physical properties between methylated and 
nonmethylated CGIs. 
(a) Plot depicting the CpG10101 vs. G+C sequence compositions of CGIs identified as being methylated 
(red spots or histogram bars) or not (dark grey spots or histogram bars) and the corresponding 
histogram plots. These indicate a small but significant difference in the median sequence compositions 
of the two CGI sets (medians denoted by blue and yellow asterisks as per the figure key). Boxplots of 
stacking energy (b), base twist (C) and TGTG/CACA frequency (d) comparing islands that were 
identified as being methylated (Meth CGIs) and those that were not (CGIs). Boxplots are depicted as 
for Fig. 3.1-1. 
Given the concordance between these sequence characteristics and CGI methylation, we 
compared the attributes of the two CGI sets with respect to stacking energy, base twist, 
XXX DNA structural parameters (twist and stacking energy) were determined using the 
EMBOSS package Rice, P., Longden, I., and Bleasby, A. (2000). EMBOSS: the European 
Molecular Biology Open Software Suite. Trends Genet 16, 276-277.). 
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simple repeats (TGTG/CACA) and repetitive elements. Methylated CGIs show a small but 
significant increase in stacking energy relative to all CGIs (Wilcoxen rank sum test"': p-
value < 0.001; Fig. 4.3-3b). In contrast we found no significant difference in the base twist of 
methylated CGIs (Fig. 4.3-3c). TGTG/CACA specific repeats were found to be significantly 
enriched in methylated CGIs (Wilcoxen rank sum test: p-value < 0.001; Fig. 4.3-3d). In 
contrast to what has been previously describe, all repetitive elements (as outlined in Repbase 
(Jurka et al., 2005)) were found to be marginally depleted in methylated CGIs (Wilcoxen 
rank sum test: p-value <0.01). 
Despite the apparent concordance between these sequence characteristics, not all match 
previous predictions, and those which do show modest differences between the CGI sets. 
Whilst it is possible that these features are characteristic of methylated CGIs and can 
distinguish them from CGIs in general it is equally possible that these represent a by-product 
of their genomic locale? To investigate this possibility the location of all methylated CGIs 
was plotted against the 22 human autosomes (Fig. 4.3-4a). However this alone was 
insufficient to determine if specific regions of the genome were more enriched as all CGIs 
are discretely localised throughout the genome (as discussed in the previous chapter). In 
order to address this problem an average autosomal profile of CGI and methyl-CGI 
distribution was determined. Each of the 44 chromosome arms were subdivided into 
windows of 5% of the total arm length. The CGI and methylated CGI content of each 
window was measured in turn with a periodicity of 1% until the centromere was reached (96 
windows). This process was repeated for each chromosomal arm and the values summed. 
The distributions of methylated and nonmethylated CGIs were then plotted against an 
averaged chromosomal arm (Fig. 4.3-4b). To refine this further, the observed number of 
methylated islands per window was divided by that expected if methylated islands 
represented a random subpopulation of all CGIs. The averaged Methylated CGI101e1 
autosomal arm schematic indicated that methylated CGIs were relatively enriched in 
subtelomeric and pericentromeric regions (Fig. 4.3-4c). The fact that there are relatively few 
islands adjacent to the centromeres suggests that the apparent enrichment of methylated 
CGIs could well be an artifact of sample size (Fig. 4.3-4b and c). However, as there is high 
density of CGIs found in subtelomeric regions, it is likely that the two-fold 
XXXI Data distributions were tested using Shapiro-Wilk test of normality. Non parametric 
significance values were determined using the Wilcoxon rank sum test between the 
Methylated and remaining sets of CGIs (n=1657 and 10661 respectively). 
XXXII Expected island count was calculated by dividing the sum of all methylated CGI for each 
window by the equivalent sum of all CGIs. The count of islands was then multiplied by this 
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Figure 4.3-4. The distribution of all methylated CGIs across the human autosomes. 
(a) The distribution of cloned CGIs (grey strokes) on human chromosomes overlaid with all MAP array 
identified methylated CGIs (Red Strokes). Chromosome numbers are indicated to the left of each 
chromosome and centromeres are denoted by blue dots. (b) Plots depicting the CGI (black line; 
primary Y axis) and methylated CGI (dashed red line; secondary Y axis) distribution across all 
autosomal arms. (c) Plot indicating the observed / expected [0/el methylated CGI density across an 
average autosomal arm. An [0/e] ratio of 1 (dashed line) and centromere position (blue point) are 
indicated. Plots (b and c) represent a window size and sliding resolution of 5% and 1% of autosomal 
arm length respectively. 
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This finding is interesting as it suggests that the subtelomeric domains are enriched for 
methylated CGIs. Furthermore, it is consistent with a previous study which cloned 
methylated CpG rich methylated DNA fragments derived from telomere-proximal regions 
(Brock et al., 1999). These regions are also enriched for a class of genes previously 
identified as being associated with methylated CGIs. Odorant receptors are known to be 
methylated in somatic tissues and to be enriched in subtelomeric regions (Riethman et al., 
2004; Weber et al., 2007). This finding is of relevance to the mechanisms by which certain 
CGIs become methylated and the organization of the mammalian genome. However it does 
not confirm the hypothesis that sequence disparities result from this spatial genomic 
arrangement. 
To address this possibility, all CGIs located at the telomere ends '°' iii  were extracted and their 
sequence characteristics compared to the remaining CGIs. CpG density was unaffected by 
this subdivision whereas the G+C composition of the telomeric CGIs (median = 66%) was 
significantly elevated relative to the remainder of the islands consistent with previous 
observations (median = 64%; Wilcoxen Rank sum test: p value: 2.2e16; (Riethman et al., 
2004)). Although the biological significance of the altered sequence characteristics of 
methylated CGIs remains unclear this provides some evidence for spatial clustering within 
the genome. 
4.3.3 Composite Methylation of CGIs 
All methylated CGIs thus far characterised by bisulfite genome sequencing have displayed a 
binary methylation pattern composing of nonmethylated and heavily methylated DNA 
strands (Fig. 4.2-9c; Fig. 4.3-2a-d; Fig. 4.3-5b and c; Fig. 4.3-6a and b). This is illustrated 
when the average percentage of methylated CpG sites present on each DNA molecule is 
plotted for each of the methylated islands assayed (Fig. 4.3-5a). This analysis identified a 
bimodal profile of methylation, indicating a 'black and white' distribution. A study 
dissecting the methylation profile of specific DNA sequences on human chromosomes 6, 20 
and 22 identified a similar phenomenon (Eckhardt et al., 2006). This finding solves the 
apparent paradox arising from the ability to identify methylated islands in blood using an 
array of CpG rich nonmethylated sequences. 






It is possible to suggest several biological explanations for these methylation profiles. At the 
highest level, these composite patterns could simply represent individual methylation 
polymorphisms within the pooled DNA. To address this possibility, compositely methylated 
CGI, 15134 was bisulfite sequenced from the muscle DNA of each of the three pooled 
individuals. Strikingly this confirmed that individual C had significantly higher levels of 
methylation at this particular CGI (Fig. 4.3-5b). Furthermore, MAP array identified 124201, 
a CGI associated with the ENDOG gene, as being methylated specifically in spleen. 
Interestingly a previous study identified this island as being compositely methylated in 
normal lung tissue in two of eight individuals (Shiraishi et al., 1999). 
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Figure 4.3-5. Composite DNA methylation patterns of CGI sequences.. 
(a) A histogram depicting the percentage of methylated CpG sites per DNA strand identifies a bimodal 
distribution of essentially nonmethylated and heavily methylated DNA molecules. (b) Bisulfite 
sequencing identifies individual-specific CGI methylation internal to the HOXC cluster in muscle DNA. 
(C) Bisulfite sequence analysis of DNA derived from mononucleocyte and granulocyte white blood cell 
preparations identifies cell type specific enrichment of DNA methylation at the SEC31B promoter. 
Bisulfite genomic sequencing results (b and d) are diagrammed as in Fig. 4.2.9. 
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Alternatively, cell specific CGI methylation patterns could account for some of the 
composite methylation identified. The methylation pattern of CGI (12985), previously shown 
to be compositely methylated in blood and spleen DNA (Fig. 4.3-2b), was examined in 
fractionated mononucleocyte and granulocyte cells. Interestingly this CGI was found to be 
more heavily methylated in mononucleocytes than granulocytes prepared from the same 
individuals (Fig. 4.3-5c). This indicates that at least some of the CGI methylation is cell type 
specific. Analysis of the DNA methylation pattern at a CGI associated with the murine PAX6 
locus determined that like it's human counterpart, it was also compositely methylated. 
Further analysis determined that the methylated and nonmethylated DNA molecules were 
not resolved when neuronal and glial DNA sequences were characterised (RI and Peter 
Skene unpublished observations). 
Other instances where composite methylation could not be resolved as for these examples, 
suggests an alternative origin for this distinct methylation pattern. Allele specific 
methylation is generally well characterised in the context of imprinted DMRs but parent 
independent allelic methylation has also been illustrated in a few cases (Yamada et al., 
2004). In the absence of informative single nucleotide polymorphism (SNP) data and 
pedigree information it was impossible to relate the methylation profiles directly to specific 
alleles. However in an attempt to address this possibility, all blood""' methylated CGIs were 
compared to a list of genes identified as being monoallelically expressed in a global screen 
(Gimelbrant et al., 2007). Of the 228 unique protein coding genes which mapped to arrayed 
CGIs, only 17 were found to be methylated by MAP array analysis (Table 4.3-3). This 
finding suggests that monoallelic methylation is not a major contributor to the observed 
composite pattern. However it is impossible to conclude the concordance between the 
methylated islands and monoallelic expression without matched allelic expression data from 
the same biological samples for which the DNA methylation patterns were derived. 
4.3.4 Differential CGI methylation and developmental gene loci 
Differentially methylated CGIs identified by MAP array showed elevated spatial localisation 
to developmental genes and gene loci (Fig. 4.3-6). In order to investigate this further, 
ontology terms for gene associated CGIs were compared with those identified as 
differentially methylated (Table 4.3-4 and Dataset 3). Interestingly, genes involved in 
developmental processes such a neurogenesis; segmentatation specification and mesoderm 
XXXIV Blood methylation was chosen for two reasons. The first is that due to the nature of the 
library preparation the likelihood of blood methylated islands being compositely methylated is 
high. Secondly monoallelic expression gene expression data was determined in peripheral 
blood mononucleocyte and lymphocyte cells. 
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development were significantly enriched for this group of islands (Table 4.3-4). 
Furthermore, the Homeobox class of developmental transcription factors was more then 3 
fold overrepresented than would be expected by proportional representation (Table 4.3-4). 
Of the genes characterised by bisulfite genomic sequencing, HOW is involved in body 
Table 4.3-3. Blood Methylated CG Is that associate with Monoallelically expressed 
genes. 
Mono Allelic CGI Gene Methylated CGI Information 
Gene ID  Gene Name' CGI IDC Gene Overlap Chr Start  Stopd 
ENSG00000196581 AJAP1 168 intragenic 1 4671134 4673025 
ENSG00000136010 ALDH1L2 15530 5 prime 12 104002162 104003256 
ENSG00000168675 C18orfl 110355 intragenic 18 13631490 13633034 
ENSG00000050767 C01-23A1 119508 intragenic 5 177935057 177936975 
ENSG00000113758 DBN1 119491 intragenic 5 176832031 176833615 
ENSG00000183495 EP400 15846 5 prime 12 130999923 131001992 
ENSG00000115641 FHL2 112903 intragenic 2 105381239 105382810 
ENSG00000152990 GPR125 117114 5prime 4 22125920 22127617 
ENSG00000131398 KCNC3 111851 intragenic 19 55522437 55524577 
ENSG000001 04044 OCA2 17431 intragenic 15 25821255 25822469 
ENSG00000178184 PARD6G 110831 intragenic 18 76018459 76019662 
ENSG00000139832 RAB20 16494 5 prime 13 110011166 110012522 
ENSG00000080293 SCTR 113000 5 prime 2 119998052 119999037 
ENSG00000198648 STK39 113334 5 prime 2 168811817 168812986 
ENSG00000187079 TEAD1 13517 intragenic 11 12843196 12843336 
ENSG00000142185 TRPM2 114898 5 prime 21 44594267 44596251 
ENSG00000196793 ZNF239 12518 5 orime 10 43389437 43390252 
'Gene IDs are based on ENSEMBL transcript annotation. 
bGene  Names: HGNC names. 
C  CGI identifiers correspond to microarray annotation and the IDs mapped to ENSEMBL 
d CGI Start and Stop sequence locations are based on NCBI v.36. 
pattern specification, PAX6 is involved in eye development and 0SR1 is related to a 
Drosophila gene encoding a protein involved in gut development (Fig. 4.3-5b and Fig. 4.3-
6a and b). The MAP array results for the extended PAX6 and HOW loci were mapped to 
determine the variability in methylation across these developmental regions (Fig. 4.3-6c and 
d). The PAX6 loci identified the 2 CGI regions which were differentially methylated, in brain 
and muscle as confirmed by bisulfite genomic sequencing (Fig. 4.3-6b and c). The 150kb 
HOW locus is composed of 19 CGIs of which eight were found to be differentially 
methylated in blood, muscle and spleen with none being methylated in brain (Fig. 4.3-6d). 
The observed variability is interesting as it suggests that expanding the panel of tissues 
would identify additional differentially methylated islands. 
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Figure 4.3-6. Enrichment of CGI methylation at developmental gene loci'. 
Bisulfite genomic sequencing confirmed tissue-specific CCI methylation associated with the 
developmental genes OSR1 (a) and PAX6 (b). MAP array determined M values are indicated in 
parenthesis for each tissue. The OSR1 (a) and PAX6 (b) bisulfite results are diagrammed as for Fig. 
4.2-9. Arrayed CCI amplicons located across the PAX6 region (b) are indicated (red bars) in addition 
to all CpG (CG) and GpC (CC) dinucleotide positions (vertical black strokes). The exonic structure of 
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the major PAX6 isoform (blue boxes), transcriptional direction (arrowed) and amplicons assayed for 
methylation depicted (solid grey bars) are indicated. (c and d) Multiple CGIs (red boxes) span the 
PAX6 (c) and HOXC (d) gene loci. MAP-CGI array profiles for blood, brain, muscle and spleen identify 
tissue-specific CGI methylation (vertical black bars extending above M = 1.5). Grey bars extending 
downwards below M = 1.5 (broken blue line) represent non-methylated CGIs. The regions of PAX6 
analysed by bisulfite genomic sequencing (see b) are indicated (asterisks in c). Tick marks on the y 
axis are spaced at intervals of 1 M value unit. Coding sequences are diagrammed as yellow bars. 
The observation that tissues presented distinct patterns of CGI methylation and that these 
often corresponded to genes with developmental functions posited the possibility that 
methylated CGIs function in tissue specific gene regulation. To address this possibility, gene 
expression data was mined for all CGIs associated with a gene TSS found to be methylated 
in a single tissue. Promoter associated CGIs were selected as all known cases of methylation 
at such sequences corresponds to gene repression. Alternatively, the transcriptional affect of 
gene body or 3' CGI methylation remains unclear. Expression data mining wa carried out 
using the GNF Symatlas (http://symatlas.gnf.org/SymAtlas/) web based browser tool (Su et 
al., 2002). The analysis indicated no obvious accord between the methylation status of these 
islands and the expression of the associated genes. Despite this fact, methylated islands 
always showed an expression value equal to or less than the median value for all tissues 
examine. However, often the genes were silent in the majority of all tissues irrespective of 
methylation status. This is illustrated for GPNMB, which associates with CGI 121166 
identified by MAP array as being methylated in skeletal muscle alone. The gene appears to 
be silent in whole blood, muscle and whole brain despite being methylated in blood alone 
(Fig. 4.3-7a). Expression analysis of SEC3I13 gene identified as being more heavily 
methylated in mononucleate blood cells (Fig. 4.3-5c) indicated that it was silent in whole 
blood but not in CD4+ and CD8+ T cells (Fig. 4.3-7b). This is surprising as these cells 
should be present in the mononuclear blood cell fraction and therefore be expected to be 
expressed at a reduced level. In order to address this further, the specific expression of the 
SEC31B gene was determined from RNA prepared form the mononucleocyte and 
granulocyte cell preparations used to generate the bisulfite methylation profiles (Fig. 4.3-5c). 
Contrary to the prediction there was little expression difference between the two cell 
populations when normalised to GAPDH expression irrespective of promoter methylation 
status (Fig. 4.3-7c). Consistent with much of the mined data, expression levels were low for 
all tissues, independent of promoter CGI methylation. This result suggests promoter CGI 
methylation is possibly a consequence of transcriptional quiescence rather than a cause. 
Alternatively, similar to the situation observed for X-inactivation, promoter CGI methylation 
may not represent an initiating event in transcriptional repression, rather than stable 
propagator of the repressed state. 
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To address these uncertainties, future studies will have to map global tissue specific CGI 
methylation events to gene expression levels in matched biological samples. Furthermore, 
individual variation will have to be accounted for should. polymorphic methylation play a 
role in individual phenotypic variation. 
Table 4.3-4. Developmental gene categories are associated with differentially 
methylated CGIs. 
All genesb Methylated Methylated 
Biological Processa (n=9542) (observed n=490) (expected) 	p.valuec 
Developmental processes 1 187 112 60.95 4.00E-09 
mRNA transcription regn 847 85 43.5 4.61 E-07 
Ectoderm development 415 51 21.31 1.94E-06 
mRNA transcription 1093 94 56.13 6.42E-05 
Neurogenesis 383 45 19.67 6.86E-05 
Segment specification 71 14 3.65 3.77E-03 
Mesoderm development 326 35 16.74 6.61 E-03 
All genes°  Methylated Methylated 
Molecular Function (n=9542) (observed n=490) (expected) 	p.valuec 
HomeoboxTF 153 37 7.86 3.16E-12 
Transcription factor 1131 99 58.08 	 2.54E-06 
Other DNA-bindina orotein 180 26 9.24 5.66E-04 
'GO terms were determined using the web based Panther classification system (Thomas et al., 2003) 
b All genes associated with an arrayed CGI 
C  Significance is corrected for multiple testing (Bonferroni adjustment). 
4.4 Discussion 
In recent years, much investigation pertaining to mammalian DNA methylation has focused 
on human neoplasias. This has resulted in a relative paucity of information regarding the 
distribution of methylation in normal human cells. For CGIs, the characteristic lack of 
methylation, an important empirical criterion of this discrete genomic fraction, was 
considered to be the general rule. Obvious exceptions to this included methylated CGIs on 
the inactive X chromosome, allelic CGI methylation at imprinted loci and CGIs associated 
with certain germ line specific genes. These unique, functionally important, exceptions to the 
dogma were followed by increasing evidence suggesting that somatic CGI methylation may 
be more prevalent than previously indicated. This chapter described the characterisation of 
the CGI methylomes in a panel of human tissues. 
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Figure 4.3-7. Gene Expression and differential CGI methylation 
Expression profiles for GPNMB (a) and SEC31B (b) produced by the visualization of array determined 
transcriptome data using the GNF Symatlas. (a) The GPNMB expression values for whole Blood (*), 
whole brain (**) and skeletal muscle (*7*)  are highlighted (red boxes) indicating relatively low 
expression levels in comparison to the panel of tissues assayed. (b) The expression of the SEC31B 
gene is low in whole blood (*) but elevated in CD4+ (*7)  and CD8+ T cells (***), (a and b) Error bars 
represent SD values between multiple hybridisations and the median (grey line) and 3xmedian (blue 
line) are depicted for each gene. Images were generated and adapted from those generated by the 
Symatlas visualization tool (Su et al., 2002). (C) A plot of GAPDH normalised SEC31B expression 
indicates equivalent low level expression in Mononucleate and Granulocyte cell fractionations from 
whole white blood cells. Expression values depicted are averaged from two biological experiments 
repeated in triplicate, the variance for which is denoted by the error bars (SD). 
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4.4.1 MAP array development and optimisation 
MAP has previously been shown to be a powerful method for the enrichment of methylated 
CpG rich DNA sequences from bulk genomic DNA (Brock et al., 1999; Cross et al., 1994; 
Selker et al., 2003; Zhang et al., 2006). Bacterial induction of the published MBD construct 
indicated that it expressed poorly and was almost exclusively restricted to insoluble inclusion 
bodies. To circumvent this problem an alternative construct representing an equivalent 
portion of the human MeCP2 MBD domain was cloned in frame with a carboxy-terminal 
histidine tag. The fusion protein was expressed at much higher levels and was found to be 
predominantly soluble throughout lysis and purification. The efficacy of the MBD for 
application to MAP was assessed by fractionation of artificially methylated plasmid 
fragments. Calibration indicated that nonmethylated sequences eluted at approximately 
0.75M NaCl concentration, whereas methylated sequences were retained until NaCl 
concentrations in excess of 0.85M. As for CAP, the affinity matrix had a preference for 
sequences bearing multiple CpG sites. This did not directly indicate elevated CpG density as 
a prerequisite for binding per Se, but did suggest that short fragments derived from bulk 
genomic DNA would have insufficient CpGs to be retained by the affinity matrix. Relatively 
low resolution separation between nonspecific and specific DNA sequences was countered 
by the introduction of an optimized wash step at 0.75M NaCI. Blood DNA fractionation 
indicated that these conditions efficiently removed the majority of bulk genomic DNA, 
whilst candidate PCR analysis confirmed the retention of endogenous methylated CGIs. 
Buffering conditions applied were consistent with those previously published (Brock et al., 
1999; Cross et al., 1994). 
DNA from 4 human somatic tissues and sperm were fragmented and prepared using this 
optimised MAP protocol. High affinity fractions from each tissue were amplified, 
fluorescently labeled and hybridised to microarrays allowing the simultaneous screening of 
60% of all human CGIs. Male and female MAP hybridisations identified that more than 40% 
of X linked CGIs were specifically methylated in female but not male DNA consistent with 
X inactivation. In addition to confirming the efficacy of the technique, this result indicated 
that sensitivity of MAP array was sufficient to identify monoallelic methylation. 
A previous study identified a sequence preference for the MBD of MeCP2 for a run of A and 
T residues adjacent to the central CpG site (Klose et al., 2005). This presented the possibility 
that MAP, utilising this affinity construct, may inadvertently be biasing sequence selection. 
However on inspecting the MAP array results, there was no apparent enrichment for 
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particular sequence compositions. It is likely that DNA containing multiple CpG sites 
provided sufficiently high affinity ligands for nonbiased enrichment. This may however, 
indicate that future application of MAP array to the analysis of more CpG deficient portions 
of the genome will be biased. This could be avoided through application of the MBD2 MBD 
which has no apparent sequence preference outwith the core CpG dinucleotide. This was 
illustrated previously by the effective purification of methylated sequences by this domain 
(Gebhard et al., 2006a; Gebhard et al., 2006b; Kiose et al., 2005). 
4.4.2 Somatic CGI methylation 
Insufficient sperm DNA was retrieved from MAP fractionations to label for microarray 
analysis. Consistent with previous findings, this observation provided empirical evidence 
that sperm CGIs are hypomethylated relative to those in somatic tissues (Brock et al., 1999; 
Weber et al., 2007). MAP array identified 7.8% of transcription start site associated CGIs as 
methylated in one or more of the tissues tested. This is significantly more than the 3% of 
promoter associated CGIs, identified in a related study (Weber et al., 2007). This disparity 
may have arisen, in part, from the inclusion of tissue specifically methylated islands missed 
in the latter investigation. Indeed 5% of all islands were identified as being differentially 
methylated in a subset of the tissues tested. Bisulfite genomic sequencing of 512 CGIs on 
chromosomes 6, 20 and 22 identified 9.2% of CGIs as hypermethylated (Eckhardt et al., 
2006). This non-gene centric analysis of CGI methylation provided a similar result to the 
11.6% identified here. 
Sequence characterisation of CGIs suggested that those with high CpG density were 
somewhat impervious to DNA methylation (Eckhardt et al., 2006). Consistently, a small but 
significant reduction in CpG density was observed for the somatically methylated islands. 
Interestingly, G+C composition was also slightly elevated for the methylated CGIs, 
consistent with their observed enrichment in telomere proximal regions (Brock et al., 1999). 
Elevated G+C composition may therefore reflect a specific spatial distribution of methylated 
islands rather than a distinct sequence composition. 
The regulatory potential for CGI methylation on gene expression, has led to the 
identification of sequence characteristics indicative of methylation (Bock et al., 2006). 
Simple repeats, sequence patterns and certain physical characteristics were identified as 
being elevated specifically in this subset of CGIs. Consistently, stacking energy and the 
simple repeat TGTG I CACA were found to be significantly enriched. However base twist 
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was unaffected and repetitive elements were somewhat depleted in methylated CGI 
sequences. Weber and colleagues reported that sequences intermediate in CpG density to that 
characteristic of CGIs and bulk genomic DNA were more frequently substrates for de novo 
methylation (Weber et a!,, 2007). On comparison with the novel CGI set employed here, it 
was apparent that 75% of these were not represented. This may be explained by the 
increased abundance of Msel cleavage sites, depleted CpG density or increased DNA 
methylation in this class of sequences. This would prevent sufficient retention of these 
sequences by the CAP and subsequently exclude them from the library. Consistent with this 
hypothesis, 22 intermediate CpG density sequences found to be methylated were absent from 
the CGI set. This suggests that the observation of altered sequence characteristics previously 
described may be somewhat confounded by the prerequisite removal of methylated and CpG 
deficient sequences from the CGI set. As such, the library will likely represent a somewhat 
unique class of islands relative to those identified by less biologically relevant means. 
4.4.3 Composite CGI Methylation 
Interestingly, bisulfite genomic sequencing of methylated CGIs uncovered a composite 
methylation pattern for almost all sequences tested. This bimodal distribution suggests that 
the DNA molecules were largely methylated or unmethylated with relatively little 
intermediate methylation. This distinct pattern may represent individual methylation 
polymorphisms resulting from the pooling of DNA samples. Indeed, detailed 
characterisation of a CGI associated within the HOXC cluster was considerably more 
methylated in one of the three individuals. Furthermore, a methylated island which 
associates with the ENDOG promoter was previously identified as being differentially 
methylated in a panel of lung samples (Shiraishi et al., 2002). An alternative possibility is 
that different cells types, composing the tissues investigated, bear distinct methylation 
patterns. Analysis of a SEC31B associated CGI, found to be compositely methylated in 
whole blood was more heavily methylated in mononucleocytes than granulocytes prepared 
from the same individuals. Finally, monoallelic methylation could also account for the 
observed methylation pattern. A study investigating the methylation status of CGIs on 
chromosomal arm 21q, identified both imprinted and parent independent monoallelic 
methylation (Yamada et al., 2004). Without SNP or familial linkage data this was impossible 
to test directly. However to address this, promoter associated CGIs were compared with a list 
of independently identified monoallelically expressed genes (Gimelbrant et al., 2007). CGIs 
methylated in blood were characterised, as the likelihood of identifying islands bearing this 
distinct pattern would be improved by the nature of the CGI library. This comparison 
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identified 17 genes that are candidates for allele specific methylation. Despite this relatively 
small overlap it is likely that this phenomenon will contribute, in part, to the observed 
composite methylation pattern characteristic of this subset of COTs. 
4.4.4 CGI methylation, gene association and expression 
Promoter CGI methylation has previously been shown to correspond with transcriptional 
gene repression (Hansen and Gartler, 1990; Stein et al., 1982). Consistently, CGI genes 
which escape X-inaction have been shown to evade the de novo methylation characteristic of 
the inactive chromosome (Weber et al., 2005). MAP array confirmed that CGI genes which 
escape X inactivation, were significantly less methylated than their inactive counterparts 
(Carrel and Willard, 2005). This observation supports the notion that transcriptional inertia 
corresponds to promoter CGI methylation. As such we hypothesized that COT genes which 
were differentially methylated would show a concordant reduction in gene expression. 
However, batch mining of tissue specific expression data yielded no obvious correlation 
between methylation and gene activity. It is possible that specific effects on gene expression 
were somewhat diluted by the composite methylation pattern observed. To address this 
possibility, SEC31B expression was assessed in mononucleocytes and granulocytes where 
the promoter COT is differentially methylated. This candidate analysis identified equivalent 
low level expression in both cell populations. This finding was consistent with the 
observation that many of the differentially methylated islands were expressed at very low 
levels in all tissues irrespective of methylation state. No attempt was made to correlate 
internal COT methylation and gene expression, as the affect of this phenomenon is not 
evident at this time. The significance of these observations will be discussed later but it is 
clear that future methylation studies will have to be associated with matched expression 
analysis. 
As an alternative means of investigating the role of COT methylation and gene function, all 
differentially methylated COT genes were classified according to their gene ontologies. 
Interestingly, this indicated that differentially methylated CGIs associated with genes 
involved in developmental processes such as neurogenesis and ectoderm development. 
Furthermore, homeobox transcription factors involved in body segment specification were 
more than 3 fold over represented with 25% of all HOX cluster genes associating with a 
differentially methylated CGI sequence. The role of this methylation remains unclear as 
many of these islands are distal to promoter regions. It is tantalising to posit that these 
methylated islands may play a functional role by mediating the expression of an antisense 
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ncRNAs. Indeed, both the Air and Tsix ncRNA transcripts originate from CGIs and are 
involved in the regulation of the sense transcript (Panning and Jaenisch, 1996; Sleutels et al., 
2002; Wutz et al., 1997). Furthermore, evidence for HOX cluster regulation by the tissue 
specific expression of the ncRNA HOTAIR further highlights the necessity for further 
investigation of these interesting developmental gene loci (Rinn et al., 2007). 
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Chapter 5: 	Discussion 
Current technical limitations have prevented the characterisation of the entire human DNA 
methylome; a feat which has only been achieved for the small genomed plant Arabidopsis 
thaliana (Cokus et al., 2008; Zhang et al., 2006; Zilberman et al., 2007). Therefore, attention 
has been directed towards sequences of evident biological interest and more pragmatically, 
those which are tractable to molecular scrutiny in the lab. CGIs are conspicuous within the 
human genome as they have an atypically elevated CpG and G+C composition (Bird, 1987; 
Cooper et al., 1983; Gardiner-Garden and Frommer, 1987). They are generally 
hypomethylated and transcriptionally permissive in all tissues (Cooper et al., 1983; Tazi and 
Bird, 1990). CGIs associate with the promoters of more than half of all protein coding genes 
and are therefore enriched for regulatory elements (Larsen et al., 1992). Moreover, CGIs are 
sites of abnormal hypermethylation in neoplastic cells, which correlates with transcriptional 
repression of the associated gene promoters (Jones, 2002; Jones and Baylin, 2007). 
Consequently, CGIs represent a genomic fraction of considerable biological interest and one 
amenable to methylation analysis. Here we discuss the development and utility of novel 
reagents to characterise these sequences in primary human cells. 
5.1 	Generation and Characterisation of a Somatic CGI 
set 
In this study we developed CAP, a novel chromatographic procedure for the selective 
enrichment of nonmethylated CGI sequences from bulk genomic DNA. This specific affinity 
is provided by a recombinant CXXC domain coupled at high density to a solid 
chromatographic matrix. This matrix provides selectivity for sequences bearing clusters of 
nonmethylated CpGs, making it ideally suited for the fractionation of CGIs. We prepared a 
somatic CGI set by CAP fractionation of human blood DNA. Extensive characterisation 
confirmed the enrichment of sequences with a base composition coherent with that of 
classical CGIs (Gardiner-Garden and Frommer, 1987; Takai and Jones, 2002). The complete 
set represents 17,387 discrete loci, which preferentially localise to gene rich regions of the 
genome. This set supersedes a previous library, which due to post-processing steps contains 
significantly fewer bona fide CGIs and a large proportion or repetitive elements (Cross et al., 
1994; Heisler et al., 2005). Analysis of gene association suggests that the CXXC library 
contains approximately 25,000 CGIs of which approximately 60% have tenable sequence. 
PCR amplicons generated from these sequences were spotted onto microarray slides to allow 
further characterisation. 
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Consistent with previous reports, CGIs were found to preferentially localise to chromosome 
ends proximal to the telomeres (Craig and Bickmore, 1994). Despite a clear association with 
the transcription start sites of protein coding genes, approximately 51% were distal to 
annotated promoters. This finding was particularly interesting, as analysis of intra- or 
intergenic islands has previously been shown to identify unanticipated gene promoters 
(Gardiner-Garden and Frommer, 1987; Macleod et al., 1998). Moreover, it is possible that 
many of these islands localise to promoters of ncRNA genes. Accordingly, transcription of 
the ncRNAs Xist and Air initiate from CGI-promoters (Panning and Jaenisch, 1996; Sleutels 
et al., 2002; Wutz et al., 1997). A recent study identified a regulatory ncRNA which is 
transcribed from the HOXC locus (Rinn et al., 2007). All four HOX clusters contain an 
atypically high density of CGIs (Fig. 4.3-6d and data not shown). These results indicate a 
potential regulatory role for CGIs at these developmental gene loci. 
One explanation for the distinct sequence composition of CGIs is transcriptional activity 
during embryogenesis (Antequera, 2003; Ponger et al., 2001). Accordingly, we found that 
approximately 78% of all CGIs associate with islands of H3K4me3 in human ES cells 
(Guenther et al., 2007). Moreover, non-promoter CGIs also display a high level of 
concordance (-64%) with these transcriptionally permissive regions of chromatin. This data 
supports the notion that CGIs persist due to a distinct chromatin state in embryonic cells. 
Moreover this affirms the suggestion that the majority of CGIs are sites of transcriptional 
initiation, at least during embryogenesis. A recent study determined that DNMT3L binding 
is inhibited by this H3K4me3 mark (Ooi et al., 2007). This proposes an intriguing scenario 
whereby transcriptionally active chromatin antagonizes the docking of the de novo 
methyltransferases. This would lead to the immunity of CGI sequence against de novo 
methylation during the phase of embryogenic reprogramming. 
The CAP library was generated based on the clustering of nonmethylated CpG dinucleotides, 
rather than sequence composition alone. Comparison with a commonly used sequence based 
detection algorithm (NCBIt),  confirmed a high level of concordance between the two 
methods. However, the CGI set contains approximately 23% of CGIs which were not 
identified by this algorithm. These sequences display a slightly reduced CpG density, 
suggesting that CAP provides a more biologically relevant method of CGI detection, without 
the imposition of arbitrary thresholds. 
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5.2 CGI Methylation in Human Cells 
Somatic CGI methylation 
Human CGI methylation is associated with important biological processes such as X-
inactivation and parental imprinting. In these systems, methylated CGIs provide an 
epigenetic mark which is required for stable gene repression (Heard et al., 1997; Reik et al., 
2001). There is also evidence to suggest that promoter-COT methylation serves as a primary 
mechanism to silence transcription of germ-line specific genes (De Smet et al., 1999). In 
these cases, the functional significance of COT methylation was realized following primary 
investigation of these systems. More recently however, DNA methylation profiling has been 
utilised as a means to identify hitherto undiscovered biological processes (Eckhardt et al., 
2006; Oakes et al., 2007; Shen et al., 2007; Weber et al., 2005; Weber et al., 2007). 
MeDIP analysis of —16,000 human gene promoters determined that 3% of those associated 
with CGIs were heavily methylated in somatic cells (Weber et al., 2007). MAP array 
analysis suggested a somewhat higher proportion (8%) although this may have arisen due to 
the sub classification of COT promoters as either 'intermediate' or 'high' in the former study 
(Weber et al., 2007). Strikingly, we observed a far higher frequency of methylation at non-
promoter CGIs (-16%) with a three fold over representation at the 3' ends of genes relative 
to those associated with the TSS. Detailed analysis of 512 human CGIs identified —9.2% 
which were heavily methylated in somatic cells, which is relatively consistent with the 
11.6% identified in this study (1, 657 of 14,318; (Eckhardt et al., 2006)). Approximately, 3% 
(408 of 14,318) of CGIs were identified as concordantly methylated in all four tissues (408 
of 14,318). It is likely however, that this represents an underestimate as complete 
methylation in blood DNA would exclude a proportion of CGIs from the library. Consistent 
with this idea, 22 methylated CGIs identified by Weber and coworkers were absent from 
CGI array (Weber et al., 2007). 
Sequence Characteristics of Methylated Islands 
An investigation of somatically methylated CGIs suggested that the most CpG-rich 
sequences were always nonmethylated (Eckhardt et al., 2006). Accordingly, analysis of gene 
promoter methylation indicated that 'intermediate' islands were more frequently methylated 
(21%) than those with a higher density of CpGs (3%; (Weber et al., 2007)). These findings 
suggest that elevated CpG-density may protect against DNA methylation at these sequences. 
However, analysis of the methylated component of the COT set detected only a modest 
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reduction in CpG density (difference = 0.02 CpG[o/e]). Bock and coworkers identified a 
correlation between specific DNA sequence, simple repeats, DNA structure and CGI 
methylation status (Bock et al., 2006). Contrary to these findings, we found that repetitive 
elements were depleted in methylated islands, and did not show a significant difference in 
predicated base twist. We did observe a small but significant enrichment of (TGTG/CACA) 
simple repeats and base-stacking energy. Consequently, our data suggests that these 
sequence characteristics are not effective predictors of CGI methylation and the biological 
significance of these small effects is unclear. One issue that was not addressed in these 
studies was the chromosomal distribution of methylated CGIs. It is therefore interesting to 
suggest that modest compositional differences observed reflects a discrete genomic 
distribution. Consistent with this hypothesis, methylated islands were found to be 
disproportionately associated with telomeres which are known to have an atypical base 
composition (Riethman et al., 2004). Both CGI methylation and shortening of the telomeres 
have been associated with aging (Issa et al., 1996; Kwabi-Addo et al., 2007; Shawi and 
Autexier, 2008; Shiraishi et al., 1999). Since the majority of the DNA samples were prepared 
from individuals over sixty years of age, it is interesting to hypothesise that these 
chromosomal regions may be enriched for age correlated CGI methylation. Further 
investigation will be required to determine the validity of this hypothesis. 
'Instructive' CGI Methylation 
Neoplastic cells often display aberrant gene promoter methylation, and it has been proposed 
that these sites are enriched for H3K27me3 in human ES cells (Ohm et al., 2007; Schlesinger 
et al., 2007; Widschwendter et al., 2007). To address the possibility that 'normal' somatic 
CGI methylated shows an equivalent association, we compared somatically methylated CGIs 
with reported sites of H3K27me3 in human ES cells (Lee et al., 2006). We determined that 
CGIs associated with this modification were only slightly more likely to be methylated in 
somatic tissues (7.7 and 5.9% of methylated and all CGIs respectively). This suggests that 
'normal' somatic CGI methylation is not preferentially targeted to sites of H3K27me3 
modification and may therefore be mechanistically distinct from that described in cancer 
cells. 
Tissue Specific CGI Methylation 
Tissue specific differential CGI methylation has been documented in mouse and man 
(Eckhardt et al., 2006; Futscher et al., 2002; Grunau et al., 2000; Imamura et al., 2001; 
Shiota, 2004). However, the majority of these variably methylated islands, are 
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hypomethylated in the germ line and methylated in all cells of the soma (Brock et al., 1999; 
De Smet et al., 1999; Eckhardt et al., 2006; Kitamura et al., 2007; Oakes et al., 2007; Shen et 
al., 2007; Strichman-Almashanu et al., 2002; Weber et al., 2007). A relatively recent study 
characterizing CpG methylation profiles in human brain, identified distinct methylation 
patterns specific to individual brain regions (Ladd-Acosta et al., 2007). MAP array results 
from Blood, Brain, Muscle and Spleen identified between 5.7 and 8.3% of CGIs as 
methylated in different tissues. Further analysis confirmed that —5% (711 of 14,318) of CGIs 
were differentially methylated within these somatic tissues. Interestingly, these islands are 
preferentially associated with developmental genes, including those of the HOX and PAX 
families (discussed in section 5.3). 
5.3 Genes, Transcription and CGI Methylation 
CGI Methylation and Transcriptional Regulation 
There is extensive evidence to support a causative role for promoter-CGI methylation in 
transcriptional repression (see for example (De Smet et al., 1999; Stein et al., 1982; Weber et 
al,, 2007)). Accordingly, we show that genes which escape inactivation on the Xi are 
atypically hypomethylated, upholding this dogma (Carrel and Willard, 2005; Weber et al., 
2007). DNA methylation of the CpG rich promoters of human MASPIN and GATA2 
correlates with tissue specific gene silencing (Futscher et al., 2002; Song et al., 2005). In 
light of this evidence, it is tantalising to hypothesise that tissue specific CGI methylation 
may provide a mechanism to regulate tissue specific gene expression. However, the 
candidate gene SEC3I13, was found to be repressed irrespective of the methylation status of 
its promoter-CGI. A comparison between differential CUT methylation and mined expression 
data also showed a poor correlation with transcriptional activity consistent with previous 
results (Oakes et al., 2007). 
A potential difficulty in interpreting the role of CGI methylation in transcriptional repression 
is that methylation profiles generated in this study could not be compared with expression 
data from the same biological samples. Secondly, many of the differentially methylated 
islands are located within intragenic regions and the consequence of methylation at these 
sites is unclear (Grunau et al., 2000; Kitamura et al., 2007; Ladd-Acosta et al., 2007). 
Finally, expression may be restricted to a subset of cells within a mixed population 
comprising the analysed tissue. To determine the validity and contribution of these factors a 
more extensive expression analysis will be required. RNA and DNA prepared from the same 
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source will provide a more robust comparison. However, this was not possible at the time of 
investigation due to the limited availability of high quality human tissue. 
CGI Merhylation. Initiation or Maintenance of Transcriptional Repression? 
Evidence from X inactivation and transgenic studies indicates that transcriptional repression 
precedes promoter-CGI methylation (see Introduction). Analysis of SEC31B and mined 
expression data suggests that differential methylation frequently occurs at constitutively 
silenced genes. This indicates that CGI methylation may follow, rather than initiate, 
transcriptional repression. Two models could account for this possibility. 1) The absence of 
TFs at silenced promoters could facilitate transient de novo methylation due to the lack of 
steric hindrance. This possibility would align with the notion that methylation is the basal 
state of the genome which is excluded from specific regions by the presence of bound 
factors. 2) DNMT recruitment could be mediated by initial repressive events, to irrevocably 
silence transcription of the associated gene. Combined analysis of RNA polymerase 
occupancy, histone modifications, expression and acquisition of CGI methylation during 
development may help to resolve this issue. 
Differential CGI Methylation and Gene Function 
Developmental gene functions such as neurogenesis, segmentatation specification and 
mesoderm development were prominent amongst genes associated with differentially 
methylated CGIs. Specifically, association of differential methylation was approximately 
three fold overrepresented at the Homeobox developmental regulatory genes. Moreover, out 
of 79 CGIs associated with the four HOX gene clusters, approximately 25% (22 of 79) were 
methylated in at least on of the four tissues tested. These highly conserved genes dictate the 
positional identities of cells within the human body and therefore represent key regulators of 
mammalian development. It is interesting to note, that expanding the panel of tissues will 
likely uncover additional methylated islands within these important developmental gene loci. 
Further characterisation of these important regulatory genes will hopefully provide further 
insight into the function of CGI methylation, during cellular differentiation. 
CGI methylation: A note regarding PAX6 
PAX6 is a transcription factor required for ocular and neural development and it's expression 
is temporally and spatially partitioned within the mammalian brain (Kleinjan et al., 2004). 
The observation that an intragenic CGI sequence was specifically methylated in brain 
suggests an interesting hypothesis (Fig. 4.3-6b). CGI methylation may serve to restrict gene 
171 
expression to a specific cell type within a tissue. In the case of PAX6, this mechanism may 
be required to prevent ectopic expression in cells containing all the TFs required for efficient 
expression. The effect of perturbed PAX6 expression is illustrated in the congenital disorder 
Aniridia, where lack of PAX6 leads to improper eye formation (Kodama and Eguchi, 1994; 
van Raamsdonk and Tilghman, 2000). 
5.4 Composite methylation 
Bisulfite sequence analysis determined that several MAP enriched CGIs display a composite 
methylation pattern. Several explanations could account for this mixed population of heavily 
methylated and nonmethylated DNA molecules. At the highest level, the composite pattern 
may indicate individual variation in the pooled DNA. To address this possibility, 
methylation analysis was carried out on muscle DNA from three individuals. Accordingly, 
individual C displayed a considerably higher level of methylation than individuals A and B 
(Fig. 4.3-5b). Therefore, such polymorphic methylation may be acquired during the course 
of human aging, although this remains a contentious issue. Whilst several studies have 
identified an increased incidence of CGI methylation with age, others have failed to confirm 
these results (Eckhardt et al., 2006; Kwabi-Addo et al., 2007; Ladd-Acosta et al., 2007). 
Alternatively, polymorphic methylation may occur as a random stochastic event or as a 
consequence of some underlying disease state. Individual polymorphic methylation is of 
significant interest as it may represent an epigenetic determinant of phenotypic variability. A 
large scale screen of individual CGI methylation will provide insight into the extent of 
variation and the relative contribution of each of these factors. 
A second possibility is that methylation patterns are distinct within tissues resulting from 
differential methylation of constituent cell types. As previously discussed, we identified 5% 
of CGIs which display variable methylation patterns between four somatic tissues. A recent 
study addressed the methylation status of 1,505 CpG sites in a panel of individual matched 
brain regions (Cerebrum, Cerebellum and Pons). Interestingly, region specific methylation 
patterns were consistently observed and the authors propose that this is indicative of regional 
specialization (Ladd-Acosta et al., 2007). It is therefore conceivable that variable 
methylation patterns exist between functionally distinct cell types. Here we show that the 
promoter-CGI of SEC3IB was more heavily methylated in mononuclear cells than 
granulocyte cells prepared from whole blood. It is interesting to propose that cell specific 
methylation patterns may serve to determine or maintain expression profiles following tissue 
differentiation. 
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Monoallelic CGI methylation is frequently associated with imprinted gene loci and an 
equivalent phenomenon could account. for composite CGI methylation (Reik, 2007). 
Accordingly, analysis of predicted CGIs on chromosome arm 21q identified -.5% (7 of 149) 
of CGIs which were compositely methylated in peripheral blood DNA. Three of these 
islands were monoallelicafly methylated as determined by SNP analysis (Yamada et al., 
2004). In the absence of parent specific SNP data we were unable to test this hypothesis 
directly. Although, comparison of genes identified as being monoallelically expressed in 
blood cells, showed a poor association with the methylated CGIs identified here (Gimelbrant 
et al., 2007). Consequently, we conclude that monoallelic methylation is not a major 
contributor to this phenomenon; however more extensive analysis is required. 
5.5 Future Work 
Second Generation CGI Libraries 
CXXC affinity purification is highly effective at selecting DNA fragments containing 
clusters of non-methylated CpG sites. This was illustrated by the characterisation of clone 
inserts from the CGI library in Chapter 3. Despite the coverage of the CGI library however, 
there are several aspects which could have been improved. I) The use of conventional 
sequencing chemistry led to a reduced coverage of the library due to bias against G+C rich 
sequence composition. 2) MseI restriction provides an effective step in the preparation of a 
CGI fraction as has been discussed previously. However, its application in the preparation of 
the CXXC fraction resulted in fragmentation of many of the CGIs. Moreover many islands 
were only represented by flanking MseI fragments which were useful for CGI localisation 
but rather ineffective as arrayed probes. 3). Due to practical considerations, the library was 
generated from blood, rather than sperm. This allowed the selection of hypomethylated CGIs 
whilst avoiding the purification of certain repeat sequences which would provide efficient 
ligands for the CXXC matrix in sperm. Consequently, the library is depleted for all CGIs 
which are heavily methylated in blood, as confirmed by the absence of previously identified 
methylated CGI sequences (Futscher et al., 2002; Weber et al., 2007). 
These factors result from the limitations of conventional sequencing, either by the inability 
to sequence specific base compositions or to generate sufficient reads to provide coverage of 
complex DNA fractions. The use of Solexa sequencing circumvents these problems by 
producing tens of millions of compositionally unbiased sequences. To this end, CXXC 
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fractions have been generated from sonicated blood and sperm DNA, and sequenced using 
the solexa technology (Wellcome Trust Sanger institute's sequencing team, under the 
direction of Dr Julian Parkhill). The CAP fractions are currently being investigated; however 
the preliminary sequences are coherent with the composition of classical CGIs (Fig. 5.5-la-
c). There are significant differences between the blood and sperm preparations, such as the 
promoter associated CGI of CATSPER2 (Cation Channel: Sperm Associated 2; Fig. 5.5-1c). 
CATSPER2 belongs to a gene family which is expressed specifically in sperm and therefore 
resembles genes of the MAGE family (De Smet et al., 1999; Li et al., 2007b). Replication 
and refinement of this data will provide a complete unbiased set of CGIs. Moreover, analysis 
of CAP preparations from blood and sperm DNA will hopefully provide an insight into the 
acquisition of CGI methylation in somatic cell lineages. 
Functional Role of Tissue Specific CGI Methylation 
Several studies including this one have identified tissue specific methylation patterns 
(Eckhardt et al., 2006; Futscher et al., 2002; Imamura et al., 2001; Ladd-Acosta et al., 2007; 
Shiota et al., 2002). However, with the exception of MASPIN, there is little direct evidence 
to suggest that tissue specific expression patterns are dictated by differential methylation 
events (Futscher et al., 2002). To address this problem it would be informative to relate 
methylation patterns to transcription status derived from the same biological samples. An 
alternative elegant technical approach is provided by sequential ChIP-bisulfite sequencing 
(D'Alessio et al., 2007). This allows the determination of DNA methylation patterns in 
chromatin associated with active or inactive marks or specific transcription factors. The 
method is particularly versatile as it allows direct comparison of DNA methylation and 
transcriptional permissivity at single molecule resolution. Cell and a1lele' ° ' specific 
methylation can be resolved by this approach. 
How Variable are CGI Methylation Patterns? 
As discussed, there are several possible explanations to account for the composite 
methylation patterns identified by bisulfite sequence analysis in this study. To dissect the 
relative contribution of individual variation (age, normal variability, disease, stochastic and 
sex specific) and tissue specific effects on the methylation patterns, a more extensive 
analysis is required. A MAP (or MeDIP) microarray screen of human tissues from a large 
number of individuals will be required to account for the relative contribution of each of 
XXXV Characterisation of allelic methylation requires the association of informative SNPs and, 





Figure 5.1-1. Mapped Solexa Sequence from CAP purified Blood and Sperm DNA 
(a-c) Solexa sequence from CAP fractionated Blood (Red) and Sperm (Blue) DNA, mapped to three 
regions of the human genome (NCBI build 36). Each region depicts nonmethylated CGIs purified from 
blood and sperm and several specific to sperm alone (panels b and C). (c) A region of chromosome 15 
and an enlarged view of the sperm specific OGI associated with the promoter of CATSPER2. 
Chromosomal region is indicated in the top centre of each panel following the convention of 
chromosome number: start-stop. Genes (green bars) are transcribed left-right on the sense strand 
(upper) and right-left on the antisense strand (lower). 
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these components. This will provide an effective means to fully appreciate the source of 
these methylation patterns and to identify the regulatory functions that they may provide. 
5.6 Concluding Remarks 
Selection of the majority of human CGIs sequences based on their intrinsic molecular 
properties has allowed for a comprehensive characterisation of this interesting genomic 
fraction. This has provided a refined understanding of the distribution and abundance of 
CGIs within the context of the genome and individual genes. Moreover, it serve as an 
analytical tool which has provided tantalising insights into the function of CGI methylation 
and development. Future analysis based on the generalizations drawn here, will hopefully 
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CpG islands (CGls) are dense clusters of CpG sequences that punctuate the CpG-deficient human genome and associate 
with many gene promoters. As CGIs also differ from bulk chromosomal DNA by their frequent lack of cytosine 
methylation, we devised a CGI enrichment method based on nonmethylated CpG affinity chromatography. The 
resulting library was sequenced to define a novel human blood CGI set that includes many that are not detected by 
current algorithms. Approximately half of CGIs were associated with annotated gene transcription start sites, the 
remainder being intra- or intergenic. Using an array representing over 17,000 CGIs, we established that 6%-8% of CGIs 
are methylated in genomic DNA of human blood, brain, muscle, and spleen. Inter- and intragenic CGIs are 
preferentially susceptible to methylation. CGIs showing tissue-specific methylation were overrepresented at numerous 
genetic loci that are essential for development, including HOX and PAX family members. The  findings enable a 
comprehensive analysis of the roles played by CGI methylation in normal and diseased human tissues. 
:itation: lllingworth R, Kerr A, DeSousa 0, Jorgensen H, Ellis P, et at (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 
5(1): e22. doi:1 0.1371 /journal.pbio.0060022 
Introduction 
DNA methylation in the mammalian genonse arises due to 
tovalent addition of a methyl group to the 5' position of 
cytosine in the context of the palindromic clinucleotide, CpG. 
Ehis modification is established and maintained by a family of 
DNA methyltransferases that are essential for development 
and viability [1,2]. The pattern of CpG methylation in the 
Esuman genome distinguishes two fractions with distinct 
properties: a major fraction (--98%), in which CpGs are 
relatively infrequent (on average I per 100 bp) but highly 
methylated (approximately 80% of all CpG sites), and a minor 
Fraction (<2%) that comprises short stretches of DNA 
--1,000 bp) in which CpG is frequent (--1 per 10 bp) and 
nsethylation-free. The latter are known as CpG islands (CGIs) 
and they frequently colocalise with the transcription start 
sites (TSSs) of genes [3,4]. 
Although CGIs are often free of methylation, there are 
:ircumstances in which they become heavily methylated, and 
this invariably correlates with silencing of any promoter 
within the CGI. Artificial methylation of CGI promoters has 
long been known to extinguish transcription when the 
:onstructs are introduced into living cells [5]. Moreover, 
lemethylation of endogenous methylated CGIs using DNA 
methytransferase inhibitors can restore expression of the 
gene [6]. These findings demonstrate that dense CpG 
nsethvlation prevents expression of CGI promoters. Because 
af this biological consequence, it is important to know the 
txtent of CGI methylation in both normal and diseased tissue 
;tates. The classical example is X chromosome inactivation in 
placental mammals, during which hundreds of CGI pro-
moters become methylated and contribute to the stability of 
ene inactivation on this chromosome [7,8]. Genomic  
imprinting can also depend upon differential CGI methyl-
ation between maternal and paternal alleles [9]. Certain 
"testis-specific antigen"  genes possess CGIs that are methy-
lated in all somatic tissues, but not in testis, where the genes 
are expressed [10]. Several additional candidates for CGI 
methylation in normal tissues have been reported [11,12], and 
the number of cases has recently grown due to large-scale 
bisulfite sequencing [13] and analysis of promoter methyl-
ation using microarrays [14]. 
In the cases of X chromosome inactivation and genonsic 
imprinting, the biological processes were described initially, 
and CpG methylation was subsequently implicated through 
mechanistic studies. To uncover new biological roles for CGI 
methylation in hitherto undiscovered biological processes, it 
would be advantageous to comprehensively screen genomic 
DNA for methylated CGIs in normal Or diseased cell types. A 
persistent limitation affecting this kind of approach has been 
uncertainty concerning CGI identification [15]. The criteria 
for designating a sequence as CGI-like are currently 
exclusively bioinformatic in nature, relying on the differences 
in the base composition and CpG frequencies (observed/ 
expected) between bulk genomic DNA and CGIs [16,17]. In an 
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Author Summary 
The human genome contains about 22,000 genes, each encoding 
one of the proteins required for human life. A particular cell type 
(e.g., blood, skin, etc.) expresses a specific subset of protein genes 
and silences the remainder. To shed light on the mechanisms that 
cause genes to be activated or shut down, we studied DNA 
sequences called CpG islands" (CGIs). These sequences are found 
at over half of all human genes and can exist in either the active or 
silent state depending on the presence or absence of methyl groups 
on the DNA. We devised a method for purifying all CGIs and showed 
that, unexpectedly, only half occur at the beginning of genes near 
the promoter, the rest occurring within or between genes. Notably, 
methylation of CGIs causes stable gene silencing. We tested 17,000 
CGIs in four human tissues and found that 6%-8% were methylated 
in each. Genes whose protein products play an essential role during 
embryonic development were preferentially methylated, suggesting 
that gene expression during development could be regulated by 
CGI methylation. 
attempt to address this limitation and create a resource for 
future analysis, we developed a method for CGI identification 
and purification based on their lack of CpG methylation in an 
otherwise highly methylated genomc. 
Our method utilised a protein domain with a specific 
affinity for clustered nonmethylated CpG sites 118,191. Using 
this reagent we physically purified DNA sequences that  
contain clusters of nonmethylated CpG-rich DNA from 
human blood DNA. Large-scale sequencing of the fraction 
identified a CGI set that was annotated on the ENSEMBL 
database. We found that man\ CGIs in the set were not 
associated with promoters of annotated genes, but were 
either within transcription units or between genes. By 
arraying the intact CGI sequences, we were able to inter-
rogate genomic DNA fractions from several human tissues in 
order to identify methylated CGIs. The results revealed large 
numbers of CGIs that are methylated in normal human 
tissues, many of which showed tissue-specific methylation. 
Results 
A Novel Technique for Purification of CpG Islands 
In enrich for nonmethylated (',p(;-rich DNA (CpG islands), 
developed the technique of CXXC affinity purification 
(CAP). This uses the cysteinc-rich CXXC3 domain that has a 
high affinity for nonmethylated CpG sites [18,191. A recombi-
nant CXXC domain from mouse Mbd 11191 was expressed in 
bacteria, and its binding specificity for nonmethylated CpG 
sites was confirmed (Figure IA). The CXXC domain had no 
detectable affinity for DNA containing only methylated CpUs 
or for DNA lacking CpUs altogether.. We linked the CXXC 
domain to a sepharose matrix and confirmed that this 
fractionated DNA fragments according to CpG density and 
methylation status (unpublished data). All DNA hound to the 
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Figure 1. The Immobilised CXXC Domain Specifically Retains DNA Containing Clusters of Nonmethylated CpGs 
EMSA showing the CXXC complex with a DNA probe containing 27 nonmethylated CpG sites. Nonmethylated probe DNA (CGI 1) or methylated 
probe (MeCG11) was incubated with 0, 250, 500, 1,000, or 2,000 ng of recombinant CXXC protein. 
A typical elution profile of bulk genomic DNA (blue line) from a CXXC affinity chromatography column. Genomic DNA (100 jig) was applied to the 
CXXC affinity matrix (see Methods) in low salt (0.1 M NaCl) and eluted with a gradient of increasing NaCl (red line; see text). Eighteen fractions were 
interrogated by PCR (blue lines). The bracket above indicates fractions that were found to contain nonmethylated CGIs. 
Elution of specific CGI sequences of known methylation status. Methylated CGIs (NYESO and MAO in females) coelute with bulk genomic DNA (see 
bracket) whereas nonmethylated CGIs (P48 and MAO) elute at high NaCl concentration. 
doi:1 0.1371 /journal.pbio.0060022.gOO1 
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:olumn at 0.1 M salt. Methylated DNA and CpG-poor DNA 
riutecl at —0.4 M NaCl, whereas elution of nonmethylated 
CpG-rich DNA required 0.6-1.0 M NaCl. To test the 
behaviour of CGIs on the column, human genomic DNA 
was digested with Msel (TFAA) [20] and fractionated over the 
CXXC column (Figure 111). The reasoning behind use of Msel 
[20] was to cut AT-rich bulk genomic DNA into small 
Fragments (predicted average = 123 bp), but to leave CGIs 
relatively intact (predicted average = 625 hp). As bulk 
enomic DNA has a CpG on average every 100 bp, most 
Msel fragments will have too few CpCs to he retained by the 
CXXC matrix. CGIs on the other hand, with I CpG per 10 
bp, will give rise to long fragments with many Cpus. Fluted 
Fractions were interrogated by l'CR using primers specific for 
a range of known CGIs and non-CGI sequences (Figure IC). 
For example, the nonmethylatecl CGI of the 1148 gene doted 
at high salt. The X-linked monoamine oxiclase (MAO) gene 
eluted as a single high salt peak from male genomic DNA 
(where it is nonmcthvlated), but as two separate peaks at high 
and low salt when female DNA (with one methylatecl and one 
nonmethylateci allele) was fractionated. The CGI associated 
with the NYESO testis-specific antigen gene (methylated in 
somatic tissues) eluted frorn the CXXC column by low salt as 
predicted. The data confirm that CAP may be used to purify a 
CGI fraction from human genomic DNA. 
A Comprehensive CGI Set from Human Blood 
Most or all CGIs are in a nonmethylated state in sperm, but 
in addition repetitive elements [21] and telomere-proximal 
sequences [22], both of which are moderately CpG-rich, are 
hypomethylated in sperm DNA. To avoid contamination of 
the CGI fraction with sequences that are nonmethylateci, 
specifically in germ cells, whole human blood was used as a 
source of CGI fragments. Pooled whole blood DNA from 
three males was fractionated using the CXXC column. High 
salt fractions were pooled, diluted, and re-chromatographecl 
before cloning in plasmids. The resulting blood CGI library 
was analysed by 221,860 sequence reads representing 119,487 
genomic templates. These compiled to give 28,013 unique 
Msel fragments. Plots of DNA insert length versus either C-+C 
content or observed/expected CpG frequency (CpG[o/e]) 
showed that the great majority of clones exhibited a higher 
G+C content (average = 62%) and CpG[o/e] (average = 0.71) 
than bulk genomic DNA (C-I-C = 41% and CpG[o/e] = 0.2) 
(Figure 2A and 2B). A fraction of small fragments with 
sequence characteristics resembling bulk genomic DNA was 
detected by these plots. As these probably represent 
contamination, we filtered out fragments shorter than 512 
bp that had a CC content less than 50% and/or a CpG[o/e] less 
than 0.6 (see grey dots in Figure 2A and 2B). The resulting 
final sequenced set corresponds to 17,387 CGIs and is 
annotated on the ENSEMBL genome browser (http://www. 
ensembl.org/index.html. DAS sources: "CPG island clones"). 
The great majority have classical CGI properties (Figure 2C). 
Due to their high average GC content, the sequence pass rate 
was 69%. Assuming that the unsequenced clones reflect the 
same proportion of CGIs as those that were sequenced, we 
estimate the total number of CGIs in the library as 25,200. It 
is likely that a higher proportion of sequence failures affect 
bona fide CGIs, as CC-richness is known to interfere with 
sequencing. If so, we estimate that the number of human 
genomic CGIs may be closer to 30,000. 
CGIs are identified bioinformamically as DNA sequences 
with a base composition greater than 50% C-I-C and a CpG[o/ 
e] of more than 0.6 [23]. The DNA length over which this 
condition applies is critical. initially the threshold most often 
used was 200 bp, whereas 500 bp is now more commonly 
applied [17]. These two criteria are formalised as "NCBI-
relaxed" and "NCBI-strict," respectively (hmtp://www.ncbi. 
nlm.nih.gov/mapview/static/humansearch.html#cpg). The re-
laxed algorithm predicts 307,193 CGIs in the human genome, 
which includes many repeated sequences and gene exons. 
Over 90% of NCBI-relaxecl CGIs are not represented in 
either our library or the set predicted by the NCBI-strict. This 
and other arguments suggest that the great majority (>90%) 
are false positives. On the other hand, 77% of clones in the 
CGI library match CGIs predicted by the "NCBI-strict" 
algorithm (Table 1). Examples of the coincidence of NCBI-
strict predicted CGIs and sequenced CGI clones are illus-
trated for the three typical regions of the human genome 
(Figure 2D). 
Altogether, NCBI-strict identifies 24,163 CGIs in the 
human genome, which accords with the adjusted CGI library 
estimate of 25,200. The coincidence of these numbers masks 
sign ificarit differences, however, as 23% of CGIs in the library 
are not detected by the NCBI-strict algorithm (4,082 out of 
17,387; Table I). Four randomly selected examples of library 
CGIs not detected by NCBI-strict (Figure 2D and 2E, 
numbered) gave CpG maps resembling CGIs; three of these 
coincided with the promoters of annotated protein-coding 
gent's (Figure 21) and 2E). The presence of bioinformatically 
predicted CGIs that are missing from the CGI library is most 
probably clue to sequence failure of —31% of library inserts. 
Analysis of the CGIs missed by the NCBI-strict algorithm 
shows them to be, as expected, significantly weaker with 
respect to CpG and C-i-C content than the total set (Figure 
Si). It was not obvious, however, that the algorithm could he 
easily improved based on this information. Relaxation of the 
sequence parameters reduces the number of false negatives, 
but leads to increased numbers of false positives. We suggest 
that CAP identifies islands that fail the NCBI criteria, hut 
reduces the false discovery rate by - excluding spurious 
methylated CpG-rich sequences. Like the majority of CGIs, 
most NCBI-missed islands are gene-associated, although with 
an increased incidence of intragenic islands (Table Si). The 
CGI library therefore includes a significant fraction of bona 
fide CGIs that are missed by one of the best available 
algorithms. 
CAP defines a set of CGIs that is coherent with respect to 
clustering of nonmerhylatecl CpG sites. The genomic distri-
bution of these CGI sequences correlates strongly with gene 
density (Figure 2F). For example, gene-rich Chromosome 19 
is also CGI-rich, whereas gene-poor Chromosome 18 is 
correspondingly CGI-poor. With respect to annotated pro-
tein-coding genes, we found that 76% of CGIs are within 1.5 
kb of a transcription unit, but only 49% overlap with the TSS 
(Table 2). It follows that half of CCIs are not TSS-associated, 
but are either within downstream regions of transcription 
units (22%) or located in intergenic DNA. Previous studies 
have detected CGIs at the TSS of 56 0z(1 of human protein-
coding genes [24]. As 43.5% of TSSs overlap sequenced CGIs, 
we calculate that the sequenced set of 17,387 CGIs represents 
78% of the CGI complement According to this calculation, 
the total CGI number would be 22,400, somewhat less than 
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Figure 2. A Library of DNA Sequences that Bind Tightly to the CXXC Column Represents a Comprehensive Set of CGIs 
(A and B) Plots of fragment length versus G+C content (A) and CpG[o/e] (B)for 28,013 unique Msel inserts. Fragments shorter than 512 bp with a G+C 
content= <50% and a CpG{o/e] = <0.6 (grey dots) were filtered Out as contamination. The dashed line indicates the base composition (A) and CpG ole 
of bulk genomic DNA. 
A filtered insert set representing 17,387 CGIs shows a discrete distribution that is distant from bulk genomic DNA (black dot). 
Three random chromosomal regions showing CGI sequences mapped by ENSEMBL (green bars). Also shown are CGIs predicted by the NCBI-strict 
and NCBI-relaxed algorithms (blue bars). The directions of transcription of coding sequences (yellow bars) are arrowed. Numbered CGIs (1-4) represent 
sequences not detected by the NCBI-strict algorithm. 
CpG maps of the four CGI clones not predicted by NCBI-strict. Transcription start sites in examples 1, 3, and 4 are indicated by arrows. Sequenced 
Msel fragments are denoted by dashed lines and CpG sites by vertical black strokes. 
The distribution of cloned CGIs (red strokes) on human chromosomes. The number of CGIs on each chromosome is shown (right) and centromeres 
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Table 1. Comparison of Human Blood CGI Set with Bioinformatic Prediction 





NCBI'' 	 307,193 	 307,193 	 24,163 (7.9%) 
NCBIC 24,163 24,163 (100%) 	 24163 






the figure of 25,200 deduced from the fraction of sequenced 
inserts. 
MBD Affinity Purification and Blood CGI Methylation 
CAP selects CGIs from blood DNA based on their lack of 
methylation and therefore excludes the small fraction of CGIs 
(<3%) that are fully methylated in somatic cells from the set 
[141. Indeed, CGIs associated with the human testis-specific 
antigen genes [10], which are methylated in somatic tissues, 
were not enriched by CAP (Figure IC) or present in the 
library (unpublished data). Despite the absence of these fully 
methylated CGIs, we reasoned that the blood CGI library 
provides an opportunity to screen for methylation that 
affects a fraction of all copies of a specific CGI in whole blood 
DNA. Also, it permits a screen for differential methylation of 
CGIs in tissues and cell types other than blood. To investigate 
CGI methylation in normal human tissues, we constructed an 
array of sequenced CGIs from the library by Immobilising 
single-stranded PCR-amplified inserts on glass slides using 5'-
aminolink chemistry as described (http:/Iwww.sanger.ac.uk/ 
Projects/Microarrays/arraylab/methods.shtml). As probes for 
the array, methylated CGIs were enriched from genomic DNA 
using MBD affinity purification (MAP), which was shown 
previously to efficiently bind methylated CGIs [201 (Figure 3A 
and 3B). Human male and female blood DNA was MseI-
digested and ligated to universal catch linkers. We verified by 
PCR that affinity fractionation using MAP effectively sepa-
rated known methylated CGIs (XIST on the active X 
chromosome and NYESO) from bulk genomic DNA and 
nonmethylated CGIs (P48 and XJST on the inactive X 
chromosome; see Figure 3B). Male and female DNA fractions 
were pooled after two rounds of MAP, amplified by linker-
mediated PCR, cyanine labeled, and hybridized to the CGI 
microarray. Quadruplicate hybridisations (inclusive of cya-
nine dye swaps) gave mean enrichment values (MAP/Input) 
that allowed a comparison between male and female 
methylated CGI complements. As expected, these were  
positively correlated (R = 0.865 Pearson correlation) suggest-
ing similar overall patterns. As the library comprises MseI 
fragments that sometimes overlap minimally with the cognate 
CpG-rich region, we chose to disregard data from spots that 
contained DNA with an average CpG frequency (observed/ 
expected) of less than 0.5. Although the omitted fragments 
often denote CGIs, they include too little of the CpG-rich 
domain to be reliable for detection of MAP probes. This 
refinement reduced the number of analysable CGIs on the 
array to 14,318. To assess the relationship between hybrid-
ization signal relative to input and degree of enrichment by 
MAP, we measured a selection of CGIs in the probe by 
quantitative PCR and compared this data with the M values 
(lo,-2 [MAP signal]/[Input signall) for those sequences (Figure 
3C). The results established that M values greater than 1.5 
denote CGIs that are significantly enriched by MAP and 
therefore methylated. CGIs of the BESTI and R4RLI genes 
were predicted to be nonmethylated (M = 0.2-0.4) and 
methylated (M = 2.2-2.8), respectively, based on the array 
data. Bisulfite genomic sequencing confirmed this expect-
ation (Figure 3G and 31-I). 
The major difference in CGI methylation between male 
and female DNA was expected to be due to X chromosome 
inactivation (see also [25]). We therefore compared the 
methylation status of CGIs on Chr 16 and Chr X in male 
versus female DNA. Chr 16 CGIs did not vary between males 
and females, whereas Chr X CGIs were significantly enriched 
in female DNA as predicted (Figure 3D-3F; Table S2). Studies 
of human X chromosome inactivation have indicated that a 
proportion of genes escape inactivation and are therefore 
expressed from both chromosomes [26,271. By comparing the 
microarray data for a set of inactivated and escaping CGIs, we 
found that inactivated genes had significantly higher M values 
(p-value = 1.213 X10) (Figure 31). This finding affirms the 
long-standing link between CGI risethylation and gene 
silencing and validates the present experimental system as a 
means of detecting genes that are shut down in this way. 
Table 2. Relationship between CGI Library Inserts and Protein-Coding Genes 
Type of Overlap Gene Type Total Genes (CGIs) Overlap with CGI (Gene) Percentage Overlap with CGI (TSS) Percentage 
Gene Overlap: CGI Protein 21,384 15,118 70.7 9,312 43.5' 
All genesb 31,524 15,433 49.0 9,529 30.2 
CGI Overlap: Genes Protein 17,387 13,271 76.3 8,491 48.8 
All genes" 17,387 13,360 76.8 8,611 49.5 
This fraction is less than the known fraction of genes with promoter CGIs (56%), because 31% of CGI inserts did not yield DNA sequence. 
"All genes as classified on the ENSMBL genome browser including noncodirig ItNAs, pseudogenes, VDJ regions, etc. 
doi:1 0.1 371/journal.pbio.0060022.t002 
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Figure 3. Use of an Arrayed CGI Library to Detect CGI Methylation in Human Blood DNA 
Schematic showing isolation of densely methylated CGls using MBD affinity purification based on reference [20]. Open and filled circles represent 
nonmethylated and methylated CpG sites, respectively. 
Examples of retention of known methylated CGls by MBD affinity chromatography. Methylated XIST and NYESO CGIs elute at high salt concentration, 
whereas nonmethylated P48 and female X1ST co-elute with bulk genomic DNA (blue line) at low salt concentration (red line). 
M values (1092[MBD/lnput]) >1.5 (dashed vertical arrow) denote DNA fragments enriched by MAP. M values are plotted against the ratio of fragment 
abundance in the MAP probe versus input DNA as determined by quantitative PCR. Error bars represent ± standard deviation. 
(D-F) MAP CGI array hybridization identifies CGI5 that are methylated on the inactive X chromosome. (D) Probes isolated by MAP from male and female 
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whole blood DNA detected female-specific CGI methylation. (E) CGIs on the X chromosome (red dots) often showed female-specific methylation. (F) 
CGIs on Chromosome 16 (red dots) were indistinguishably methylated between male and female. 
(G and H) Confirmation of methylated CGIs by bisulfite genomic sequencing. CGI clones 11387 (G) and 19112 (H) are nonmethylated and methylated, 
respectively, as predicted by the microarray data. Open and filled circles represent nonmethylated and methylated CpG sites, respectively. The genomic 
locus including annotated transcripts and CpG maps (vertical strokes) are shown above each profile. Each column represents products of amplification 
by a single primer pair (brackets below CpG map). Each line corresponds to a sequenced DNA strand. Red bars indicate the location of the Msel 
fragment cloned in the CGI library. 
(I) The CGI array distinguishes genes inactivated on the X chromosome (inactive) from genes that escape inactivation (escaping). CGIs associated with 
inactivated genes (n = 103) show significantly higher M values than CGIs at escaping genes (n = 14; KS test: p = 1.2 x10-5). 
doi:1 0.1371 /journal.pbio.0060022.g003 
Differential CGI Methylation in Human Tissues 
Methylation of CGIs on the inactive X chromosome and at 
imprinted genes is well known, but CGI methylation at other 
chromosomal loci in normal cells and tissues is incompletely 
characterized [12,13,28,29,30]. To investigate this issue on a 
large scale, we probed CGI arrays with MAP fractions from 
genomic DNA (three individuals per pool) of brain, muscle, 
spleen, and sperm in addition to blood (Figure 4A). MAP 
enrichment of methylated CGIs in sperm DNA consistently 
failed to generate enough DNA for labeling using our 
standard PCR amplification conditions and was therefore 
not analysed further. We conclude that the level of CGI 
methylation in sperm is far lower than in any of the somatic 
tissues. 'Faking M values greater than 1.5 to signify methyl-
ation, we observed between 5.7% and 8.3% of CGIs 
methylated in the somatic tissues that were tested (Figure 
4B; Table 3; Dataset SI). Some CGIs were methylated in 
common between all the tested somatic tissues, whereas 
others were methylated in only one or a subset of the tissues. 
We noted that methylated CGIs disproportionately involved 
those that are remote from the TSS of an annotated gene. In 
the dataset as a whole, only 8% of TSS CGIs showed evidence 
of methylation in at least one tissue, whereas 22% of 3' CGIs 
were methylated (Table 4). Do the methylated CGIs differ in 
sequence characteristics from CGIs that remain methylation-
free? We plotted the CpG[ole] frequencies of 1,657 CGIs that 
acquired methylation in one or more tissues and found a 
mean CpG[o/e] of 0.77 compared with 0.75 for methylated 
CGIs (Figure 4C). Though statistically significant (p-value = 
1.413e-10) the biological significance of this small difference 
is unclear. 
We checked by bisulfite sequence analysis a panel of seven 
CGIs with M values suggestive of tissue-specific methylation 
M values differing between tissues by >0.75). In each case, 
bisulfite data confirmed the rnicroarray predictions. CGI 
11878 is not associated with an annotated gene (±1.5 kb) and 
is methylated exclusively in muscle and brain (Figure 4D). 
CGI 12985 spans the transcription start site of the SEc31B 
gene, whose product is implicated in vesicular trafficking, and 
is compositely methylated only in blood and spleen (Figure 
4E). CGIs 113406 (Figure 4F) and 112175 (Figure SA) are 
methylated specifically in muscle. These overlap the pre-
dicted gene 67313 and the 3' end of OSRI. CGI 13654, which is 
associated with the promoter region of an annotated PAX6 
transcript (Q59GD2), previously shown to contain methylated 
CpG Sites [311, is specifically methylated in brain (Figure SB). 
111878 is a 3' CGI of ZN649 and is only methylated in spleen 
(Figure 4G). 
Many methylated CGIs were associated with genes that are 
essential for development (Figure 5). This was confirmed by 
analysis of gene ontology, which showed significant over-
representation of genes whose products are involved in 
developmental processes, including ectoderm and mesoderm 
PL0S Biology I www.plosbiology.org  
development, neurogenesis, and segment specification (Table 
S3). Transcription factors, including homeobox family 
members and other DNA binding proteins, were twice as 
abundant as expected by chance. Other gene categories did 
not show significant enrichment Among the CGIs whose 
methylation status was confirmed by bisulfite sequencing, 
PAX6 is involved in eye (level opmen and neurogenesis [321, 
the HOXC cluster lays down the embryonic body plan, and 
OSRI is related to a gene involved in Drosophila gilt develop-
ment. We examined the extended I-JOXC and PAX6 loci for 
CGI methylation status using the MAP-CGI array data. Our-
library 
r
r  identified 19 CGIs within the ISO-kb HOXC gene 
cluster of which eight were methylated differentially in blood, 
muscle, and spleen (Figure SC). Brain was the only tissue that 
lacked obvious I-IOXC CGI methylation. Of nine CGIs near 
PAX6, two showed differential methylation. In addition to 
brain-specific methylation of the PAX6-Q59GD2 CGI (see 
Figure SB), we observed methylation of a CGI upstream of the 
major 11AX6 promoter in muscle ant! brain (Figure SD). 
The majority of CGIs identified as niethylated by MAP-CGI 
array hybridization display composite methylation (Figures 3, 
4, and 5), whereby DNA strands at a specific locus were either-
heavily ily methylated or essentially nonmethylated. This can 
explain why CGIs that were initially selected by being 
nonmethylated in blood DNA (by CAP) nevertheless register 
as methylated by MAP-CGI array analysis. One potential 
explanation for composite CGI methylation is that different 
individuals within the tissue pools exhibit different CGI 
methylation. To look for such "polymorphism," we examined 
CGI 15134, which is within the HOXC cluster and shows 
composite methylation by bisulfite genomic sequencing. 
Analysis of individuals by MAP-CGI arrays showed highly 
significant differences between individual C and individuals 
A and B (Figure SE). This strikingly confirms individual 
variability in methylation at this CGI. 
Another potential explanation for composite CGI methyl-
ation is that cell types within the tissue sample possess 
different CGI methylation profiles. Blood, for example, 
consists of monocytes and granulocytes, each of which is 
subdivided into other cell types. As CGI 12985 was methylated 
at about half of DNA strands in blood, we tested the level of 
CGI methylation in DNA from monocytes and granulocytes 
separately. The results showed that monocytes had high 
methylation levels at this CGI, whereas granulocytes had very 
low methylation (Figure SF). These findings indicate a 
developmental origin for cell type-specific methylation at 
this genomic CGI. 
Discussion 
A Comprehensive CGI Set 
We describe the characterisation of a comprehensive, 
verified CGI set derived from human blood genomic DNA 
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Figure 4. Tissue-Specific CGI Methylation in a Panel of Human Tissues 
Examples of pairwise comparisons using MAP CGI probes derived from blood, brain, muscle, and spleen. Broken red lines indicate threshold M 
values used to determine differential CGI methylation. 
Frequencies of methylated CGIs in blood, brain, muscle, and spleen. The following catagories are represented: CGIs methylated in all tested tissues 
(black); CGIs methylated in more than one tissue tested but not all (green); CGIs methylated in one tissue only (blue); CGIs methylated in one tissue 
tested but unclassified in other tissues (white). 
Somatically methylated CGIs display a very small but significant reduction in CpG[o/e] (0.75) relative to the whole CGI set (0.77; n = 1,657 and 12,661, 
Wilcoxon rank test: p-value: 1.022e-").   The histogram shows the CpG[o/e]  profile for the total CGI set (white bars) overlaid with the CpG[o/eI  profile for 
methylated CGIs (red line). 
(D-G) Confirmation of candidate CGIs showing evidence of tissue specific methylation by bisulfite genomic sequencing. Layout is as for Figure 3G. 
doi:1 0.1371 /journal.pbio.0060022.g004 
that will he beneficial for studies of CGIs in normal human 
tissues and in disease settings. By focusing on CGIs alone, we 
excluder! —98% of the genome from our analysis. While it 
will ultimately be important to know in detail the methylation 
slants of whole genomes, this currently represents a technical 
challenge that has been addressed only for the small-genomed 
plant Arabidopsis [33,341. These studies used indirect micro-
array-based methods for mapping DNA methylation that 
depend upon probes enriched in nscthylated domains. 
Current enrichment methods require clusters of CpG 
methylation, which are notably absent from the CpG-
deficient majority of the mammalian genome. As a result, 
much bulk genomic DNA is beyond the resolution limit of 
this approach. Whole genome hisulfite sequencing, the most 
direct and reliable method for mapping methylated sites, has 
not yet been attempted in any organism. We therefore 
decided to study a discrete genomic fraction with evident 
biological relevance whose methylation status can be inter-
rogated using microarray-based methods. 
To isolate nonmethylated duplex CGIs from total genomic 
DNA, we harnessed the binding specificity of the CXXC 
protein domain. Extensive sequencing of the resulting library 
confirmed that CGIs represent a discrete fraction of the 
human genome with shared DNA sequence characteristics. 
The present CGI set supercedes a previous human CGI 
library that was prepared in our laboratory using an indirect 
affinity purification procedure [201. The initial library was 
not comprehensive and appears to have acquired significant 
levels of non-CGI contamination following amplifications. 
We estimate that the new library represents --25,000 CGIs, of 
which --60% have been arrayed as full-length single strands 
on glass slides. Additional analysis of inserts that initially 
failed conventional sequencing strategies will generate an 
array that covers the great majority of CGIs that are 
nonmethylated in human blood. The choice of blood DNA 
as a starting material necessarily excludes from the set any 
CGIs that are nonmethylated in germ cells, but densely 
Table 3. CGI Methylation in Human Tissues 
Methylation Status Blood Brain Muscle Spleen 
Methylated in all 408 408 408 408 
Differentially methylated (multiple') 149 135 214 247 
Differentially methylated (single') 50 35 178 140 
Unclassified methylation 303 237 392 381 
Total 910 815 1,192 1,176 
CGIs 14,318 14,318 14,318 14,318 
Percentage methylated 6.4 5.7 8.3 8.2 
'Refers to number of tissues tested. 
doi:1 0.1 371/journal.pbio.0060022.t003 
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methylated in the soma [14]. In the future, it will he 
instructive to compare an exhaustive sequence analysis of 
this set with comparable sequences isolated by CAP from 
spenn DNA. 
The library prepared using CAP defines CGIs based on the 
empirical criterion of clustered nonmethylated CpGs, where-
as criteria based purely on base sequeitce and composition 
necessarily ignore methylation status. Comparing our set with 
predicted CGIs on the NCBI database shows good overlap 
with predictions based on the "strict" algorithm. The CGI 
library did, however, identify 23% of CGIs that were negative 
by this criterion. This suggests that the software for DNA 
sequence-based CGI identification misses almost one in four-
CGIs CIs that the more biological criterion of CAP is able to 
include. Recent CGI analyses identified large numbers of 
human CGI promoters that are enriched in methylation at 
lysine 4 of histone 1-13, a mark of transcriptional activity 
[14,35,36]. Since it has been proposed that hypomethylation is 
dependent on germ line and early embryonic transcription 
[31, we determined the overlap between our CGI set and the 
I-13K4 sites in human embryonic stern cells [37]. We calculate 
that 90% of CGIs in the filtered set (14,318) coincide with 
H3K4 inethylated promoters that were reported in the 
chromatin study. A better test of the relationship between 
CGIs and I13K4 methylation islands in ES cells is to exclude 
promoters of annotated genes and focus on intra- and 
intergenic CGIs. Here again, a high proportion (75%) of CGIs 
overlap with I-13K4 methylation islands. These findings are 
compatible with the notion that the presence of CGIs is 
connected with specialised chromatin configurations in early 
embryonic cells. An intriguing proposal is that H3K4 
methylation may be incompatible with docking of de novo 
methyltransferases [38]. This could in theory insure that these 
regions remain free of CpG methylation at a time when the 
rest of the embryonic genome is subject to global methyl-
ation. 
We found that 49% of CGIs overlap the TSS of an 
annotated gene. In considering the function of the half of 
CGIs that are remote from an annotated TSS, it is noteworthy 
that several intragenic CGIs have been shown to coincide 
with previously unforeseen promoters that initiate bona fide 
transcripts [39,40]. This raises the possibility that all CGIs 
function as promoters and are therefore TSS-associated [40]. 
In this connection, it is of interest that genome-wide analysis 
by tiling arrays detected over 10,000 unanticipated human 
transcripts, many of which may represent noncoding RNAs 
[41]. It is conceivable that many inter- and intragenic CGIs 
mark promoters that drive the synthesis of these novel 
transcripts. The noncoding transcripts XIST and AIR, for 
example, whose RNA products play regulatory roles [42-44], 
both initiate within CGI promoters. The proximity of many 
methylated CGIs to developmentally important genes raises 
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Table 4. Location of Methylated CGI Relative to Protein-Coding Genes 
CGI Gene Association All CGIs Methylated Methylated (%) Differentially Methylated Differentially Methylated (%) 
All CGIs 14,318 1,657 11.6 711 5 
Genes 11,383 1,209 10.6 501 4.4 
5' 7,915 620 7.8 243 3.1 
3' 765 166 21.7 77 10.1 
Intragenic 3,478 536 15.4 230 6.6 
Intergenic 2,863 435 15.2 203 7.1 
doi:1 0.137 1 /jou rnal.pbio.0060022.tOO4 
the possibility that putative CGI transcripts play regulatory 
roles during development. Recent analyses of the human 
HOX gene cluster highlight the functional importance of 
noncocling RNAs [451. Large numbers of potential CGI 
promoters within I-lOX gene loci may therefore contribute 
to the regulation of these complex loci. 
CGI Methylation in Normal Tissues 
CGI snethylation has been extensively studied in cancers 
and their derivative cell lines, but relatively less attention has 
been paid to the phenomenon in normal tissues. Several 
studies have reported somatic CGI methylation, but in early 
examples the bioinformatics procedure used to identify these 
sequences was often equivalent to the NCBI-relaxed algo-
rithm, which generates a large excess of questionable CGI 
candidates. The MASPIN gene, for example, scores as a 
methylated CGI promoter by the relaxed criterion [281, but it 
is not detected as such either by the NCBI-strict algorithm or 
by CAP (unpublished data). A recent report addressing the 
methylation status of 16,000 human promoters identified that 
3% of TSS-associated CGIs are normally methylated in 
somatic tissue [14], which is somewhat below the levels 
observed in our study (7.8%; Table 4). We detect a much 
higher frequency of methylation at nonpromoter CGIs 
(average = 16%), which are obviously absent from promoter 
arrays. In particular, 22% of CGIs near the 3' ends of genes 
are methylated. Extensive bisulfite sequence analysis [131 
surveyed 512 CGIs on Chrs 6, 20, and 21 and reported 9.2% to 
be methylated in somatic tissues. This is similar to the overall 
level of 11.6% methylation among 14,318 CGIs detected by 
our study (Table 4). 
Our findings raise important questions about the relation-
ship of CGI methylation to gene expression. On the X 
chromosome, it is clear that methylated CGIs correlate with 
inactivated genes whereas unmethylated CGIs correlate with 
genes known to escape inactivation. The generalisation that 
CGI methylation silences promoters is therefore supported 
(see also [25]). The relevance to gene expression of the 
autosomal methylated CGIs identified here is complicated by 
the frequent presence of both methylated and nonmethylatedl 
alleles in a specific tissue (see below). This means that even if 
CGI methylation silences a promoter completely, large 
changes in gene expression are not to be expected. Also, 
many CGIs are not at promoters of annotated genes, but are 
within or between transcription units. Their function with 
respect to transcription, if any, may be positive or negative. 
Finally, any transcripts originating from these "orphan" CGIs 
have yet to be identified and cannot be tested. For these 
reasons, it is difficult to make predictions about the effect of 
PL0S Biology I www.plosbiology.org  
CGI methylation on global transcription levels. We never-
theless mined published expression microarray data to 
determine whether tissues in which a specific set of promoter 
CGIs was methylated expressed the associated genes at a 
different level from tissues where the same CCI was 
unmethylateci. The results showed no obvious correlation 
between CGI methylation and expression. This, therefore, 
remains an open question that demands detailed analysis of 
specific cases. 
Genes that play an important role in development were 
prominent among the set of methylated CGIs identified by 
MAP-CGI array hybridization. Out of 109 CGI-associated 
genes that contain homeobox-like domains, 27 (-25%) were 
unniethylated in at least one tissue compared with 11% of 
all CGI-associated genes (see Table 4). Specifically, we 
identified 79 CGIs in the four human IIOX gene clusters A-
D, of which 22 were methylated in at least one of the tissues 
that we tested. Given the relatively small selection of tissues 
analysed in the study, the actual frequency of I/OX CGI 
methylation in all human tissues is likely to be higher than 
one in fur. Interestingly, methylatiori of I/OX gene CGIs is 
also reported in cancers [46], raising the possibility that 
cancer CGI methylation patterns mimic patterns that arise 
during development. A potential link between normal 
development and cancer is suggested by the finding that 
CGIs methylated in cancer preferentially include promoters 
that are marked by association with polycomb group proteins 
in embryonic stem cells [47-49]. In contrast, we found little 
difference between the fractions of all CGIs (5.9% = 845/ 
14,318) and of methylated CGIs (7.7% = 127/1,657) that were 
polycomb-associated in embryonic cells [371. The origins of 
CGI methylation in cancer may be distinct from the 
mechanisms that lead to CGI methylation in normal tissues. 
It was reported that the most CpG-rich CGIs among 512 
analysed on Chr 6, Chr 20, and Chr 22 were never methylated, 
suggesting that the CpG-richness may protect from methyl-
ation [13]. In a larger CGI set, we detected a very small, but 
statistically significant, difference in sequence properties 
between CGIs that become methylated and those that remain 
immune in the tested cell types. The mean CpG[o/e]  was 0.75 
for methylated CGIs compared with 0.77 for bulk CGIs 
(Figure 4C). Bock and colleagues [50] identified sequence 
features that were predictive for CGI methylation, including 
specific repeats, sequence patterns, and DNA structure. 
Contrary to predictions of this method, methylated CGIs 
were significantly depleted in repetitive elements and showed 
no difference in predicted base twist. We did, however, 
observe small, but statistically significant, increases in simple 
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Figure 5. Tissue, CeilType, and Individual-Specific CGI Methylation at Developmental Gene Loci 
(A-B and E-F) Bisulfite genomic sequencing confirmed tissue-specific CGI methylation associated with the developmental genes OSR1 (A) and PAX6 (B). 
Multiple CGIs (red boxes) span the HOXC (C) and PAX6 (D) gene loci. Plots of the MAP-CGI array profiles for blood, brain, muscle, and spleen identify 
tissue-specific CGI methylation (vertical black bars extending above M = 1.5). Gray bars extending downwards below Al = 1.5 (broken blue line) 
represent nonmethylated CGIs. The region of PAX6 analysed by bisulfite genomic sequencing (see Figure SB) is indicated (asterisk in panel D). Tick 
marks on the y-axis are spaced at intervals of 1 M value unit. Coding sequences are diagrammed as yellow bars. 
Individual-specific CGI methylation internal to the HOXC cluster in muscle DNA. 
Cell type-specific methylation is seen at the SFC3IB promoter CGI in monocytes and granulocytes derived from whole human blood. Bisulfite 
genomic sequencing results (A-B and E-F) are diagrammed as in Figure 3G. 
doi:1 0.1371 /journal.pbio.0060022.g005 
sequence elements (TG1G/CACA) and base-stacking energy 
(see Figure S2). The biological relevance of these minimal 
differences is uncertain. 
Weber and coworkers [14] identified —2,000 promoters out 
of 16,000 that were more susceptible to methylation than CGIs 
themselves. These so-called 'weak CpG islands" had an average 
CpG[o/e] ratio intermediate between CGIs and hulk genomic 
DNA. We have determined that 75% of weak CpG islands 
reported by Weber et al. are absent from the CGI library. Weak 
CGIs may be depleted because they are heavily methylated and 
therefore not enriched by CAP. Indeed, 22 methvlated weak 
CpG islands [14] were not detected in our library. Alter-
natively, their relatively low CpG density and somewhat 
elevated frequency of Msel sites may result in too few CpGs 
per fragment for efficient retention by the CXXC matrix. 
Composite Methylation of CGIs 
Those CGIs that were methylated often showed a mixture 
of heavily methylated and nonniethylated strands by bisulfite 
analysis. There are several possible explanations for compo-
site methylation patterns. Firstly, at the highest level, it is 
possible that different individuals contributing to the DNA 
pool are polymorphic with respect to this epigenetic mark. 
We analysed specific CGIs in muscle DNA from three 
individuals and found evidence of individual variation of 
this kind. A large-scale survey would be required to 
determine the extent of inter-individual variability. A second 
possibility is that cells within the analysed tissue are 
heterogeneous with respect to CGI methylation. Each of the 
analysed tissues consists of multiple differentiated cell types 
that should be analysed separately to address this possibility. 
Analysis of three compositely methylated CGIs in blood 
showed one that was highly methylated in monocytes, but 
weakly methylated in granulocytes, indicating that cell type-
specific CGI methylation underlay heterogeneous DNA 
methylation. A third possible explanation for composite 
methylation is monoallelic methylation. A previous study of 
149 CGIs on Chr 21q detected three that were mono-
allelically methylated, indicating that this explanation also 
accounts for some cases of composite CGI methylation [12]. 
Methods 
Plasmid cloning and recombinant protein purification. Cloning of 
the His-CXXC construct from murine Mbdla was described pre-
viously [19]. The MBD construct was subeloned from pET30bhMeCP2 
[51]. A fragment of human MeCP2 corresponding to amino acids 76-
167 was PCR-amplified and ligated into the Ndel and EcoRl sites of 
pct30b (Novagen) to generate a C terminally His-tagged pet30b-
MeCP276- 167. Primers: pet30bMeCP2_76- 1 67Nde 1 CGG YFC 
ATA ACC ATA TGG crc CTG CCT CCC CCA AAC AGC GG and 
pet30bMeCP276-167EcoR1 CGG AAG TCA AAG AAT TCT CAT 
GAG TGG TGG TGG TGG TGC CGG GA. Recombinant peptides 
were purified from 10 1 of induced BL2I(DE3)pLysS (Stratagene) 
culture on Nickel Charged Fast Flow Chelating Scpharose (GE 
Healthcare). The CXXC construct was further purified by cation  
exchange using Sp-Sepharosc (GE Healthcare) cation exchange as 
presiouslv described [51]. Recombinant protein was bound to Nickel 
sepharose prior to longer term storage. 
Electrophoretic mobility shift assay (EMSA). CXXC-EMSA was 
carried out essentially as described in [19]. Briefly, binding reactions 
including 0, 250, 500, 1,000, or 2.000 ng of purified recombinant His-
CXXC were preincnbated in IX binding buffer 15 X binding buffer: 30 
mM Tris-HCI [p][18], 750 mM NaCI, 5 mM DIT, 30 mM MgCl2, 15% 
Glycerol, 50 ng/pl BSA, and 0.05 )tg/pl of poly(dAdT) (Amersham). 
End-labeled CGI 1[52] probe (1 jig) isas added to each reaction and 
incubated for a further 25 mm. Complexes between probe DNA and 
the CXXC domain were resolved on a 1.3% a--arose 'Iris-borate-
EDTA gel and imaged by Phosphor Imager (Molecular Devices). 
Human DNA samples. Whole blood was collected from voluntary 
donors and used in anonymized pools. Donors were aware of. and 
consented to, its use for preparation of DNA. Monocyte and 
granulocyte cells were prepared from whole human blood using 
Ficoll gradient centrifugation- Whole blood (3 ml) was layered onto 
an equivalent volume of ilistopaque-1077 Ficoll (Sigma-Aldri(h) and 
sedimented according to the manufacturer's Instructions. Mononn-
cleocytes were recovered from the plasma_ficoll inlerphase and 
granulocytes from the cell pellet. Whole human blood, monocyte, and 
granulocyte DNA was extracted using the Geisonsic-tip 500/c; (Qiagen 
10262) genomic DNA Purification kit. Sperm DNA was prepared as 
described [53]. Human skeletal muscle, spleen, and brain genomic 
DNA5 were purchased from Amhion. 
CXXC affinity purification. 50-60 mg of recombinant CXXC was 
dialysed into WI buffet' (50 mM sodium phosphate buffer [ph8]. 30)) 
mM NaCl, 10%. glycerol, 15 mM (3-mercaploethanol. 0.5 mM PMSF), 
bound to nickel-charged sepharosc, and then washed with 10 column 
volumes (CVs) of Wi, 10 CVs of W2 (Wi + It) mM lmadazole), and 1)) 
CVs of Wi. Beads were packed onto a 1-in] Tricorn chromatography 
cohitmn (GE l-lcalthcare). Msei digested male DNA (100 )Ig) pooled 
from three individuals was bound to the CXXC column in 90% CA 
buffer (20 mM 1-lepes [p][-Ii.O], 0.1 6Y(, Triton X-100, 10% glycerol. 0.5 
mM PMSF, 10 mM 2-Mereaptoe)hano0andl 10% CB buffer (CA+ I M 
NaCl). Equilibrated DNA was then eluted over an increasing NaCI 
gradient of 10%-I00% CB buffer (Figure 1 B). Fractions (3 ml) were 
collected and 200 p1 of each was precipitated and resuspended in 40 
p1 1 X TE buffer. Aliquots were ['CR- interrogated using Redhot taq 
DNA polymerase (Ahgene) for XIST (for CACGTGACAAAAGC-
CATG, rev GGTTAGCATGG'rGGTGGAc), NYESO (for 
CCCAGCGTCTGGTAACCATC. revCCACGGGACAGGTACCTC ), 
MAO (for CGGGTATCAGAYT'GAAACAT. rev CTCTAAGCATGGC-
TACACTACA). P48 (for cagaaggtcatcatctgCca, rev tgagttgtttttcat-
cagtcca) under the following conditions: 2 min at 94 'C; followed by 
30 cycles of 94 'C for 50 s, 	for 5)) s, 72 'C for I mm; and a final 
extension of 72 'C for 7 mm. PCR products were resolved on a 1.5% 
TAE-agarose gel (Figure IB). Fractions retaining nonmethylated 
CpG-rich Msel fragments (Figure lB) were pooled, diluted with CA 
buffer, and re-chromatographed. The relevant fractions were 
precipitated and ligated into the Ndei site of pGEM5zf- (Promega). 
CGI library sequencing. The clone set was arrayed into 384-well 
plates in glycerol for long-term storage. Copies were taken and DNA 
prepared for sequencing using a modified alkaline lysis method, Cells 
were lvsed in glucose. Tris, EDTA (pH 8) buffer plus NaOFl and SIDS 
and spun through Millipore Montage filter plates directly into 
propan_2_ol to precipitate, followed by elution in water. In all, 
172.800 clones were sequenced forward and reverse using '17 and SP6 
primers and BigDve V3.1 chemistry, under the following conditions: 
30 s at 96 'C, followed by 44 cycles of 92 'C S s, 55 'C 8 s, 60 'C 2 mm. 
Samples were separated using 3730 XL sequencers (Applied 
Biosvstems). Extraction was performed using sequence analysis v3.1, 
and base-called using Phred [54]. DNA sequences were identified 
using NCB136 and mapped using the ENSMBI. Genome Browser 
(http://www.ensembl.org/index.html). CGIs that mapped within 1.5 kb 
of annotated genes were considered to be gene-associated in order to 
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take into account mis-annotation of transcription start sites within 
poorly defined 5' UTRs. 
Microarray fabrication. Amino-linked clone insert amplicons were 
generated by vector-specific PCR in 50 mM KCI, 5 mM Tris (pH 8.5), 
and 2.5 mM MgCl,, including 1 M Betainc (10 inin at 95 °C; followed 
by 35 cycles of 95 °C for I mm. 60 °C for IS s. 72 °C for 7 olin; and a 
final extension of 92 °C for 10 mm; 5' aminolink forward primer 5' - 
CTC ACT ATA ggg CgA ATTg g -3' reverse primer 5' -CgC CAA gCT 
ATF TAg IT,  AC-3'). PCR products were ethanol-precipitated and 
resuspended in 1 X microarray spotting buffer (250 mM sodium 
phosphate [pH 8.51, 0.01% sarkosvl, 0.1% sodium azide). Arrays were 
spotted onto amine-binding slides at 20-25 °C, 40%-50% relative 
humidity. After an overnight incubation in a humid chamber, the 
slides were blocked (1% ammonium hydroxide for 5 nun, followed by 
0.1% SDS for 5 olin) and denatured (95 °C ddH2O for 2 min), rinsed 
in ddll2O, and dried by centrifugation for 5 min at 250 Xg. 
MAP, labeling, and Microarray hybridization. human tissue DNA 
pooled from three individuals was digested with Msel, phosphatase-
treated, and ligated to 5 pmol of phosphorylated catch-linkers 
(upper—OCT CCA TCC AAC CGA TCT and lower—CCA GGT AGO 
YFG GCT AGA AT phosphate) that had been annealed in lx TE for 5 
h. DNA was hound to an MBI) chromatography column and affinity-
purified essentially as described (20). Fractions containing methvlated 
CpG-rich Mse I fragments were pooled and re-chromatographecl 
before precipitation (Figure SB). Purified DNA was resuspended in 
IXTE and amplified in parallel with input DNA, using the GC Rich 
PCR system (Roche; 2 rnin at 95°C; followed by 18 cycles 01 95°C for I 
min, T"' °C for I min, 72°C for 4 min; and a final extension of 72°C 
for 7 ruin; universal primer_CC1 CCA 'FCC AAC CGA TCS....A). 
MAP and Input DNAs (200 ng) were fluorescently labeled by random 
priming using the Bioprime labeling kit (Invitrogen), I X dNTS (lOX 
dNTPS; 2mM of each dATP, dGTP, dF'J'P, 1 mM clC'TP) and 1.5 nniol 
of Cy3 or CyS-dCTI' (GE Healthcare). The labeled Input and MAP 
probes were purified (Invitrogen "Purelink"), pooled, and precipi-
tated with 100 ig of human Cot-i DNA (Invitrogen). Labeled DNA 
was resuspended in 400 tl of hybridisation buffer )2XSSC, 50% 
cleionised formamide, 10 mM Tris-i lCl [p1-17.5], 10% dextran 
sulphate, 0.1% Tween 20), denatured at 100 °C for 10 olin, snap-
chilled on ice, and incubated for 1 Ii at 37 °C. The CGI nlicroarrays 
were prehybridised with Cot-i and herring sperm DNA (Sigma) 
before being hybridised for 48 h at 37 T. Arrays were washed four 
times at 37 °C in IX phosphate buffered saline/0.05% 'l'ween 20, three 
times at 52 °C in I X saline sodium citrate, twice at RT in I X 
phosphate buffered saline/0.05% Tween 20, and finally rinsed in 
water, before being dried by centrifugation (500g). 
Microarray scanning and data analysis. Arrays were scanned with a 
GenePix Autoloader 4200A1. (Axon) and then processed using the 
GenePix Pro 6.0 (Axon) software package. All subsequent analysis was 
carried out with the LIMMA package in the R statistical environment. 
Features with poor signal-to-noise ratios were stabilised using a base 
value of 1,000 for background-subtracted intensities. Cy3 and Cy5 
signals were transformed into M values (log9[red/green]) and 
normalised by print-tip loess. Each tissue analysis is represented by 
four microarrays comprising two independent replicates with 
respective dye swaps. Processed values were averaged through linear 
modeling and used to determine the relative enrichment of MAP 
DNA relative to Input. An IVI value of >1.5 was designated as the 
threshold for hypermethylation as determined by quantitative PCR 
(Figure 3C) and bisulfite genomie sequencing (Figures 30 and 3H, 
4D-4G, and 5A and SB). This threshold was confirmed as significant 
by calculation of a t-statistic by eBayes modeling and BH multiple 
testing correction. Differential niethylation was deduced when 
features displayed an M value >1.5 in one or more tissues and a 
differential of 0.75 between tissues (upper boundary capped at M= 
2.5). To avoid complications due to X chromosome inactivation, CGIs 
on sex chromosomes were not included in the analysis. In addition, 
spots that gave no signal on the microarray (NA values) and spots 
containing DNA in which CpG[o/e] values were <0.5 were excluded. 
Quantitative PCR. Real-time PCR was carried out on MAP and 
Input material with iQ SYBR Green Supermix (Bio-Rad) on an 
iCyeler (Bio-Rad) according to manufacturers instructions. For 
primer sequences see Table S4. 
Bisulfite genomic sequencing. Bisulfite treatment of genonlic DNA 
was carried out as described by Fcil et al. [55], and prepared for 
sequencing as outlined by Suzuki et al. [56]. Genomic DNA (5 jig) was 
digested by EcoRl prior to bisulfite treatment, and precipitated after 
the desulfonation step. Samples were resuspended in I XTris-EDTA 
buffer for subsequent PCR and sequencing reactions. Bisulfite 
specific primers were designed both manually and with the aid of 
the MethPrimer software [3] (sequences are available on request). 
PCR was carried out on the bisulfite-treated DNA using RedHot 'Faq 
DNA polymerase (Abgene) under the following conditions: 2 min at 
94 °C; followed by 40 cycles of 94 °C for 50 s. T°" °C for 50 s, 72 °Cfor 
1 min; and a final extension of 72 °C for 5 olin. PCR fragments were 
cloned using the Strataclone PCR cloning system (Stratagene) and at 
least tell products amplified (as above) and sequenced (BigDvc 
Terminator N -3.1 Cycle Sequencing Kit; Applied Biosystems). Methyl-
ation status and experimental quality control was carried out with the 
aid of BiqAnalvzer [571. 
Supporting Information 
Dataset Si. (;haracierizatiomi of Human CGIs Identified as Being 
Methylated in One or 310cc Somatic tissues 
Included are sequence characteristics (OH-C and CpC;(ulc]), gene 
association (Gene ID, ENSEMBI. nomenclature ), and the methvlation 
profile in the four tissues tested (categories of mcthlation at-(-
colour-coded 
re
l ur-coded as for Figure 4B). She CpG island identifier (ID) 
corresponds to the arrayed CGI fragment. The genoniic position of 
each CCI (Location) corresponds to the chromosomal coordinates 
derived from NCBI build 36. 
Found at doi:I0.I371ljournal.pbio.0060022.sd0Ol (373 KB XLS). 
Figure Sl. Sequence Characteristics of CGIs Missed by NCBI-Strict 
NCBI-strict relies on base composition to identify CGIs, utilising 
threshold values for CpG(o/e[ and 0+0 density (0.6% and 50%, 
respectively) as determinants. Boxplots of 0-I-C and CpG[o/e] indicate 
that CGIs retained by the CXXC affinity matrix but missed by NCBI-
strict have significantly reduced 0-4: base composition (p-value < 
-- tole] and CpG ( ] (p-value < 2.2e 
is)  A nonparanletric distribu-
tion was determined using a Shapiro-Wilk test of normality and 
subsequent significance was determined using a two-sample Kolmo-
gorov-Smirnov test (NCB1-missed )i = 4,082 and all CGIs n = 13,305). 
Found at doi:10.13710ourrial.pbio.0060022.sgOOI (48 KB DOC). 
Figure S2. Sequence Properties of MethylitecI CGIs 
Bock and colleagues determined a number of DNA sequence features 
that, are correlated with DNA methylation at CGIs [50). Here we 
compare the sequence attributes of tile methylated and total CGI Sets 
with respect to DNA structure (stacking energy and base twist) and 
specific repeats (TG'FG/CACA). Methylated CGIs show small but 
significant increase in stacking energy relative to all CGIs (j)-value < 
0.001). In contrast Ave found no significant difference in the base twist 
of methylated CGIs. 
TGTG/CACA specific repeats were found to be significantly enriched 
in methylated CGIs (P-value < 0.001; see text for discussion). In 
contrast, all repetitive elements (as outlined in Rephase [581) were 
found to be marginally depleted in methvlatt'd CGIs (p-value < 0.01, 
Wilcoxon rank sum test, n = 4,082 and 10.236). Stacking energy and 
base twist were calculated using the EMBOSS b-twisted program with 
default settings[59]. All distributions were tested for parametric 
distribution by the Shapiro-Wilk test of normality. Nonparametric 
significance values were determined using the Wilcoxon rank sum 
test (it = 4,082 and 10,236). 
Found at doi; 10.1371 /journal.pbio.0060022.sgOO2 (66 KB DOC). 
Table Si. Gene Association; CpG Islands Missed by NCBI-Strict 
All CGIs (n = 4,082) retained by the CXXC affinity matrix but not 
predicted by NCBI-strict were mapped relative to protein-coding 
genes. Gene overlap indicates the spatial association of CGIs relative 
to protein-coding genes. 
Found at doi: l0.l371)journai.pbio.0060022.stOOl (27 KB DOC). 
Table S2. Methylated CGIs on Chromosome 16 and Chromosome X 
in Human Whole Blood! DNA 
CGI arrays hvbridised with MBD probe from male and female human 
blood DNA identify extensive methviation of X-linked CGIs. In 
contrast, the percentage of X-linked CGIs methylated on the single 
male X chromosome was comparable to the levels found on the 
human autosomes, as illustrated for Chrl6. 
Found at doi: I0.1371)journal.pbio.0060022.stOO2 (30 KB DOC). 
Table S3. Developmental Gene Categories Are Associated with 
Differentially Methylated CpG Islands 
Ontology terms for gene-associated CGIs were compared with those 
for differentially methylated CGI-genes. Genes involved in devel-
opmental processes such a neurogenesis and segmentation are 
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significantly enriched and include transcriptional regulators such as 
homeobox genes. Significantly enriched biological processes and 
molecular functions were determined using the Web-based Panther 
classification system (http:/Iwww.pantherdb.org/)[60].  
Found at doi:10.l37lljournal.pbio.0060022.st003 (41 KB DOC). 
Table S4. Quantitative PCR Primers for Microarray Validation 
CGI ID: CpG island identifiers which correspond to the CGI library. 
M value: Logal MBD/Input] for human blood microarray experiment. 
Found at doi:I0.1371journal.pbio.0060022.st004 (36 KB DOC). 
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